The following table shows a list of patent term extension applications filed with Japanese Patent Office from 2011 to 2015.
The list includes patent term extension application numbers, patent numbers, Drug names. The drug names were translated from Japanese to English by machine translation.
○: Application
■: Granted
| Application No. | Patent No. | Drugs |
|---|---|---|
| 2015-700376 (○) | JP5717768 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, paritaprevir, Ritonavir |
| 2015-700376 (■) | JP5717768 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, paritaprevir, Ritonavir |
| 2015-700375 (○) | JP5534533 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, paritaprevir, Ritonavir |
| 2015-700375 (■) | JP5534533 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, paritaprevir, Ritonavir |
| 2015-700374 (○) | JP5259537 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, paritaprevir, Ritonavir |
| 2015-700374 (■) | JP5259537 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, paritaprevir, Ritonavir |
| 2015-700373 (○) | JP5530514 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, paritaprevir, Ritonavir |
| 2015-700373 (■) | JP5530514 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, paritaprevir, Ritonavir |
| 2015-700372 (○) | JP5557146 | Name of sale: Mulpleta Tablet 3 mg Common name: Lusutrombopag Chemical name: (2E) -3- {2,6-dichloro-4-[(4- {3-[(1S) -1-] (Hexyloxy) ethyl] -2-methoxyphenyl} -1,3-thiazol-2-yl) carbamoyl] phenyl} -2-methyl-2-propenoic acid |
| 2015-700372 (■) | JP5557146 | Name of sale: Mulpleta Tablet 3 mg Common name: Lusutrombopag Chemical name: (2E) -3- {2,6-dichloro-4-[(4- {3-[(1S) -1-] (Hexyloxy) ethyl] -2-methoxyphenyl} -1,3-thiazol-2-yl) carbamoyl] phenyl} -2-methyl-2-propenoic acid |
| 2015-700371 (○) | JP5164181 | Name of sale: Mulpleta Tablet 3 mg Common name: Lusutrombopag Chemical name: (2E) -3- {2,6-dichloro-4-[(4- {3-[(1S) -1-] (Hexyloxy) ethyl] -2-methoxyphenyl} -1,3-thiazol-2-yl) carbamoyl] phenyl} -2-methyl-2-propenoic acid |
| 2015-700371 (■) | JP5164181 | Name of sale: Mulpleta Tablet 3 mg Common name: Lusutrombopag Chemical name: (2E) -3- {2,6-dichloro-4-[(4- {3-[(1S) -1-] (Hexyloxy) ethyl] -2-methoxyphenyl} -1,3-thiazol-2-yl) carbamoyl] phenyl} -2-methyl-2-propenoic acid |
| 2015-700370 (○) | JP4136371 | Name of sale: Mulpleta Tablet 3 mg Common name: Lusutrombopag Chemical name: (2E) -3- {2,6-dichloro-4-[(4- {3-[(1S) -1-] (Hexyloxy) ethyl] -2-methoxyphenyl} -1,3-thiazol-2-yl) carbamoyl] phenyl} -2-methyl-2-propenoic acid |
| 2015-700370 (■) | JP4136371 | Name of sale: Mulpleta Tablet 3 mg Common name: Lusutrombopag Chemical name: (2E) -3- {2,6-dichloro-4-[(4- {3-[(1S) -1-] (Hexyloxy) ethyl] -2-methoxyphenyl} -1,3-thiazol-2-yl) carbamoyl] phenyl} -2-methyl-2-propenoic acid |
| 2015-700369 (○) | JP4106066 | Name of sale: Mulpleta Tablet 3 mg Common name: Lusutrombopag Chemical name: (2E) -3- {2,6-dichloro-4-[(4- {3-[(1S) -1-] (Hexyloxy) ethyl] -2-methoxyphenyl} -1,3-thiazol-2-yl) carbamoyl] phenyl} -2-methyl-2-propenoic acid |
| 2015-700369 (■) | JP4106066 | Name of sale: Mulpleta Tablet 3 mg Common name: Lusutrombopag Chemical name: (2E) -3- {2,6-dichloro-4-[(4- {3-[(1S) -1-] (Hexyloxy) ethyl] -2-methoxyphenyl} -1,3-thiazol-2-yl) carbamoyl] phenyl} -2-methyl-2-propenoic acid |
| 2015-700368 (○) | JP5442924 | An extract of the house dust mites mite and an extract of the house mite mites mite |
| 2015-700368 (■) | JP5442924 | Extracts of the diamondback mite mites and turnips of the house dust mites mite |
| 2015-700367 (○) | JP5081158 | Spiolto Respimat 60 Inhalation (active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700367 (■) | JP5081158 | Spiolto Respimat 60 Inhaled (active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700366 (○) | JP5081158 | Spiolto Respimat 28 Inhaled (Active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700366 (■) | JP5081158 | Spiolto Respimat 28 Inhaled (active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700365 (○) | JP5015896 | Spiolto Respimat 60 Inhalation (active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700364 (○) | JP5015896 | Spiolto Respimat 28 Inhaled (Active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700363 (○) | JP4659160 | Spiolto Respimat 60 Inhalation (active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700363 (■) | JP4659160 | Spiolto Respimat 60 Inhaled (active ingredient tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700362 (○) | JP4659160 | Spiolto Respimat 28 Inhaled (Active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700362 (■) | JP4659160 | Spiolto Respimat 28 Inhaled (active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700361 (○) | JP4344135 | Spiolto Respimat 60 Inhalation (active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700361 (■) | JP4344135 | Spiolto Respimat 60 Inhaled (active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700360 (○) | JP4344135 | Spiolto Respimat 28 Inhaled (Active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700360 (■) | JP4344135 | Spiolto Respimat 28 Inhaled (active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700359 (○) | JP4317138 | Spiolto Respimat 60 Inhalation (Active ingredient: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700359 (■) | JP4317138 | Spiolto Respimat 60 Inhaled (active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700358 (○) | JP4317138 | Spiolto Respimat 28 Inhalation (Active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700358 (■) | JP4317138 | Spiolto Respimat 28 Inhaled (active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700357 (○) | JP3488717 | Spiolto Respimat 60 Inhalation (active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700357 (■) | JP3488717 | Spiolto Respimat 60 Inhaled (active ingredient tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700356 (○) | JP3488717 | Spiolto Respimat 28 Inhaled (Active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700356 (■) | JP3488717 | Spiolto Respimat 28 Inhaled (active ingredients: tiotropium bromide hydrate and olodaterol hydrochloride) |
| 2015-700355 (○) | JP4672647 | Name of Sale: EquMet Combination Tablet HD Active Ingredient: Vildagliptin and Metformin Hydrochloride |
| 2015-700355 (■) | JP4672647 | Name of Sale: EquMet Combination Tablet HD Active Ingredient: Vildagliptin and Metformin Hydrochloride |
| 2015-700354 (○) | JP4672647 | Name of sale: EquMet combination tablet LD Active ingredient: vildagliptin and metformin hydrochloride |
| 2015-700354 (■) | JP4672647 | Name of sale: EquMet combination tablet LD Active ingredient: vildagliptin and metformin hydrochloride |
| 2015-700353 (○) | JP5415762 | Name of Sale: EquMet Combination Tablet HD Active Ingredient: Vildagliptin and Metformin Hydrochloride |
| 2015-700353 (■) | JP5415762 | Name of Sale: EquMet Combination Tablet HD Active Ingredient: Vildagliptin and Metformin Hydrochloride |
| 2015-700352 (○) | JP5415762 | Name of sale: EquMet combination tablet LD Active ingredient: vildagliptin and metformin hydrochloride |
| 2015-700352 (■) | JP5415762 | Name of sale: EquMet combination tablet LD Active ingredient: vildagliptin and metformin hydrochloride |
| 2015-700351 (○) | JP3681110 | Name of Sale: EquMet Combination Tablet HD Active Ingredient: Vildagliptin and Metformin Hydrochloride |
| 2015-700351 (■) | JP3681110 | Name of Sale: EquMet Combination Tablet HD Active Ingredient: Vildagliptin and Metformin Hydrochloride |
| 2015-700350 (○) | JP3681110 | Name of sale: EquMet combination tablet LD Active ingredient: vildagliptin and metformin hydrochloride |
| 2015-700350 (■) | JP3681110 | Name of sale: EquMet combination tablet LD Active ingredient: vildagliptin and metformin hydrochloride |
| 2015-700349 (○) | JP5710430 | Name of sale: JAKAVI Tablets 5mg Active ingredient: Ruxolitinib phosphate |
| 2015-700349 (■) | JP5710430 | Name of sale: JAKAVI tablet 5mg Active ingredient: Ruxolitinib phosphate |
| 2015-700348 (○) | JP5475653 | Name of sale: JAKAVI Tablets 5mg Active ingredient: Ruxolitinib phosphate |
| 2015-700348 (■) | JP5475653 | Name of sale: JAKAVI tablet 5mg Active ingredient: Ruxolitinib phosphate |
| 2015-700347 (○) | JP5017278 | Name of sale: JAKAVI Tablets 5mg Active ingredient: Ruxolitinib phosphate |
| 2015-700347 (■) | JP5017278 | Name of sale: JAKAVI tablet 5mg Active ingredient: Ruxolitinib phosphate |
| 2015-700346 (○) | JP5654546 | Name (trade name) Capulersa Tablet 100mg Active Ingredient Name: Bandetanibe |
| 2015-700346 (■) | JP5654546 | Name (trade name) Capulersa Tablet 100mg Active Ingredient Name: Bandetanibe |
| 2015-700345 (○) | JP4740947 | Name (trade name) Capulersa Tablet 100mg Active Ingredient Name: Bandetanibe |
| 2015-700345 (■) | JP4740947 | Name (trade name) Capulersa Tablet 100mg Active Ingredient Name: Bandetanibe |
| 2015-700344 (○) | JP3522727 | Name (trade name) Capulersa Tablet 100mg Active Ingredient Name: Bandetanibe |
| 2015-700344 (■) | JP3522727 | Name (trade name) Capulersa Tablet 100mg Active Ingredient Name: Bandetanibe |
| 2015-700343 (○) | JP3438818 | Name (trade name) Capulersa Tablet 100mg Active Ingredient Name: Bandetanibe |
| 2015-700343 (■) | JP3438818 | Name (trade name) Capulersa Tablet 100mg Active Ingredient Name: Bandetanibe |
| 2015-700342 (○) | JP5258844 | Name of sale: Leuplin PRO Injection Kit 22.5mg Active Ingredient: Leuprorelin acetate |
| 2015-700342 (■) | JP5258844 | Name of sale: Leuplin PRO Injection Kit 22.5mg Active Ingredient: Leuprorelin acetate |
| 2015-700341 (○) | JP4564098 | Name of sale: Leuplin PRO Injection Kit 22.5mg Active Ingredient: Leuprorelin acetate |
| 2015-700341 (■) | JP4564098 | Name of sale: Leuplin PRO Injection Kit 22.5mg Active Ingredient: Leuprorelin acetate |
| 2015-700340 (○) | JP5191544 | Name of sale: MESACUP anti-MDA5 test Common name: anti-MDA5 antibody kit (84079000) Component involved in reaction system: MDA5 protein (MDA5 sensitized micro cup) Peroxidase-labeled anti-human IgG polyclonal antibody ( Goat) (enzyme-labeled antibody) 3,3 ', 5,5'-tetramethylbenzidine and hydrogen peroxide (enzyme substrate solution) |
| 2015-700340 (■) | JP5191544 | Sales name: MESACUP anti-MDA5 test Common name: anti-MDA5 antibody kit (84079000) Ingredient involved in reaction system: MDA5 protein (MDA5 sensitized micro cup) peroxidase labeled Anti-Human IgG Polyclonal Antibody (Goat) (Enzyme Labeled Antibody) 3,3 ', 5,5'-Tetramethylbenzidine and Hydrogen Peroxide (Enzyme Substrate Solution) |
| 2015-700339 (○) | JP4268163 | Yondelis Intravenous Injection 0.25 mg |
| 2015-700339 (■) | JP4268163 | Yondelis Intravenous Injection 0.25 mg |
| 2015-700338 (○) | JP4268163 | Yondelis Intravenous Injection 1 mg |
| 2015-700338 (■) | JP4268163 | Yondelis Intravenous Injection 1 mg |
| 2015-700337 (○) | JP5311742 | Active ingredient: River Loxaban Product name: Xazaret fine particle package 10 mg |
| 2015-700337 (■) | JP5311742 | Active ingredient: River Loxaban Product name: Xazaret fine particle package 10 mg |
| 2015-700336 (○) | JP5311742 | Active ingredient: River Loxaban Product name: Xazaret fine-grained sachets 15 mg |
| 2015-700336 (■) | JP5311742 | Active ingredient: River Loxaban Product name: Xazaret fine-grained sachets 15 mg |
| 2015-700335 (○) | JP5311742 | Active ingredient: River Loxaban Sales name: Xazarelt tablet 10 mg |
| 2015-700335 (■) | JP5311742 | Active ingredient: River Loxaban Sales name: Xazarelt tablet 10 mg |
| 2015-700334 (○) | JP5311742 | Active Ingredients: River Loxaban Name: Xazaret Tablets 15 mg |
| 2015-700334 (■) | JP5311742 | Active Ingredients: River Loxaban Name: Xazaret Tablets 15 mg |
| 2015-700333 (○) | JP4852423 | Active ingredient: River Loxaban Product name: Xazaret fine particle package 10 mg |
| 2015-700333 (■) | JP4852423 | Active ingredient: River Loxaban Product name: Xazaret fine particle package 10 mg |
| 2015-700332 (○) | JP4852423 | Active ingredient: River Loxaban Product name: Xazaret fine-grained sachets 15 mg |
| 2015-700332 (■) | JP4852423 | Active ingredient: River Loxaban Product name: Xazaret fine-grained sachets 15 mg |
| 2015-700331 (○) | JP4852423 | Active ingredient: River Loxaban Sales name: Xazarelt tablet 10 mg |
| 2015-700331 (■) | JP4852423 | Active ingredient: River Loxaban Sales name: Xazarelt tablet 10 mg |
| 2015-700330 (○) | JP4852423 | Active Ingredients: River Loxaban Name: Xazaret Tablets 15 mg |
| 2015-700330 (■) | JP4852423 | Active Ingredients: River Loxaban Name: Xazaret Tablets 15 mg |
| 2015-700329 (○) | JP4143297 | Active ingredient: River Loxaban Product name: Xazaret fine particle package 10 mg |
| 2015-700329 (■) | JP4143297 | Active ingredient: River Loxaban Product name: Xazaret fine particle package 10 mg |
| 2015-700328 (○) | JP4143297 | Active ingredient: River Loxaban Product name: Xazaret fine-grained sachets 15 mg |
| 2015-700328 (■) | JP4143297 | Active ingredient: River Loxaban Product name: Xazaret fine-grained sachets 15 mg |
| 2015-700327 (○) | JP4143297 | Active ingredient: River Loxaban Sales name: Xazarelt tablet 10 mg |
| 2015-700327 (■) | JP4143297 | Active ingredient: River Loxaban Sales name: Xazarelt tablet 10 mg |
| 2015-700326 (○) | JP4143297 | Active Ingredients: River Loxaban Name: Xazaret Tablets 15 mg |
| 2015-700326 (■) | JP4143297 | Active Ingredients: River Loxaban Name: Xazaret Tablets 15 mg |
| 2015-700325 (○) | JP4740452 | (I) General name: human (homologous) bone marrow-derived mesenchymal stem cells (ii) Sales name: Temcel Maru RHS injection |
| 2015-700325 (■) | JP4740452 | (I) General name: human (homologous) bone marrow-derived mesenchymal stem cells (ii) Sales name: Temucel RHS injection |
| 2015-700324 (○) | JP4441115 | (I) General name: human (homologous) bone marrow-derived mesenchymal stem cells (ii) Sales name: Temcel Maru RHS injection |
| 2015-700323 (○) | JP5568137 | Type of pesticide: Tolprocarb granules Name of pesticide: Sanbrass granules |
| 2015-700323 (■) | JP5568137 | Type of pesticide: Tolprocarb granules Name of pesticide: Sanbrass granules |
| 2015-700322 (○) | JP4854825 | Common Name: Omari Gliptin Tablet Name: Marizeb Tablet 25 mg Active Ingredient: Omari Gliptin |
| 2015-700322 (■) | JP4854825 | Common Name: Omari Gliptin Tablet Name: Marizeb Tablet 25 mg Active Ingredient: Omari Gliptin |
| 2015-700321 (○) | JP4854825 | Common Name: Omari Gliptin Tablet Name: Marizeb Tablet 12.5 mg Active Ingredient: Omari Gliptin |
| 2015-700321 (■) | JP4854825 | Common Name: Omari Gliptin Tablet Name: Marizeb Tablet 12.5 mg Active Ingredient: Omari Gliptin |
| 2015-700320 (○) | JP4627496 | Type of pesticide: Tolprocarb granules Name of pesticide: Sanbrass granules |
| 2015-700320 (■) | JP4627496 | Type of pesticide: Tolprocarb granules Name of pesticide: Sanbrass granules |
| 2015-700319 (○) | JP5802298 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700319 (■) | JP5802298 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700318 (○) | JP5657674 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700318 (■) | JP5657674 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700317 (○) | JP5730433 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700317 (■) | JP5730433 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700316 (○) | JP5634646 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700316 (■) | JP5634646 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700315 (○) | JP5727665 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700315 (■) | JP5727665 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700314 (○) | JP5667357 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700314 (■) | JP5667357 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constituting cells or transgene: Human autologous skeletal myoblasts |
| 2015-700313 (○) | JP5770921 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700313 (■) | JP5770921 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700312 (○) | JP5677559 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700312 (■) | JP5677559 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constituting cells or transgene: Human autologous skeletal myoblasts |
| 2015-700311 (○) | JP5436905 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700311 (■) | JP5436905 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700310 (○) | JP5763829 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700310 (■) | JP5763829 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700309 (○) | JP5667680 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700309 (■) | JP5667680 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700308 (○) | JP5378743 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700308 (■) | JP5378743 | General name: Human (self) skeletal muscle cell sheet Name of sale: Heart sheet Constitutive cells or transgene: human autologous skeletal myoblast |
| 2015-700307 (○) | JP5466164 | Common Name: Scuroxy Oxyhydroxide Name: Petruchuable Tablet 500 mg |
| 2015-700307 (■) | JP5466164 | Common Name: Scuroxy Oxyhydroxide Name: Petruchuable Tablet 500 mg |
| 2015-700306 (○) | JP3665345 | Common Name: Scuroxy Oxyhydroxide Name: Petruchuable Tablet 500 mg |
| 2015-700306 (■) | JP3665345 | Common Name: Scuroxy Oxyhydroxide Name: Petruchuable Tablet 500 mg |
| 2015-700305 (○) | JP3665345 | Common Name: Scuroxy Oxyhydroxide Name: Petruchuable Tablet 250 mg |
| 2015-700305 (■) | JP3665345 | Common Name: Scuroxy Oxyhydroxide Name: Petruchuable Tablet 250 mg |
| 2015-700304 (○) | JP5394932 | General name: Human (homologous) bone marrow-derived mesenchymal stem cells Sales name: TEMCEL HS injection |
| 2015-700304 (■) | JP5394932 | General name: Human (homologous) bone marrow-derived mesenchymal stem cells Sales name: TEMCEL HS injection |
| 2015-700303 (○) | JP4971068 | Name (product name) Apokil Tablet 16 Active Ingredient Name: Okrasinib Maleate |
| 2015-700303 (■) | JP4971068 | Name (trade name) Apokil Tablet 16 Active Ingredient Name: Okrasinib Maleate |
| 2015-700302 (○) | JP4971068 | Name (trade name) Apokil Tablet 5.4 Active Ingredient Name: Okrasinib Maleate |
| 2015-700302 (■) | JP4971068 | Name (brand name) Apokiru tablet 5.4 Active ingredient name: Okrasinib maleate |
| 2015-700301 (○) | JP4971068 | Name (trade name) Apokil Tablet 3.6 Active Ingredient Name: Okrasinib Maleate |
| 2015-700301 (■) | JP4971068 | Name (trade name) Apokil Tablet 3.6 Active Ingredient Name: Okrasinib Maleate |
| 2015-700300 (○) | JP4884570 | Name (product name) Apokil Tablet 16 Active Ingredient Name: Okrasinib Maleate |
| 2015-700300 (■) | JP4884570 | Name (product name) Apokil Tablet 16 Active Ingredient Name: Okrasinib Maleate |
| 2015-700299 (○) | JP4884570 | Name (trade name) Apokil Tablet 5.4 Active Ingredient Name: Okrasinib Maleate |
| 2015-700299 (■) | JP4884570 | Name (trade name) Apokil Tablet 5.4 Active Ingredient Name: Okrasinib Maleate |
| 2015-700298 (○) | JP4884570 | Name (trade name) Apokil Tablet 3.6 Active Ingredient Name: Okrasinib Maleate |
| 2015-700298 (■) | JP4884570 | Name (trade name) Apokil Tablet 3.6 Active Ingredient Name: Okrasinib Maleate |
| 2015-700297 (○) | JP5006987 | Name of sale: AleSensa Capsule 150mg Active Ingredient: Alectinib hydrochloride |
| 2015-700297 (■) | JP5006987 | Name of sale: AleSensa Capsule 150mg Active Ingredient: Alectinib hydrochloride |
| 2015-700296 (○) | JP4918630 | Name of sale: AleSensa Capsule 150mg Active Ingredient: Alectinib hydrochloride |
| 2015-700296 (■) | JP4918630 | Name of sale: AleSensa Capsule 150mg Active Ingredient: Alectinib hydrochloride |
| 2015-700295 (○) | JP4588121 | Name of sale: AleSensa Capsule 150mg Active Ingredient: Alectinib hydrochloride |
| 2015-700295 (■) | JP4588121 | Name of sale: AleSensa Capsule 150mg Active Ingredient: Alectinib hydrochloride |
| 2015-700294 (○) | JP5488778 | Types of pesticides: Dimethamethrin, Dimron, tefuryl trione, metazosulfuron granules Name of pesticides: Lebras 1 kg granules Types of active ingredients: 1- {3-Chloro-1-methyl-4-[( 5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2015-700294 (■) | JP5488778 | Types of pesticides: Dimethamethrin, Dimron, tefuryl trione, metazosulfuron granules Name of pesticides: Lebras 1 kg granules Types of active ingredients: 1- {3-Chloro-1-methyl-4-[( 5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2015-700293 (○) | JP5488778 | Types of pesticides: Dimron, pyraclonyl, benzobicyclon, metazosulfuron granules Name of pesticides: Geppard 1 kg granules Types of active ingredients: 1- {3-chloro-1-methyl-4-[( 5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2015-700293 (■) | JP5488778 | Types of pesticides: Dimron, pyraclonyl, benzobicyclon, metazosulfuron granules Name of pesticides: Geppard 1 kg granules Types of active ingredients: 1- {3-chloro-1-methyl-4-[( 5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2015-700292 (○) | JP5363307 | Name: Effient Tablets 2.5 mg Active Ingredient: Prasugrel Hydrochloride |
| 2015-700292 (■) | JP5363307 | Name: Effient Tablets 2.5 mg Active Ingredient: Prasugrel Hydrochloride |
| 2015-700291 (○) | JP5274261 | Name: Effient Tablets 2.5 mg Active Ingredient: Prasugrel Hydrochloride |
| 2015-700291 (■) | JP5274261 | Name: Effient Tablets 2.5 mg Active Ingredient: Prasugrel Hydrochloride |
| 2015-700290 (○) | JP5289975 | Name: Effient Tablets 2.5 mg Active Ingredient: Prasugrel Hydrochloride |
| 2015-700290 (■) | JP5289975 | Name: Effient Tablets 2.5 mg Active Ingredient: Prasugrel Hydrochloride |
| 2015-700289 (○) | JP4029974 | Name: Effient Tablets 2.5 mg Active Ingredient: Prasugrel Hydrochloride |
| 2015-700289 (■) | JP4029974 | Name: Effient Tablets 2.5 mg Active Ingredient: Prasugrel Hydrochloride |
| 2015-700288 (○) | JP4874482 | Name: Effient Tablets 2.5 mg Active Ingredient: Prasugrel Hydrochloride |
| 2015-700288 (■) | JP4874482 | Name: Effient Tablets 2.5 mg Active Ingredient: Prasugrel Hydrochloride |
| 2015-700287 (○) | JP4001199 | Name: Effient Tablets 2.5 mg Active Ingredient: Prasugrel Hydrochloride |
| 2015-700287 (■) | JP4001199 | Name: Effient Tablets 2.5 mg Active Ingredient: Prasugrel Hydrochloride |
| 2015-700286 (○) | JP5242413 | Name (trade name) Nexgard Spectra 180 Active ingredient name: Afoxoranel, Milbemycin oxime |
| 2015-700286 (■) | JP5242413 | Name (trade name) Nexgard Spectra 180 Active ingredient name: Afoxolanel, Milbemycin oxime |
| 2015-700285 (○) | JP5242413 | Name (trade name) Nexgard Spectra 90 Active ingredient name: afoxolanel, milbemycin oxime |
| 2015-700285 (■) | JP5242413 | Name (trade name) Nexgard Spectra 90 Active ingredient name: afoxolanel, milbemycin oxime |
| 2015-700284 (○) | JP5242413 | Name (trade name) Nexgard Spectra 45 Active ingredient name: Afoxoranel, Milbemycin oxime |
| 2015-700284 (■) | JP5242413 | Name (trade name) Nexgard Spectra 45 Active ingredient name: Afoxolanel, Milbemycin oxime |
| 2015-700283 (○) | JP5242413 | Name (trade name) Nexgard Spectra 22.5 Active ingredient name: afoxoranel, milbemycin oxime |
| 2015-700283 (■) | JP5242413 | Name (trade name) Nexgard Spectra 22.5 Active ingredient name: afoxoranel, milbemycin oxime |
| 2015-700282 (○) | JP5242413 | Name (trade name) Nexgard Spectrum 11.3 Active ingredient name: Afoxoranel, Milbemycin oxime |
| 2015-700282 (■) | JP5242413 | Name (trade name) Nexgard Spectra 11.3 Active ingredient name: Afoxoranel, Milbemycin oxime |
| 2015-700281 (○) | JP3346766 | Name of sale: Zeviax Lotion 2% Active Ingredient: Ozenoxacin |
| 2015-700281 (■) | JP3346766 | Name of sale: Zeviax Lotion 2% Active Ingredient: Ozenoxacin |
| 2015-700280 (○) | JP4753864 | Mesalazine (brand name: Pentasa Granules 94%) |
| 2015-700280 (■) | JP4753864 | Mesalazine (brand name: Pentasa Granules 94%) |
| 2015-700279 (○) | JP5620977 | Common Name: Montelukast Sodium Tablet Orally Disintegrating Tablet Name: Shingrea OD Tablet 10 mg Active Ingredient: Montelukast Sodium |
| 2015-700279 (■) | JP5620977 | Common Name: Montelukast Sodium Tablet Orally Disintegrating Tablet Name: Shingrea OD Tablet 10 mg Active Ingredient: Montelukast Sodium |
| 2015-700278 (○) | JP5620976 | Common Name: Montelukast Sodium Tablet Orally Disintegrating Tablet Name: Shingrea OD Tablet 10 mg Active Ingredient: Montelukast Sodium |
| 2015-700278 (■) | JP5620976 | Common Name: Montelukast Sodium Tablet Orally Disintegrating Tablet Name: Shingrea OD Tablet 10 mg Active Ingredient: Montelukast Sodium |
| 2015-700277 (○) | JP5688799 | Name of Sales: Olmetec OD Tablet 40 mg Active Ingredient: Olmesartan Medoxomil |
| 2015-700277 (■) | JP5688799 | Name of Sales: Olmetec OD Tablet 40 mg Active Ingredient: Olmesartan Medoxomil |
| 2015-700276 (○) | JP5688799 | Name of Sale: Olmetec OD Tablet 20 mg Active Ingredient: Olmesartan Medoxomil |
| 2015-700276 (■) | JP5688799 | Name of Sale: Olmetec OD Tablet 20 mg Active Ingredient: Olmesartan Medoxomil |
| 2015-700275 (○) | JP5688799 | Name of Sale: Olmetec OD Tablet 10mg Active Ingredient: Olmesartan Medoxomil |
| 2015-700275 (■) | JP5688799 | Name of Sale: Olmetec OD Tablet 10mg Active Ingredient: Olmesartan Medoxomil |
| 2015-700274 (○) | JP4393552 | Name of sale: Zeviax Lotion 2% Active Ingredient: Ozenoxacin |
| 2015-700274 (■) | JP4393552 | Name of sale: Zeviax Lotion 2% Active Ingredient: Ozenoxacin |
| 2015-700273 (○) | JP4117883 | Name (trade name) Torokishil Chewable 95 Active Ingredient Name: Mabacoxib |
| 2015-700273 (■) | JP4117883 | Name (trade name) Torokishil Chewable 95 Active Ingredient Name: Mabacoxib |
| 2015-700272 (○) | JP4117883 | Name (trade name) Toro Kokishiru Chewable 75 Active Ingredient Name: Mabacoxib |
| 2015-700272 (■) | JP4117883 | Name (trade name) Toro Kokishiru Chewable 75 Active Ingredient Name: Mabacoxib |
| 2015-700271 (○) | JP4117883 | Name (trade name) Torokishil Chewable 30 Active Ingredient Name: Mabacoxib |
| 2015-700271 (■) | JP4117883 | Name (trade name) Torokishil Chewable 30 Active Ingredient Name: Mabacoxib |
| 2015-700270 (○) | JP4117883 | Name (trade name) Torokishil Chewable 20 Active Ingredient Name: Mabacoxib |
| 2015-700270 (■) | JP4117883 | Name (trade name) Torokishil Chewable 20 Active Ingredient Name: Mabacoxib |
| 2015-700269 (○) | JP4117883 | Name (trade name) Torokishil Chewable 6 Active Ingredient Name: Mabacoxib |
| 2015-700269 (■) | JP4117883 | Name (trade name) Torokishil Chewable 6 Active Ingredient Name: Mabacoxib |
| 2015-700268 (○) | JP4477701 | Name of Sale: Yavoy Intravenous Drip Solution 50mg Active Ingredient: Common Name: Ipilimumab (genetically modified) |
| 2015-700268 (■) | JP4477701 | Name of Sale: Yavoy Intravenous Drip Solution 50mg Active Ingredient: General Name: Ipilimumab (genetically modified) |
| 2015-700267 (○) | JP4093757 | Name of Sale: Yavoy Intravenous Drip Solution 50mg Active Ingredient: General Name: Ipilimumab (genetically modified) |
| 2015-700267 (■) | JP4093757 | Name of Sale: Yavoy Intravenous Drip Solution 50mg Active Ingredient Common Name: Ipilimumab (genetically modified) |
| 2015-700266 (○) | JP5599158 | Name of Sale: Yavoy Intravenous Drip Solution 50mg Active Ingredient: General Name: Ipilimumab (genetically modified) |
| 2015-700266 (■) | JP5599158 | Name of Sale: Yavoy Intravenous Drip Solution 50mg Active Ingredient Common Name: Ipilimumab (genetically modified) |
| 2015-700265 (○) | JP4772905 | Acoran for intravenous injection 600 antithrombin gamma (genetically modified) |
| 2015-700265 (■) | JP4772905 | Acoran for intravenous injection 600 antithrombin gamma (genetically modified) |
| 2015-700264 (○) | JP4850922 | Acoran for intravenous injection 600 antithrombin gamma (genetically modified) |
| 2015-700264 (■) | JP4850922 | Acoran for intravenous injection 600 antithrombin gamma (genetically modified) |
| 2015-700263 (○) | JP4263191 | Acoran for intravenous injection 600 antithrombin gamma (genetically modified) |
| 2015-700263 (■) | JP4263191 | Acoran for intravenous injection 600 antithrombin gamma (genetically modified) |
| 2015-700262 (○) | JP5268982 | Name of sale: Oracene liquid 1.5% applicator for disinfection 25mL Active ingredient: Oranexidine Gluconate |
| 2015-700262 (■) | JP5268982 | Name of sale: Oracene liquid 1.5% applicator for disinfection 25mL Active ingredient: Oranexidine Gluconate |
| 2015-700261 (○) | JP5268982 | Name of sale: Oracene liquid 1.5% applicator for disinfection 10 mL Active ingredient: Oranexidine Gluconate |
| 2015-700261 (■) | JP5268982 | Name of sale: Oracene liquid 1.5% applicator for disinfection 10 mL Active ingredient: Oranexidine Gluconate |
| 2015-700260 (○) | JP5268982 | Name of sale: Oracene Disinfectant 1.5% Active Ingredient: Oranexidine Gluconate |
| 2015-700260 (■) | JP5268982 | Name of sale: Oracene Disinfectant 1.5% Active Ingredient: Oranexidine Gluconate |
| 2015-700259 (○) | JP4526300 | Name of sale: Oracene liquid 1.5% applicator for disinfection 25mL Active ingredient: Oranexidine Gluconate |
| 2015-700259 (■) | JP4526300 | Name of sale: Oracene liquid 1.5% applicator for disinfection 25mL Active ingredient: Oranexidine Gluconate |
| 2015-700258 (○) | JP4526300 | Name of sale: Oracene liquid 1.5% applicator for disinfection 10 mL Active ingredient: Oranexidine Gluconate |
| 2015-700258 (■) | JP4526300 | Name of sale: Oracene liquid 1.5% applicator for disinfection 10 mL Active ingredient: Oranexidine Gluconate |
| 2015-700257 (○) | JP4526300 | Name of sale: Oracene Disinfectant 1.5% Active Ingredient: Oranexidine Gluconate |
| 2015-700257 (■) | JP4526300 | Name of sale: Oracene Disinfectant 1.5% Active Ingredient: Oranexidine Gluconate |
| 2015-700256 (○) | JP4629047 | Name of sale: Trullicity subcutaneous injection 0.75 mg Ateos Active ingredient: Duraglutide (genetically modified) |
| 2015-700256 (■) | JP4629047 | Name of sale: Trullicity subcutaneous injection 0.75 mg Ateos Active ingredient: Duraglutide (genetically modified) |
| 2015-700255 (○) | JP5732603 | Strendic subcutaneous injection 80 mg / 0.8 mL (Common name: Asphotase alpha (genetically modified)) |
| 2015-700255 (■) | JP5732603 | Strendic subcutaneous injection 80 mg / 0.8 mL (General name: Asphotase alpha (genetically modified)) |
| 2015-700254 (○) | JP5732603 | Strendic subcutaneous injection 40 mg / 1 mL (General name: asphotase alpha (genetically modified)) |
| 2015-700254 (■) | JP5732603 | Strendic subcutaneous injection 40 mg / 1 mL (common name: asphotase alpha (genetically modified)) |
| 2015-700253 (○) | JP5732603 | Strendic subcutaneous injection 28 mg / 0.7 mL (General name: asphotase alpha (genetically modified)) |
| 2015-700253 (■) | JP5732603 | Strendic subcutaneous injection 28 mg / 0.7 mL (General name: Asphotase alpha (genetically modified)) |
| 2015-700252 (○) | JP5732603 | Strendic subcutaneous injection 18 mg / 0.45 mL (General name: asphotase alpha (genetically modified)) |
| 2015-700252 (■) | JP5732603 | Strendic subcutaneous injection 18 mg / 0.45 mL (Common name: Asphotase alpha (genetically modified)) |
| 2015-700251 (○) | JP5732603 | Strendic subcutaneous injection 12 mg / 0.3 mL (common name: asphotase alpha (genetically modified)) |
| 2015-700251 (■) | JP5732603 | Strendic subcutaneous injection 12 mg / 0.3 mL (General name: Asphotase alpha (genetically modified)) |
| 2015-700250 (○) | JP4874954 | Strendic subcutaneous injection 80 mg / 0.8 mL (Common name: Asphotase alpha (genetically modified)) |
| 2015-700250 (■) | JP4874954 | Strendic subcutaneous injection 80 mg / 0.8 mL (General name: Asphotase alpha (genetically modified)) |
| 2015-700249 (○) | JP4874954 | Strendic subcutaneous injection 40 mg / 1 mL (General name: asphotase alpha (genetically modified)) |
| 2015-700249 (■) | JP4874954 | Strendic subcutaneous injection 40 mg / 1 mL (common name: asphotase alpha (genetically modified)) |
| 2015-700248 (○) | JP4874954 | Strendic subcutaneous injection 28 mg / 0.7 mL (General name: asphotase alpha (genetically modified)) |
| 2015-700248 (■) | JP4874954 | Strendic subcutaneous injection 28 mg / 0.7 mL (General name: Asphotase alpha (genetically modified)) |
| 2015-700247 (○) | JP4874954 | Strendic subcutaneous injection 18 mg / 0.45 mL (General name: asphotase alpha (genetically modified)) |
| 2015-700247 (■) | JP4874954 | Strendic subcutaneous injection 18 mg / 0.45 mL (Common name: Asphotase alpha (genetically modified)) |
| 2015-700246 (○) | JP4874954 | Strendic subcutaneous injection 12 mg / 0.3 mL (common name: asphotase alpha (genetically modified)) |
| 2015-700246 (■) | JP4874954 | Strendic subcutaneous injection 12 mg / 0.3 mL (General name: Asphotase alpha (genetically modified)) |
| 2015-700245 (○) | JP5431926 | Name of sale: Faridac capsule 15 mg Common name: panobinostat lactate |
| 2015-700245 (■) | JP5431926 | Name of sale: Faridac capsule 15 mg Common name: panobinostat lactate |
| 2015-700244 (○) | JP5431926 | Name of sale: Faridac capsule 10 mg Common name: Panobinostat lactate |
| 2015-700244 (■) | JP5431926 | Name of sale: Faridac capsule 10 mg Common name: Panobinostat lactate |
| 2015-700243 (○) | JP5665271 | Name of sale: Faridac capsule 15 mg Common name: panobinostat lactate |
| 2015-700243 (■) | JP5665271 | Name of sale: Faridac capsule 15 mg Common name: panobinostat lactate |
| 2015-700242 (○) | JP5665271 | Name of sale: Faridac capsule 10 mg Common name: Panobinostat lactate |
| 2015-700242 (■) | JP5665271 | Name of sale: Faridac capsule 10 mg Common name: Panobinostat lactate |
| 2015-700241 (○) | JP4012819 | Name of sale: Faridac capsule 15 mg Common name: panobinostat lactate |
| 2015-700241 (■) | JP4012819 | Name of sale: Faridac capsule 15 mg Common name: panobinostat lactate |
| 2015-700240 (○) | JP4012819 | Name of sale: Faridac capsule 10 mg Common name: Panobinostat lactate |
| 2015-700240 (■) | JP4012819 | Name of sale: Faridac capsule 10 mg Common name: Panobinostat lactate |
| 2015-700239 (○) | JP5269945 | Name (sale name) Lantus XR injection solo star Active ingredient: insulin glargine (genetically modified) |
| 2015-700239 (■) | JP5269945 | Name (brand name) Lantus XR injection solo star active ingredient: insulin glargine (genetically modified) |
| 2015-700238 (○) | JP5661031 | Offe Capsule 150 mg (active ingredient: Nintedanibe ethane sulfonate) |
| 2015-700238 (■) | JP5661031 | Offe Capsule 150 mg (active ingredient: Nintedanibe ethane sulfonate) |
| 2015-700237 (○) | JP5661031 | Offe Capsule 100mg (Active Ingredient: Nintedanibuteethanesulfonate) |
| 2015-700237 (■) | JP5661031 | Offe Capsule 100mg (Active Ingredient: Nintedanibuteethanesulfonate) |
| 2015-700236 (○) | JP5583119 | Offe Capsule 150 mg (active ingredient: Nintedanibe ethane sulfonate) |
| 2015-700236 (■) | JP5583119 | Offe Capsule 150 mg (active ingredient: Nintedanibe ethane sulfonate) |
| 2015-700235 (○) | JP5583119 | Offe Capsule 100mg (Active Ingredient: Nintedanibuteethanesulfonate) |
| 2015-700235 (■) | JP5583119 | Offe Capsule 100mg (Active Ingredient: Nintedanibuteethanesulfonate) |
| 2015-700234 (○) | JP5269907 | Offe Capsule 150 mg (active ingredient: Nintedanibe ethane sulfonate) |
| 2015-700234 (■) | JP5269907 | Offe Capsule 150 mg (active ingredient: Nintedanibe ethane sulfonate) |
| 2015-700233 (○) | JP5269907 | Offe Capsule 100mg (Active Ingredient: Nintedanibuteethanesulfonate) |
| 2015-700233 (■) | JP5269907 | Offe Capsule 100mg (Active Ingredient: Nintedanibuteethanesulfonate) |
| 2015-700232 (○) | JP5122976 | Offe Capsule 150 mg (active ingredient: Nintedanibe ethane sulfonate) |
| 2015-700232 (■) | JP5122976 | Offe Capsule 150 mg (active ingredient: Nintedanibe ethane sulfonate) |
| 2015-700231 (○) | JP5122976 | Offe Capsule 100mg (Active Ingredient: Nintedanibuteethanesulfonate) |
| 2015-700231 (■) | JP5122976 | Offe Capsule 100mg (Active Ingredient: Nintedanibuteethanesulfonate) |
| 2015-700230 (○) | JP5216002 | Airia intravitreal injection kit 40 mg / mL aflibercept (genetically modified) |
| 2015-700230 (■) | JP5216002 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2015-700229 (○) | JP5216002 | Airia Intravitreal Injection 40 mg / mL Aflibercept (genetically modified) |
| 2015-700229 (■) | JP5216002 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2015-700228 (○) | JP5273746 | Airia intravitreal injection kit 40 mg / mL aflibercept (genetically modified) |
| 2015-700228 (■) | JP5273746 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2015-700227 (○) | JP5273746 | Airia Intravitreal Injection 40 mg / mL Aflibercept (genetically modified) |
| 2015-700227 (■) | JP5273746 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2015-700226 (○) | JP4723140 | Airia intravitreal injection kit 40 mg / mL aflibercept (genetically modified) |
| 2015-700226 (■) | JP4723140 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2015-700225 (○) | JP4723140 | Airia Intravitreal Injection 40 mg / mL Aflibercept (genetically modified) |
| 2015-700225 (■) | JP4723140 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2015-700224 (○) | JP4021664 | Offe Capsule 150 mg (active ingredient: Nintedanibe ethane sulfonate) |
| 2015-700224 (■) | JP4021664 | Offe Capsule 150 mg (active ingredient: Nintedanibe ethane sulfonate) |
| 2015-700223 (○) | JP4021664 | Offe Capsule 100mg (Active Ingredient: Nintedanibuteethanesulfonate) |
| 2015-700223 (■) | JP4021664 | Offe Capsule 100mg (Active Ingredient: Nintedanibuteethanesulfonate) |
| 2015-700222 (○) | JP5582662 | Name of sale: Harbony combination tablet Common name: Recipesvir sohosbuvir combination drug Active ingredient: Recipesville and Sohosbuville |
| 2015-700222 (■) | JP5582662 | Name of sale: Harbony combination tablet Common name: Recipesvir sohosbuvir combination drug Active ingredient: Recipesville and Sohosbuville |
| 2015-700221 (○) | JP5318085 | Name of sale: Harbony combination tablet Common name: Recipesvir sohosbuvir combination drug Active ingredient: Recipesville and Sohosbuville |
| 2015-700221 (■) | JP5318085 | Name of sale: Harbony combination tablet Common name: Recipesvir sohosbuvir combination drug Active ingredient: Recipesville and Sohosbuville |
| 2015-700220 (○) | JP5309289 | Collagenase (Clostridium histolyticum) (Brand name: Ziyaflex for injection) Active ingredient: Collagenase (Clostridium histolyticum) |
| 2015-700220 (■) | JP5309289 | Collagenase (Clostridium histolyticum) (Brand name: Ziyaflex for injection) Active ingredient: Collagenase (Clostridium histolyticum) |
| 2015-700219 (○) | JP3306473 | Tazobactam / piperacillin hydrate |
| 2015-700219 (■) | JP3306473 | Tazobactam / piperacillin hydrate |
| 2015-700218 (○) | JP3306473 | Tazobactam / piperacillin hydrate |
| 2015-700218 (■) | JP3306473 | Tazobactam / piperacillin hydrate |
| 2015-700217 (○) | JP3306473 | Tazobactam / piperacillin hydrate |
| 2015-700217 (■) | JP3306473 | Tazobactam / piperacillin hydrate |
| 2015-700216 (○) | JP4988204 | Name of sale: Radio-cut intravenous drip infusion bag 30 mg (Edaravone (General name)) |
| 2015-700216 (■) | JP4988204 | Name of sale: Radio-cut intravenous drip infusion bag 30 mg (Edaravone (General name)) |
| 2015-700215 (○) | JP4988204 | Sales name: Radicut injection 30 mg (Edaravone (general name)) |
| 2015-700215 (■) | JP4988204 | Sales name: Radicut injection 30 mg (Edaravone (general name)) |
| 2015-700214 (○) | JP4666421 | Name of sale: Radio-cut intravenous drip infusion bag 30 mg (Edaravone (General name)) |
| 2015-700214 (■) | JP4666421 | Name of sale: Radio-cut intravenous drip infusion bag 30 mg (Edaravone (General name)) |
| 2015-700213 (○) | JP3758164 | Name of sale: Radio-cut intravenous drip infusion bag 30 mg (Edaravone (General name)) |
| 2015-700213 (■) | JP3758164 | Name of sale: Radio-cut intravenous drip infusion bag 30 mg (Edaravone (General name)) |
| 2015-700212 (○) | JP3758164 | Sales name: Radicut injection 30 mg (Edaravone (general name)) |
| 2015-700212 (■) | JP3758164 | Sales name: Radicut injection 30 mg (Edaravone (general name)) |
| 2015-700211 (○) | JP3770500 | Types of Pesticides: Cyantrani liprole wettable powder Name of Pesticides: Dupont Benedia OD Active Ingredient (chemical name): 3-bromo-1- (3-chloro-2-pyridyl) -4'- Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide |
| 2015-700211 (■) | JP3770500 | Types of Pesticides: Cyantrani liprole wettable powder Name of Pesticides: Dupont Benedia OD Active Ingredient (chemical name): 3-bromo-1- (3-chloro-2-pyridyl) -4'- Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide |
| 2015-700210 (○) | JP3764895 | Types of Pesticides: Cyantrani liprole wettable powder Name of Pesticides: Dupont Benedia OD Active Ingredient (chemical name): 3-bromo-1- (3-chloro-2-pyridyl) -4'- Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide |
| 2015-700210 (■) | JP3764895 | Types of Pesticides: Cyantrani liprole wettable powder Name of Pesticides: Dupont Benedia OD Active Ingredient (chemical name): 3-bromo-1- (3-chloro-2-pyridyl) -4'- Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide |
| 2015-700209 (○) | JP3770500 | Types of Pesticides: Cyantraniriprole Water Hydrate Pesticide Name: DuPont Verimark SC Active Ingredients (Chemical Name): 3-Bromo-1- (3-chloro-2-pyridyl) -4 -Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide |
| 2015-700209 (■) | JP3770500 | Types of Pesticides: Cyantraniriprole Water Hydrate Pesticide Name: DuPont Verimark SC Active Ingredients (Chemical Name): 3-Bromo-1- (3-chloro-2-pyridyl) -4 -Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide |
| 2015-700208 (○) | JP3764895 | Types of Pesticides: Cyantraniriprole Water Hydrate Pesticide Name: DuPont Verimark SC Active Ingredients (Chemical Name): 3-Bromo-1- (3-chloro-2-pyridyl) -4'- Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide |
| 2015-700208 (■) | JP3764895 | Types of Pesticides: Cyantraniriprole Water Hydrate Pesticide Name: DuPont Verimark SC Active Ingredients (Chemical Name): 3-Bromo-1- (3-chloro-2-pyridyl) -4'- Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide |
| 2015-700207 (○) | JP3770500 | Types of Pesticides: Cyantraniriprole Water Hydrate Name of Pesticides: DuPont Excirel SE Active Ingredient (chemical name): 3-bromo-1- (3-chloro-2-pyridyl) -4'- Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide |
| 2015-700207 (■) | JP3770500 | Types of Pesticides: Cyantraniriprole Water Hydrate Name of Pesticides: DuPont Excirel SE Active Ingredient (chemical name): 3-bromo-1- (3-chloro-2-pyridyl) -4'- Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide |
| 2015-700206 (○) | JP3764895 | Types of Pesticides: Cyantraniriprole Water Hydrate Name of Pesticides: DuPont Excirel SE Active Ingredient (chemical name): 3-bromo-1- (3-chloro-2-pyridyl) -4'- Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide |
| 2015-700206 (■) | JP3764895 | Types of Pesticides: Cyantraniriprole Water Hydrate Name of Pesticides: DuPont Excirel SE Active Ingredient (chemical name): 3-bromo-1- (3-chloro-2-pyridyl) -4'- Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide |
| 2015-700205 (○) | JP4632204 | Ramosetron hydrochloride |
| 2015-700205 (■) | JP4632204 | Ramosetron hydrochloride |
| 2015-700204 (○) | JP4632204 | Ramosetron hydrochloride |
| 2015-700204 (■) | JP4632204 | Ramosetron hydrochloride |
| 2015-700203 (○) | JP3763360 | Ramosetron hydrochloride |
| 2015-700203 (■) | JP3763360 | Ramosetron hydrochloride |
| 2015-700202 (○) | JP3763360 | Ramosetron hydrochloride |
| 2015-700202 (■) | JP3763360 | Ramosetron hydrochloride |
| 2015-700201 (○) | JP3763360 | Ramosetron hydrochloride |
| 2015-700201 (■) | JP3763360 | Ramosetron hydrochloride |
| 2015-700200 (○) | JP3763360 | Ramosetron hydrochloride |
| 2015-700200 (■) | JP3763360 | Ramosetron hydrochloride |
| 2015-700199 (○) | JP5365949 | Iribomaru ROD tablet 5 micro g |
| 2015-700199 (■) | JP5365949 | Iribomaru ROD tablet 5 micro g |
| 2015-700198 (○) | JP5365949 | Iribomaru ROD tablet 2.5 microg |
| 2015-700198 (■) | JP5365949 | Iribomaru ROD tablet 2.5 microg |
| 2015-700197 (○) | JP3689104 | Iribomaru ROD tablet 5 micro g |
| 2015-700197 (■) | JP3689104 | Iribomaru ROD tablet 5 micro g |
| 2015-700196 (○) | JP3689104 | Iribomaru ROD tablet 2.5 microg |
| 2015-700196 (■) | JP3689104 | Iribomaru ROD tablet 2.5 microg |
| 2015-700195 (○) | JP3689104 | Iribomaru R Tablet 5 micro g |
| 2015-700195 (■) | JP3689104 | Iribomaru R Tablet 5 micro g |
| 2015-700194 (○) | JP3689104 | Iribomaru R Tablet 2.5 microg |
| 2015-700194 (■) | JP3689104 | Iribomaru R Tablet 2.5 microg |
| 2015-700193 (○) | JP3747070 | Common name: Peginterferon alpha-2b Sales name: 150 microg / 0.5mL for pegintron subcutaneous injection Active ingredient: Peginterferon alpha-2b (genetically modified) |
| 2015-700193 (■) | JP3747070 | Common name: Peginterferon alpha-2b Sales name: 150 microg / 0.5mL for pegintron subcutaneous injection Active ingredient: Peginterferon alpha-2b (genetically modified) |
| 2015-700192 (○) | JP3747070 | Common name: Peginterferon alpha-2b Sale name: PegIntron for subcutaneous injection for 100 microg / 0.5mL Active ingredient: Peginterferon alpha-2b (genetically modified) |
| 2015-700192 (■) | JP3747070 | Common name: Peginterferon alpha-2b Sale name: PegIntron for subcutaneous injection for 100 microg / 0.5mL Active ingredient: Peginterferon alpha-2b (genetically modified) |
| 2015-700191 (○) | JP3747070 | Common name: Peginterferon alpha-2b Sales name: 50 microg / 0.5mL for pegintron subcutaneous injection Active ingredient: Peginterferon alpha-2b (genetically modified) |
| 2015-700191 (■) | JP3747070 | Common name: Peginterferon alpha-2b Sales name: 50 microg / 0.5mL for pegintron subcutaneous injection Active ingredient: Peginterferon alpha-2b (genetically modified) |
| 2015-700190 (○) | JP3643034 | Common name: Peginterferon alpha-2b Sales name: 150 microg / 0.5mL for pegintron subcutaneous injection Active ingredient: Peginterferon alpha-2b (genetically modified) |
| 2015-700190 (■) | JP3643034 | Common name: Peginterferon alpha-2b Sales name: 150 microg / 0.5mL for pegintron subcutaneous injection Active ingredient: Peginterferon alpha-2b (genetically modified) |
| 2015-700189 (○) | JP3643034 | Common name: Peginterferon alpha-2b Sale name: PegIntron for subcutaneous injection for 100 microg / 0.5mL Active ingredient: Peginterferon alpha-2b (genetically modified) |
| 2015-700189 (■) | JP3643034 | Common name: Peginterferon alpha-2b Sale name: PegIntron for subcutaneous injection for 100 microg / 0.5mL Active ingredient: Peginterferon alpha-2b (genetically modified) |
| 2015-700188 (○) | JP3643034 | Common name: Peginterferon alpha-2b Sales name: 50 microg / 0.5mL for pegintron subcutaneous injection Active ingredient: Peginterferon alpha-2b (genetically modified) |
| 2015-700188 (■) | JP3643034 | Common name: Peginterferon alpha-2b Sales name: 50 microg / 0.5mL for pegintron subcutaneous injection Active ingredient: Peginterferon alpha-2b (genetically modified) |
| 2015-700187 (○) | JP5564425 | Name of sale: Bravectablet 1400 mg Active Ingredient: Flura Rananel |
| 2015-700187 (■) | JP5564425 | Name of sale: Bravectablet 1400 mg Active Ingredient: Flura Rananel |
| 2015-700186 (○) | JP5564425 | Name of sale: Bravectablet 1000 mg Active ingredient: full laranel |
| 2015-700186 (■) | JP5564425 | Name of sale: Bravectablet 1000 mg Active ingredient: full laranel |
| 2015-700185 (○) | JP5564425 | Name of sale: Bravectablet 500 mg Active Ingredient: Flura Rananel |
| 2015-700185 (■) | JP5564425 | Name of sale: Bravectablet 500 mg Active Ingredient: Flura Rananel |
| 2015-700184 (○) | JP5564425 | Name of sale: Bravect Tablets 250 mg Active Ingredient: Flu Laranel |
| 2015-700184 (■) | JP5564425 | Name of sale: Bravect Tablets 250 mg Active Ingredient: Flu Laranel |
| 2015-700183 (○) | JP5564425 | Name of sale: Bravectablet 112.5mg Active ingredient: full laranel |
| 2015-700183 (■) | JP5564425 | Name of sale: Bravectablet 112.5mg Active ingredient: full laranel |
| 2015-700182 (○) | JP4479917 | Name of sale: Bravectablet 1400 mg Active Ingredient: Flura Rananel |
| 2015-700182 (■) | JP4479917 | Name of sale: Bravectablet 1400 mg Active Ingredient: Flura Rananel |
| 2015-700181 (○) | JP4479917 | Name of sale: Bravectablet 1000 mg Active ingredient: full laranel |
| 2015-700181 (■) | JP4479917 | Name of sale: Bravectablet 1000 mg Active ingredient: full laranel |
| 2015-700180 (○) | JP4479917 | Name of sale: Bravectablet 500 mg Active Ingredient: Flura Rananel |
| 2015-700180 (■) | JP4479917 | Name of sale: Bravectablet 500 mg Active Ingredient: Flura Rananel |
| 2015-700179 (○) | JP4479917 | Name of sale: Bravect Tablets 250 mg Active Ingredient: Flu Laranel |
| 2015-700179 (■) | JP4479917 | Name of sale: Bravect Tablets 250 mg Active Ingredient: Flu Laranel |
| 2015-700178 (○) | JP4479917 | Name of sale: Bravectablet 112.5mg Active ingredient: full laranel |
| 2015-700178 (■) | JP4479917 | Name of sale: Bravectablet 112.5mg Active ingredient: full laranel |
| 2015-700177 (○) | JP5185143 | Symdia subcutaneous injection 200 mg syringe (active ingredient: "Certolizumab pegol" (genetically modified)) |
| 2015-700177 (■) | JP5185143 | Symdia subcutaneous injection 200 mg syringe (active ingredient "Certolizumab pegol" (genetically modified)) |
| 2015-700176 (○) | JP4476989 | Symdia subcutaneous injection 200 mg syringe (active ingredient: "Certolizumab pegol" (genetically modified)) |
| 2015-700176 (■) | JP4476989 | Symdia subcutaneous injection 200 mg syringe (active ingredient "Certolizumab pegol" (genetically modified)) |
| 2015-700175 (○) | JP4064812 | Symdia subcutaneous injection 200 mg syringe (active ingredient: "Certolizumab pegol" (genetically modified)) |
| 2015-700175 (■) | JP4064812 | Symdia subcutaneous injection 200 mg syringe (active ingredient "Certolizumab pegol" (genetically modified)) |
| 2015-700174 (○) | JP4694202 | Pexion Tablet 400 mg (Active Ingredient: Imepitoin) |
| 2015-700174 (■) | JP4694202 | Pexion Tablet 400 mg (Active Ingredient: Imagepitoin) |
| 2015-700173 (○) | JP4694202 | Pexion Tablets 100 mg (Active Ingredient: Imepitoin) |
| 2015-700173 (■) | JP4694202 | Pexion Tablets 100 mg (Active Ingredient: Imepitoin) |
| 2015-700172 (○) | JP4694202 | Pexion Tablets 50 mg (Active Ingredient: Imepitoin) |
| 2015-700172 (■) | JP4694202 | Pexion Tablets 50 mg (Active Ingredient: Imepitoin) |
| 2015-700171 (○) | JP4030578 | Pexion Tablet 400 mg (Active Ingredient: Imepitoin) |
| 2015-700171 (■) | JP4030578 | Pexion Tablet 400 mg (Active Ingredient: Imagepitoin) |
| 2015-700170 (○) | JP4030578 | Pexion Tablets 100 mg (Active Ingredient: Imepitoin) |
| 2015-700170 (■) | JP4030578 | Pexion Tablets 100 mg (Active Ingredient: Imepitoin) |
| 2015-700169 (○) | JP4030578 | Pexion Tablets 50 mg (Active Ingredient: Imepitoin) |
| 2015-700169 (■) | JP4030578 | Pexion Tablets 50 mg (Active Ingredient: Imepitoin) |
| 2015-700168 (○) | JP3707831 | Product Name: Cyvarta Capsule 30 mg Common Name: Duloxetine Hydrochloride Chemical Name: (+)-(S) -N-Methyl-3- (1-naphthyloxy) -3- (2-thienyl) ) Propylamine monohydrochloride |
| 2015-700168 (■) | JP3707831 | Product Name: Cyvarta Capsule 30 mg Common Name: Duloxetine Hydrochloride Chemical Name: (+)-(S) -N-Methyl-3- (1-naphthyloxy) -3- (2-thienyl) ) Propylamine monohydrochloride |
| 2015-700167 (○) | JP3707831 | Product Name: Cyvarta Capsule 20 mg Common Name: Duloxetine Hydrochloride Chemical Name: (+)-(S) -N-Methyl-3- (1-naphthyloxy) -3- (2-thienyl) ) Propylamine monohydrochloride |
| 2015-700167 (■) | JP3707831 | Product Name: Cyvarta Capsule 20 mg Common Name: Duloxetine Hydrochloride Chemical Name: (+)-(S) -N-Methyl-3- (1-naphthyloxy) -3- (2-thienyl) ) Propylamine monohydrochloride |
| 2015-700166 (○) | JP5341962 | Iminoctadine albesylate (15.0%) Pyriophenone (4.0%) |
| 2015-700166 (■) | JP5341962 | Iminoctadine albesylate (15.0%) Pyrophenone (4.0%) |
| 2015-700165 (○) | JP4608140 | Pyrophenon |
| 2015-700165 (■) | JP4608140 | Pyrophenon |
| 2015-700164 (○) | JP4902945 | ABILIFY Continuous Suspension Injection 400mg (Common Name: Aripiprazole) |
| 2015-700164 (■) | JP4902945 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2015-700163 (○) | JP4902945 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole) |
| 2015-700163 (■) | JP4902945 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole Hydrate) |
| 2015-700162 (○) | JP5575269 | ABILIFY Continuous Suspension Injection 400mg (Common Name: Aripiprazole) |
| 2015-700161 (○) | JP5575269 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole) |
| 2015-700160 (○) | JP5683010 | ABILIFY Continuous Suspension Injection 400mg (Common Name: Aripiprazole) |
| 2015-700159 (○) | JP5683010 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole) |
| 2015-700158 (○) | JP4879349 | ABILIFY Continuous Suspension Injection 400mg (Common Name: Aripiprazole) |
| 2015-700158 (■) | JP4879349 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2015-700157 (○) | JP4879349 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole) |
| 2015-700157 (■) | JP4879349 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole Hydrate) |
| 2015-700156 (○) | JP5300194 | ABILIFY Continuous Suspension Injection 400mg (Common Name: Aripiprazole) |
| 2015-700156 (■) | JP5300194 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2015-700155 (○) | JP5300194 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole) |
| 2015-700155 (■) | JP5300194 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole Hydrate) |
| 2015-700154 (○) | JP5453194 | ABILIFY Continuous Suspension Injection 400mg (Common Name: Aripiprazole) |
| 2015-700154 (■) | JP5453194 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2015-700153 (○) | JP5453194 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole) |
| 2015-700153 (■) | JP5453194 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole Hydrate) |
| 2015-700152 (○) | JP5372032 | ABILIFY Continuous Suspension Injection 400mg (Common Name: Aripiprazole) |
| 2015-700152 (■) | JP5372032 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2015-700151 (○) | JP5372032 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole) |
| 2015-700151 (■) | JP5372032 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole Hydrate) |
| 2015-700150 (○) | JP4836797 | ABILIFY Continuous Suspension Injection 400mg (Common Name: Aripiprazole) |
| 2015-700150 (■) | JP4836797 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2015-700149 (○) | JP4836797 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole) |
| 2015-700149 (■) | JP4836797 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole Hydrate) |
| 2015-700148 (○) | JP3760264 | ABILIFY Continuous Suspension Injection 400mg (Common Name: Aripiprazole) |
| 2015-700148 (■) | JP3760264 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2015-700147 (○) | JP3760264 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole) |
| 2015-700147 (■) | JP3760264 | ABILIFY 400mg Syringe for Continuous Suspension Injection (Common Name: Aripiprazole Hydrate) |
| 2015-700146 (○) | JP5615323 | Name of sale: Synflorix aqueous suspension injection Active ingredient: Pneumococcal capsular polysaccharide (serotype 1)-protein D conjugate Active ingredient: Pneumococcal capsular polysaccharide (serotype 4) -Protein D conjugate Active ingredient: Streptococcus pneumoniae capsular polysaccharide (serotype 5)-Protein D conjugate Active ingredient: Streptococcus pneumoniae capsular polysaccharide (serotype 6B)-Protein D conjugate < br> active ingredient: pneumococcal capsular polysaccharide (serotype 7F)-protein D conjugate active ingredient: pneumococcal capsular polysaccharide (serotype 9V)-protein D conjugate active ingredient: pneumonia Streptococcus capsular polysaccharide (serotype 14) -protein D conjugate active ingredient: pneumococcal capsular polysaccharide (serotype 18C) -tetanus toxoid conjugate active ingredient: pneumococcal capsular polysaccharide Ride (serotype @ 19 F) - diphtheria toxoid conjugate active ingredient: pneumococcal capsular polysaccharide (serotype 23F) - protein D conjugate |
| 2015-700146 (■) | JP5615323 | Name of sale: Synflorix aqueous suspension injection Active ingredient: Pneumococcal capsular polysaccharide (serotype 1)-protein D conjugate Active ingredient: Pneumococcal capsular polysaccharide (serotype 4) -Protein D conjugate Active ingredient: Streptococcus pneumoniae capsular polysaccharide (serotype 5)-Protein D conjugate Active ingredient: Streptococcus pneumoniae capsular polysaccharide (serotype 6B)-Protein D conjugate < br> active ingredient: pneumococcal capsular polysaccharide (serotype 7F)-protein D conjugate active ingredient: pneumococcal capsular polysaccharide (serotype 9V)-protein D conjugate active ingredient: pneumonia Streptococcus capsular polysaccharide (serotype 14) -protein D conjugate active ingredient: pneumococcal capsular polysaccharide (serotype 18C) -tetanus toxoid conjugate active ingredient: pneumococcal capsular polysaccharide Ride (serotype @ 19 F) - diphtheria toxoid conjugate active ingredient: pneumococcal capsular polysaccharide (serotype 23F) - protein D conjugate |
| 2015-700145 (○) | JP4846906 | Name of sale: Synflorix aqueous suspension injection Active ingredient: Pneumococcal capsular polysaccharide (serotype 1)-protein D conjugate Active ingredient: Pneumococcal capsular polysaccharide (serotype 4) -Protein D conjugate Active ingredient: Streptococcus pneumoniae capsular polysaccharide (serotype 5)-Protein D conjugate Active ingredient: Streptococcus pneumoniae capsular polysaccharide (serotype 6B)-Protein D conjugate < br> active ingredient: pneumococcal capsular polysaccharide (serotype 7F)-protein D conjugate active ingredient: pneumococcal capsular polysaccharide (serotype 9V)-protein D conjugate active ingredient: pneumonia Streptococcus capsular polysaccharide (serotype 14) -protein D conjugate active ingredient: pneumococcal capsular polysaccharide (serotype 18C) -tetanus toxoid conjugate active ingredient: pneumococcal capsular polysaccharide Ride (serotype @ 19 F) - diphtheria toxoid conjugate active ingredient: pneumococcal capsular polysaccharide (serotype 23F) - protein D conjugate |
| 2015-700145 (■) | JP4846906 | Name of sale: Synflorix aqueous suspension injection Active ingredient: Pneumococcal capsular polysaccharide (serotype 1)-protein D conjugate Active ingredient: Pneumococcal capsular polysaccharide (serotype 4) -Protein D conjugate Active ingredient: Streptococcus pneumoniae capsular polysaccharide (serotype 5)-Protein D conjugate Active ingredient: Streptococcus pneumoniae capsular polysaccharide (serotype 6B)-Protein D conjugate < br> active ingredient: pneumococcal capsular polysaccharide (serotype 7F)-protein D conjugate active ingredient: pneumococcal capsular polysaccharide (serotype 9V)-protein D conjugate active ingredient: pneumonia Streptococcus capsular polysaccharide (serotype 14) -protein D conjugate active ingredient: pneumococcal capsular polysaccharide (serotype 18C) -tetanus toxoid conjugate active ingredient: pneumococcal capsular polysaccharide Ride (serotype @ 19 F) - diphtheria toxoid conjugate active ingredient pneumococcal capsular polysaccharide (serotype 23F) - protein D conjugate |
| 2015-700144 (○) | JP5476404 | Name of sale: Syramza Intravenous Drip Solution 500 mg Common name: Rhamsylumab (genetically modified) |
| 2015-700144 (■) | JP5476404 | Name of sale: Syramza Intravenous Drip Solution 500 mg Common name: Rhamsylumab (genetically modified) |
| 2015-700143 (○) | JP5476404 | Name of sale: Syramza IV infusion solution 100 mg Common name: Rhamsylumab (genetically modified) |
| 2015-700143 (■) | JP5476404 | Name of sale: Syramza IV infusion solution 100 mg Common name: Rhamsylumab (genetically modified) |
| 2015-700142 (○) | JP4970483 | Name of sale: Syramza Intravenous Drip Solution 500 mg Common name: Rhamsylumab (genetically modified) |
| 2015-700142 (■) | JP4970483 | Name of sale: Syramza Intravenous Drip Solution 500 mg Common name: Rhamsylumab (genetically modified) |
| 2015-700141 (○) | JP4970483 | Name of sale: Syramza IV infusion solution 100 mg Common name: Rhamsylumab (genetically modified) |
| 2015-700141 (■) | JP4970483 | Name of sale: Syramza IV infusion solution 100 mg Common name: Rhamsylumab (genetically modified) |
| 2015-700140 (○) | JP4503709 | Gadobist IV injection 1.0 mol / L syringe 10 mL |
| 2015-700140 (■) | JP4503709 | Gadobist IV injection 1.0 mol / L syringe 10 mL |
| 2015-700139 (○) | JP4503709 | Gadobist IV injection 1.0 mol / L syringe 7.5 mL |
| 2015-700139 (■) | JP4503709 | Gadobist IV injection 1.0 mol / L syringe 7.5 mL |
| 2015-700138 (○) | JP4503709 | Gadovist intravenous injection 1.0 mol / L syringe 5 mL |
| 2015-700138 (■) | JP4503709 | Gadovist intravenous injection 1.0 mol / L syringe 5 mL |
| 2015-700137 (○) | JP4503709 | Gadobist intravenous injection 1.0 mol / L 7.5 mL |
| 2015-700137 (■) | JP4503709 | Gadobist IV injection 1.0 mol / L 7.5 mL |
| 2015-700136 (○) | JP5227348 | Sadelga Capsule 100mg (Active Ingredient: Eligurstat Tartrate) |
| 2015-700136 (■) | JP5227348 | Sadelga Capsule 100 mg (Active ingredient: Eligurstat tartrate) |
| 2015-700135 (○) | JP4708073 | Sadelga Capsule 100mg (Active Ingredient: Eligurstat Tartrate) |
| 2015-700135 (■) | JP4708073 | Sadelga Capsule 100 mg (Active ingredient: Eligurstat tartrate) |
| 2015-700134 (○) | JP5038582 | Sadelga Capsule 100mg (Active Ingredient: Eligurstat Tartrate) |
| 2015-700134 (■) | JP5038582 | Sadelga Capsule 100 mg (Active ingredient: Eligurstat tartrate) |
| 2015-700133 (○) | JP5318085 | Name: Sobaldi Tablet 400 mg General name: Sohos bubiru |
| 2015-700133 (■) | JP5318085 | Name: Sobaldi Tablet 400 mg General name: Sohos bubiru |
| 2015-700132 (○) | JP3712393 | Renvimar Capsule 10mg (active ingredient: lenvatinib mesylate) |
| 2015-700132 (■) | JP3712393 | Renvimar Capsule 10mg (active ingredient: lenvatinib mesylate) |
| 2015-700131 (○) | JP3712393 | Renvimar Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2015-700131 (■) | JP3712393 | Renvimar Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2015-700130 (○) | JP5048871 | Renvimar Capsule 10mg (active ingredient: lenvatinib mesylate) |
| 2015-700130 (■) | JP5048871 | Renvimar Capsule 10mg (active ingredient: lenvatinib mesylate) |
| 2015-700129 (○) | JP5048871 | Renvimar Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2015-700129 (■) | JP5048871 | Renvimar Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2015-700128 (○) | JP5190361 | Renvimar Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2015-700128 (■) | JP5190361 | Renvimar Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2015-700127 (○) | JP5190361 | Renvimar Capsule 10mg (active ingredient: lenvatinib mesylate) |
| 2015-700127 (■) | JP5190361 | Renvimar Capsule 10mg (active ingredient: lenvatinib mesylate) |
| 2015-700126 (○) | JP4834553 | Renvimar Capsule 10mg (active ingredient: lenvatinib mesylate) |
| 2015-700126 (■) | JP4834553 | Renvimar Capsule 10mg (active ingredient: lenvatinib mesylate) |
| 2015-700125 (○) | JP4834553 | Renvimar Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2015-700125 (■) | JP4834553 | Renvimar Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2015-700124 (○) | JP4648835 | Renvimar Capsule 10mg (active ingredient: lenvatinib mesylate) |
| 2015-700124 (■) | JP4648835 | Renvimar Capsule 10mg (active ingredient: lenvatinib mesylate) |
| 2015-700123 (○) | JP4648835 | Renvimar Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2015-700123 (■) | JP4648835 | Renvimar Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2015-700122 (○) | JP5594612 | Name of sale: Synflorix aqueous suspension intramuscular injection active ingredient: pneumococcal capsular polysaccharide (serotype 1)-protein D conjugate pneumococcal capsular polysaccharide (serotype 4)-protein D Conjugate pneumococcal capsular polysaccharide (serotype 5) -protein D conjugate pneumococcal capsular polysaccharide (serotype 6B) -protein D conjugate pneumococcal capsular polysaccharide ( Serotype 7F) -Protein D conjugate Pneumococcal capsular polysaccharide (Serotype 9V) -Protein D conjugate Pneumococcal capsular polysaccharide (Serotype 14) -Protein D conjugate Pneumococcal capsular polysaccharide (serotype 18C)-tetanus toxoid conjugate Pneumococcal capsular polysaccharide (serotype 19F)-diphtheria toxoid conjugate pneumococcal polysaccharides De (serotype 23F)-Protein D conjugate |
| 2015-700122 (■) | JP5594612 | Name of sale: Synflorix aqueous suspension intramuscular injection active ingredient: pneumococcal capsular polysaccharide (serotype 1)-protein D conjugate pneumococcal capsular polysaccharide (serotype 4)-protein D Conjugate pneumococcal capsular polysaccharide (serotype 5) -protein D conjugate pneumococcal capsular polysaccharide (serotype 6B) -protein D conjugate pneumococcal capsular polysaccharide ( Serotype 7F) -Protein D conjugate Pneumococcal capsular polysaccharide (Serotype 9V) -Protein D conjugate Pneumococcal capsular polysaccharide (Serotype 14) -Protein D conjugate Pneumococcal capsular polysaccharide (serotype 18C)-tetanus toxoid conjugate Pneumococcal capsular polysaccharide (serotype 19F)-diphtheria toxoid conjugate pneumococcal polysaccharides De (serotype 23F)-Protein D conjugate |
| 2015-700121 (○) | JP4621736 | Name of sale: Ekryla 400 μg for Genuair 60 inhalation General name: acridinium bromide |
| 2015-700121 (■) | JP4621736 | Name of sale: Ekryla 400 μg for Genuair 60 inhalation General name: acridinium bromide |
| 2015-700120 (○) | JP4621736 | Name of sale: Ekryra 400 μg for Genuair 30 inhalation Common name: acridinium bromide |
| 2015-700120 (■) | JP4621736 | Name of sale: Ekryra 400 μg for Genuair 30 inhalation Common name: acridinium bromide |
| 2015-700119 (○) | JP4116537 | Name of sale: Ekryla 400 μg for Genuair 60 inhalation General name: acridinium bromide |
| 2015-700119 (■) | JP4116537 | Name of sale: Ekryla 400 μg for Genuair 60 inhalation General name: acridinium bromide |
| 2015-700118 (○) | JP4116537 | Name of sale: Ekryra 400 μg for Genuair 30 inhalation Common name: acridinium bromide |
| 2015-700118 (■) | JP4116537 | Name of sale: Ekryra 400 μg for Genuair 30 inhalation Common name: acridinium bromide |
| 2015-700117 (○) | JP3299971 | Name of sale: Ekryla 400 μg for Genuair 60 inhalation General name: acridinium bromide |
| 2015-700117 (■) | JP3299971 | Name of sale: Ekryla 400 μg for Genuair 60 inhalation General name: acridinium bromide |
| 2015-700116 (○) | JP3299971 | Name of sale: Ekryra 400 μg for Genuair 30 inhalation Common name: acridinium bromide |
| 2015-700116 (■) | JP3299971 | Name of sale: Ekryra 400 μg for Genuair 30 inhalation Common name: acridinium bromide |
| 2015-700115 (○) | JP5279708 | Name of sale: Ekryla 400 μg for Genuair 60 inhalation General name: acridinium bromide |
| 2015-700115 (■) | JP5279708 | Name of sale: Ekryla 400 μg for Genuair 60 inhalation General name: acridinium bromide |
| 2015-700114 (○) | JP5279708 | Name of sale: Ekryra 400 μg for Genuair 30 inhalation Common name: acridinium bromide |
| 2015-700114 (■) | JP5279708 | Name of sale: Ekryra 400 μg for Genuair 30 inhalation Common name: acridinium bromide |
| 2015-700113 (○) | JP4030040 | Name of sale: Ekryla 400 μg for Genuair 60 inhalation General name: acridinium bromide |
| 2015-700113 (■) | JP4030040 | Name of sale: Ekryla 400 μg for Genuair 60 inhalation General name: acridinium bromide |
| 2015-700112 (○) | JP4030040 | Name of sale: Ekryra 400 μg for Genuair 30 inhalation Common name: acridinium bromide |
| 2015-700112 (■) | JP4030040 | Name of sale: Ekryra 400 μg for Genuair 30 inhalation Common name: acridinium bromide |
| 2015-700111 (○) | JP5025066 | Name of sale: Onetram Tablet 100 mg Active ingredient: Tramadol hydrochloride |
| 2015-700111 (■) | JP5025066 | Name of sale: Onetram Tablet 100 mg Active ingredient: Tramadol hydrochloride |
| 2015-700110 (○) | JP4897930 | Name of sale: Onetram Tablet 100 mg Active ingredient: Tramadol hydrochloride |
| 2015-700110 (■) | JP4897930 | Name of sale: Onetram Tablet 100 mg Active ingredient: Tramadol hydrochloride |
| 2015-700109 (○) | JP4430229 | Name of Sale: ELPLAT Intravenous Drip Solution 200mg Active Ingredient: Oxaliplatin |
| 2015-700108 (○) | JP4430229 | Name of Sale: ELPLAT Intravenous Drip Solution 100mg Active Ingredient: Oxaliplatin |
| 2015-700107 (○) | JP4430229 | Name of sale: ELPLAT Intravenous Drip Solution 50mg Active Ingredient: Oxaliplatin |
| 2015-700106 (○) | JP5576591 | Name of sale: Ronsurf combination tablet T20 Active ingredient: Trifluridine and tipiracil hydrochloride |
| 2015-700106 (■) | JP5576591 | Name of sale: Ronsurf combination tablet T20 Active ingredient: Trifluridine and tipiracil hydrochloride |
| 2015-700105 (○) | JP5576591 | Name of sale: Ronsurf combination tablet T15 Active ingredient: Trifluridine and tipiracil hydrochloride |
| 2015-700105 (■) | JP5576591 | Name of sale: Ronsurf combination tablet T15 Active ingredient: Trifluridine and tipiracil hydrochloride |
| 2015-700104 (○) | JP3088757 | Name of sale: Ronsurf combination tablet T20 Active ingredient: Trifluridine and tipiracil hydrochloride |
| 2015-700104 (■) | JP3088757 | Name of sale: Ronsurf combination tablet T20 Active ingredient: Trifluridine and tipiracil hydrochloride |
| 2015-700103 (○) | JP3088757 | Name of sale: Ronsurf combination tablet T15 Active ingredient: Trifluridine and tipiracil hydrochloride |
| 2015-700103 (■) | JP3088757 | Name of sale: Ronsurf combination tablet T15 Active ingredient: Trifluridine and tipiracil hydrochloride |
| 2015-700102 (○) | JP5086478 | Name of sale: Triomek combination tablet General name of active ingredient: dolutegravir sodium, abacavir sulfate and lamivudine |
| 2015-700102 (■) | JP5086478 | Name of sale: Triomek combination tablet General name of active ingredient: dolutegravir sodium, abacavir sulfate and lamivudine |
| 2015-700101 (○) | JP4295353 | Name of sale: Triomek combination tablet General name of active ingredient: dolutegravir sodium, abacavir sulfate and lamivudine |
| 2015-700101 (■) | JP4295353 | Name of sale: Triomek combination tablet General name of active ingredient: dolutegravir sodium, abacavir sulfate and lamivudine |
| 2015-700100 (○) | JP3150711 | Name of sale: Triomek combination tablet General name of active ingredient: dolutegravir sodium, abacavir sulfate and lamivudine |
| 2015-700100 (■) | JP3150711 | Name of sale: Triomek combination tablet General name of active ingredient: dolutegravir sodium, abacavir sulfate and lamivudine |
| 2015-700099 (○) | JP2954357 | Name of sale: Triomek combination tablet General name of active ingredient: dolutegravir sodium, abacavir sulfate and lamivudine |
| 2015-700099 (■) | JP2954357 | Name of sale: Triomek combination tablet General name of active ingredient: dolutegravir sodium, abacavir sulfate and lamivudine |
| 2015-700098 (○) | JP5054061 | Common Name: Machiten Tan Name: Opsmit Tablet 10 mg |
| 2015-700098 (■) | JP5054061 | Common Name: Machiten Tan Name: Opsmit Tablet 10 mg |
| 2015-700097 (○) | JP4955685 | Common Name: Machiten Tan Name: Opsmit Tablet 10 mg |
| 2015-700097 (■) | JP4955685 | Common Name: Machiten Tan Name: Opsmit Tablet 10 mg |
| 2015-700096 (○) | JP4245130 | Common Name: Machiten Tan Name: Opsmit Tablet 10 mg |
| 2015-700096 (■) | JP4245130 | Common Name: Machiten Tan Name: Opsmit Tablet 10 mg |
| 2015-700095 (○) | JP5693817 | Active ingredient: Exenatide Name: 2 mg pen for subcutaneous injection of bidurion |
| 2015-700095 (■) | JP5693817 | Active ingredient: Exenatide Name: 2 mg pen for subcutaneous injection of bidurion |
| 2015-700094 (○) | JP5030292 | Active ingredient: Exenatide Name: 2 mg pen for subcutaneous injection of bidurion |
| 2015-700094 (■) | JP5030292 | Active ingredient: Exenatide Name: 2 mg pen for subcutaneous injection of bidurion |
| 2015-700093 (○) | JP4899021 | Active ingredient: Exenatide Name: 2 mg pen for subcutaneous injection of bidurion |
| 2015-700092 (○) | JP4798814 | Active ingredient: Exenatide Name: 2 mg pen for subcutaneous injection of bidurion |
| 2015-700092 (■) | JP4798814 | Active ingredient: Exenatide Name: 2 mg pen for subcutaneous injection of bidurion |
| 2015-700091 (○) | JP4502355 | Active ingredient: Exenatide Name: 2 mg pen for subcutaneous injection of bidurion |
| 2015-700091 (■) | JP4502355 | Active ingredient: Exenatide Name: 2 mg pen for subcutaneous injection of bidurion |
| 2015-700090 (○) | JP5122462 | Name of Sale: Zafatec Tablets 100 mg Active Ingredients: (General name) Trela ??Gliptin Succinate |
| 2015-700090 (■) | JP5122462 | Name of Sale: Zafatec Tablets 100 mg Active Ingredients: (General name) Trela ??Gliptin Succinate |
| 2015-700089 (○) | JP5122462 | Name of Sale: Zafatec Tablets 50 mg Active Ingredients: (General name) Trela ??Gliptin Succinate |
| 2015-700089 (■) | JP5122462 | Name of Sale: Zafatec Tablets 50 mg Active Ingredients: (General name) Trela ??Gliptin Succinate |
| 2015-700088 (○) | JP5027137 | Name of Sale: Zafatec Tablets 100 mg Active Ingredients: (General name) Trela ??Gliptin Succinate |
| 2015-700088 (■) | JP5027137 | Name of Sale: Zafatec Tablets 100 mg Active Ingredients: (General name) Trela ??Gliptin Succinate |
| 2015-700087 (○) | JP5027137 | Name of Sale: Zafatec Tablets 50 mg Active Ingredients: (General name) Trela ??Gliptin Succinate |
| 2015-700087 (■) | JP5027137 | Name of Sale: Zafatec Tablets 50 mg Active Ingredients: (General name) Trela ??Gliptin Succinate |
| 2015-700086 (○) | JP501411 | Name of product: Enclase 62.5 microg Elliptor 30 for inhalation Active ingredient: Umeclizinium bromide |
| 2015-700086 (■) | JP501411 | Name of product: Enclase 62.5μg ELIPTA 30 for inhalation Active ingredient: Umeclizinium bromide |
| 2015-700085 (○) | JP501411 | Name of product: Encrusce 62.5 microg Elliptor 7 for inhalation Active ingredient: Umeclizinium bromide |
| 2015-700085 (■) | JP501411 | Name of sale: Enclase 62.5μg ELIPTA 7 for inhalation Active ingredient: Umeclizinium bromide |
| 2015-700084 (○) | JP5490767 | Imidacloprid, Spinosad, Isotianil, Penflufen Granules Routine Expert Box Granules-2 '-[(RS) -1,3-Dimethylbutyl] -5-fluoro-1,3-dimethylpyrazole-4-carboxanilide (Also known as N- [2- (1,3-dimethylbutyl) phenyl] -5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide) (General name: penflufen) and 3,4 -Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide (another name: 3,4-dichloro-N- (2-cyanophenyl) -5-isothiazole carboxamide) (general name: isothianyl) |
| 2015-700084 (■) | JP5490767 | Imidacloprid, Spinosad, Isotianil, Penflufen granules |
| 2015-700083 (○) | JP5345617 | Imidacloprid, Spinosad, Isotianil, Penflufen Granules Routine Expert Box Granules 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide (also called 3,4-dichloro-N-) (2-Cyanophenyl) -5-isothiazolecarboxamide) (general name: isotianil), 1- (6-chloro-3-pyridylmethyl) -N-nitroimidazolidin-2-ylideneamine (general name: imidacloprid) And Spinosyn A (2R, 3aS, 5aR, 5bS, 9S, 13S, 14R, 16aS, 16bR) -2- (6-deoxy-2,3,4-tri-O-methyl-α-L- Mannopyranosyloxy) -13- (4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy) 9-ethyl-2,3,3a, 5a, 5b, 6,7,9,10,11,12,13,14,15,16a, 16b-hexadecahydro-14-methyl-1H-as-indaseno [ 3,2-d] oxacyclododecin-7,15-dione spinosyn D (2S, 3aR, 5aS, 5bS, 9S, 13S, 14R, 16aS, 16bS) -2- (6-deoxy-2,3, 4-tri-O-methyl-α-L-mannopyranosyloxy) -13- (4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)- 9-ethyl-2,3,3a, 5a, 5b, 6,7,9,10,11,12,13,14,15,16a, 16b-hexadecahydro-4,14-dimethyl-1H-as- Indaseno [3,2-d] oxacyclode Shin -7,15- dione] (General name: spinosad) |
| 2015-700083 (■) | JP5345617 | Imidacloprid, Spinosad, Isotianil, Penflufen granules |
| 2015-700082 (○) | JP4068118 | Name of Sale: Zafatec Tablets 100mg Active Ingredient: Trelagliptin Succinate |
| 2015-700082 (■) | JP4068118 | Name of Sale: Zafatec Tablets 100mg Active Ingredient: Trelagliptin Succinate |
| 2015-700081 (○) | JP4068118 | Name of Sale: Zafatec Tablets 50 mg Active Ingredient: Trelagliptin Succinate |
| 2015-700081 (■) | JP4068118 | Name of Sale: Zafatec Tablets 50 mg Active Ingredient: Trelagliptin Succinate |
| 2015-700080 (○) | JP4455321 | Sales name: Adempas Tablet 2.5 mg Common name: Rio Siguat |
| 2015-700080 (■) | JP4455321 | Name of sale: Adempass 2.5 mg General name: Rio Siguat |
| 2015-700079 (○) | JP4455321 | Sales name: Adempas Tablet 1.0 mg Common name: Rio Siguat |
| 2015-700079 (■) | JP4455321 | Name of sale: Adempas Tablets 1.0 mg General name: Rio Siguat |
| 2015-700078 (○) | JP4455321 | Sales name: Adempas tablet 0.5 mg Common name: Rio Siguat |
| 2015-700078 (■) | JP4455321 | Name of sale: Adempass Tablet 0.5 mg General name: Rio Siguat |
| 2015-700077 (○) | JP2882882 | Cinacalcet hydrochloride (trade name: Regpara Tablet 12.5 mg) |
| 2015-700076 (○) | JP5077523 | Pifurubumido Name of the drug: Danichong flowable Active ingredient: 3'-isobutyl-N-isobutyryl-1,3,5-trimethyl-4 '-[2,2,2-trifluoro-1-methoxy-1- (trifluoro) Methyl) ethyl] pyrazole-4-carboxanilide |
| 2015-700076 (■) | JP5077523 | Pifurubumido Name of Pesticide: Danichong flowable Active ingredient: 3'-isobutyl-N-isobutyryl-1,3,5-trimethyl-4 '-[2,2,2-trifluoro-1-methoxy -1- (Trifluoromethyl) ethyl] pyrazole-4-carboxanilide |
| 2015-700075 (○) | JP5210154 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2015-700075 (■) | JP5210154 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2015-700074 (○) | JP4913104 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2015-700074 (■) | JP4913104 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2015-700073 (○) | JP4759102 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2015-700073 (■) | JP4759102 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2015-700072 (○) | JP4222450 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2015-700072 (■) | JP4222450 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2015-700071 (○) | JP4035559 | Takecab Tablets 20 mg Bonoprazan Fumaric Acid Salt |
| 2015-700071 (■) | JP4035559 | Takecab Tablets 20mg Bonoprazan Fumaric Acid Salt |
| 2015-700070 (○) | JP4035559 | Takecab Tablets 10 mg Bonoprazan Fumaric Acid Salt |
| 2015-700070 (■) | JP4035559 | Takecab Tablets 10 mg Bono plasan fumaric acid salt |
| 2015-700069 (○) | JP5600328 | Jadiance Tablet 25 mg (active ingredient: empagliflozin) |
| 2015-700069 (■) | JP5600328 | Jadiance Tablet 25mg (Active Ingredient: Empagliflozin) |
| 2015-700068 (○) | JP5600328 | Jadiance Tablet 10 mg (active ingredient: empagliflozin) |
| 2015-700068 (■) | JP5600328 | Jadiance Tablet 10 mg (Active ingredient: Empagliflozin) |
| 2015-700067 (○) | JP4834080 | Jadiance Tablet 25 mg (active ingredient: empagliflozin) |
| 2015-700067 (■) | JP4834080 | Jadiance Tablet 25mg (Active Ingredient: Empagliflozin) |
| 2015-700066 (○) | JP4834080 | Jadiance Tablet 10 mg (active ingredient: empagliflozin) |
| 2015-700066 (■) | JP4834080 | Jadiance Tablet 10 mg (Active ingredient: Empagliflozin) |
| 2015-700065 (○) | JP4226070 | Jadiance Tablet 25 mg (active ingredient: empagliflozin) |
| 2015-700065 (■) | JP4226070 | Jadiance Tablet 25mg (Active Ingredient: Empagliflozin) |
| 2015-700064 (○) | JP4226070 | Jadiance Tablet 10 mg (active ingredient: empagliflozin) |
| 2015-700064 (■) | JP4226070 | Jadiance Tablet 10 mg (Active ingredient: Empagliflozin) |
| 2015-700063 (○) | JP4181605 | Jadiance Tablet 25 mg (active ingredient: empagliflozin) |
| 2015-700063 (■) | JP4181605 | Jadiance Tablet 25mg (Active Ingredient: Empagliflozin) |
| 2015-700062 (○) | JP4181605 | Jadiance Tablet 10 mg (active ingredient: empagliflozin) |
| 2015-700062 (■) | JP4181605 | Jadiance Tablet 10 mg (Active ingredient: Empagliflozin) |
| 2015-700061 (○) | JP3531170 | Name of sale: Nopicol capsule 2.5 microg Active ingredient: Nalfurafine hydrochloride |
| 2015-700061 (■) | JP3531170 | Name of sale: Nopicol capsule 2.5 microg Active ingredient: Nalfurafine hydrochloride |
| 2015-700060 (○) | JP5537740 | Name of sale: Cosentertics for subcutaneous injection 150 mg Common name: Sequkinumab (genetically modified) |
| 2015-700060 (■) | JP5537740 | Name of sale: Cosentertics for subcutaneous injection 150 mg Common name: Sequkinumab (genetically modified) |
| 2015-700059 (○) | JP5537740 | Name of sale: Cosentix subcutaneous injection 150 mg syringe Common name: Sequkinumab (genetically modified) |
| 2015-700059 (■) | JP5537740 | Name of sale: Cosentix subcutaneous injection 150 mg syringe Common name: Sequkinumab (genetically modified) |
| 2015-700058 (○) | JP4682200 | Name of sale: Cosentertics for subcutaneous injection 150 mg Common name: Sequkinumab (genetically modified) |
| 2015-700058 (■) | JP4682200 | Name of sale: Cosentertics for subcutaneous injection 150 mg Common name: Sequkinumab (genetically modified) |
| 2015-700057 (○) | JP4682200 | Name of sale: Cosentix subcutaneous injection 150 mg syringe Common name: Sequkinumab (genetically modified) |
| 2015-700057 (■) | JP4682200 | Name of sale: Cosentix subcutaneous injection 150 mg syringe Common name: Sequkinumab (genetically modified) |
| 2015-700056 (○) | JP5511942 | Vemurafenib (trade name Zelborav Tablet 240 mg) |
| 2015-700056 (■) | JP5511942 | Vemurafenib (trade name: Zelborav Tablet 240 mg) |
| 2015-700055 (○) | JP5138938 | Vemurafenib (trade name Zelborav Tablet 240 mg) |
| 2015-700055 (■) | JP5138938 | Vemurafenib (trade name: Zelborav Tablet 240 mg) |
| 2015-700054 (■) | JP5007304 | Vemurafenib (trade name: Zelborav Tablet 240 mg) |
| 2015-700053 (○) | JP3743449 | Name of sale: Nopicol capsule 2.5 microg Active ingredient: Nalfurafine hydrochloride (general name) |
| 2015-700053 (■) | JP3743449 | Vemurafenib (trade name Zelborav Tablet 240 mg) |
| 2015-700052 (○) | JP5091480 | Name of Sales: Iroquoit for Intravenous Injection 3000 Common Name: Efrarot Tocog Alpha (genetically modified) |
| 2015-700052 (■) | JP5091480 | Name of Sales: Iroquoit for Intravenous Injection 3000 Common Name: Efrarot Tocog Alpha (genetically modified) |
| 2015-700051 (○) | JP5091480 | Name of sale: Iroquoit for Intravenous injection 2000 General name: Efra-loctocog alpha (genetically modified) |
| 2015-700051 (■) | JP5091480 | Name of sale: Iroquoit for Intravenous injection 2000 General name: Efra-loctocog alpha (genetically modified) |
| 2015-700050 (○) | JP5091480 | Name of sale: Iroquoit for intravenous injection 1500 Common name: Efra-loctocog alpha (genetically modified) |
| 2015-700050 (■) | JP5091480 | Name of sale: Iroquoit for intravenous injection 1500 Common name: Efra-loctocog alpha (genetically modified) |
| 2015-700049 (○) | JP5091480 | Name of sale: Iroquoit 1000 for intravenous injection Common name: Efra-loctocog alpha (genetically modified) |
| 2015-700049 (■) | JP5091480 | Name of sale: Iroquoit 1000 for intravenous injection Common name: Efra-loctocog alpha (genetically modified) |
| 2015-700048 (○) | JP5091480 | Name of sale: Iroquoit for intravenous injection 750 Common name: Efra-loctocog alpha (genetically modified) |
| 2015-700048 (■) | JP5091480 | Name of sale: Iroquoit for intravenous injection 750 Common name: Efra-loctocog alpha (genetically modified) |
| 2015-700047 (○) | JP5091480 | Name of sale: Iroquoito for intravenous injection 500 Common name: Efra-loctocog alpha (genetically modified) |
| 2015-700047 (■) | JP5091480 | Name of sale: Iroquoito for intravenous injection 500 Common name: Efra-loctocog alpha (genetically modified) |
| 2015-700046 (○) | JP5091480 | Name of sale: Iroquoit for intravenous injection 250 Common name: Efra-loctocog alpha (genetically modified) |
| 2015-700046 (■) | JP5091480 | Name of sale: Iroquoit for intravenous injection 250 Common name: Efra-loctocog alpha (genetically modified) |
| 2015-700045 (○) | JP3306473 | Tazobactam / piperacillin hydrate |
| 2015-700045 (■) | JP3306473 | Tazobactam / piperacillin hydrate |
| 2015-700044 (○) | JP4493334 | Nesp injection solution 180 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700044 (■) | JP4493334 | Nesp injection solution 180 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700043 (○) | JP4493334 | Nesp injection solution 120 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700043 (■) | JP4493334 | Nesp injection solution 120 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700042 (○) | JP4493334 | Nesp injection solution 60 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700042 (■) | JP4493334 | Nesp injection solution 60 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700041 (○) | JP4493334 | Nesp injection solution 40 microg syringe darbepoetin alpha (genetically modified) |
| 2015-700041 (■) | JP4493334 | Nesp injection solution 40 microg syringe Syrube Darbepoetin alpha (genetically modified) |
| 2015-700040 (○) | JP4493334 | Nesp injection solution 30 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700040 (■) | JP4493334 | Nesp injection solution 30 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700039 (○) | JP4493334 | Nesp injection solution 20 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700039 (■) | JP4493334 | Nesp injection solution 20 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700038 (○) | JP4493334 | Nesp injection solution 15 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700038 (■) | JP4493334 | Nesp injection solution 15 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700037 (○) | JP4493334 | Nesp injection solution 10 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700037 (■) | JP4493334 | Nesp injection solution 10 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700036 (○) | JP4493334 | Nesp injection solution 5 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700036 (■) | JP4493334 | Nesp injection solution 5 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700035 (○) | JP4141156 | Nesp injection solution 180 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700035 (■) | JP4141156 | Nesp injection solution 180 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700034 (○) | JP4141156 | Nesp injection solution 120 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700034 (■) | JP4141156 | Nesp injection solution 120 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700033 (○) | JP4141156 | Nesp injection solution 60 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700033 (■) | JP4141156 | Nesp injection solution 60 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700032 (○) | JP4141156 | Nesp injection solution 40 microg syringe darbepoetin alpha (genetically modified) |
| 2015-700032 (■) | JP4141156 | Nesp injection solution 40 microg syringe Syrube Darbepoetin alpha (genetically modified) |
| 2015-700031 (○) | JP4141156 | Nesp injection solution 30 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700031 (■) | JP4141156 | Nesp injection solution 30 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700030 (○) | JP4141156 | Nesp injection solution 20 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700030 (■) | JP4141156 | Nesp injection solution 20 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700029 (○) | JP4141156 | Nesp injection solution 15 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700029 (■) | JP4141156 | Nesp injection solution 15 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700028 (○) | JP4141156 | Nesp injection solution 10 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700028 (■) | JP4141156 | Nesp injection solution 10 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700027 (○) | JP4141156 | Nesp injection solution 5 microg plastic syringe darbepoetin alpha (genetically modified) |
| 2015-700027 (■) | JP4141156 | Nesp injection solution 5 microg plastic syringe Darbepoetin alfa (genetically modified) |
| 2015-700026 (○) | JP4865937 | Name of sale: Abraxane 100 mg for intravenous infusion General name: paclitaxel |
| 2015-700026 (■) | JP4865937 | Name of sale: Abraxane 100 mg for intravenous infusion General name: paclitaxel |
| 2015-700025 (○) | JP4837809 | Name of sale: Abraxane 100 mg for intravenous infusion General name: paclitaxel |
| 2015-700025 (■) | JP4837809 | Name of sale: Abraxane 100 mg for intravenous infusion General name: paclitaxel |
| 2015-700024 (○) | JP3258672 | Common Name: Caspofungin Acetate for Injection Name: Cancidas Intravenous Drip Injection 70 mg Active Ingredient: Caspofungin Acetate |
| 2015-700024 (■) | JP3258672 | Common Name: Caspofungin Acetate for Injection Name: Cancidas Intravenous Drip Injection 70 mg Active Ingredient: Caspofungin Acetate |
| 2015-700023 (○) | JP3258672 | General name: caspofungin acetate for injection Name of sale: Cansidas intravenous drip 50 mg Active ingredient: caspofungin acetate |
| 2015-700023 (■) | JP3258672 | General name: caspofungin acetate for injection Name of sale: Cansidas intravenous drip 50 mg Active ingredient: caspofungin acetate |
| 2015-700022 (○) | JP2852128 | Common Name: Caspofungin Acetate for Injection Name: Cancidas Intravenous Drip Injection 70 mg Active Ingredient: Caspofungin Acetate |
| 2015-700022 (■) | JP2852128 | Common Name: Caspofungin Acetate for Injection Name: Cancidas Intravenous Drip Injection 70 mg Active Ingredient: Caspofungin Acetate |
| 2015-700021 (○) | JP2852128 | General name: caspofungin acetate for injection Name of sale: Cansidas intravenous drip 50 mg Active ingredient: caspofungin acetate |
| 2015-700021 (■) | JP2852128 | General name: caspofungin acetate for injection Name of sale: Cansidas intravenous drip 50 mg Active ingredient: caspofungin acetate |
| 2015-700020 (○) | JP4219932 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2015-700020 (■) | JP4219932 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2015-700019 (○) | JP4052515 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2015-700019 (■) | JP4052515 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2015-700018 (○) | JP3926153 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2015-700018 (■) | JP3926153 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2015-700017 (○) | JP5460315 | Methylthioninium chloride hydrate (brand name: methylene blue intravenous injection 50 mg "Daiichi Sankyo") |
| 2015-700017 (■) | JP5460315 | Methylthioninium chloride hydrate (brand name: methylene blue intravenous injection 50 mg "Daiichi Sankyo") |
| 2015-700016 (○) | JP4173195 | Name of sale: Complera combination tablet Common name: rilpivirine hydrochloride / tenofovir Disoproxil fumarate / Emtricitabine combination tablet |
| 2015-700015 (○) | JP4996241 | Name of sale: Complera combination tablet Common name: rilpivirine hydrochloride / tenofovir Disoproxil fumarate / Emtricitabine combination tablet |
| 2015-700015 (■) | JP4996241 | Name of sale: Complera combination tablet Common name: rilpivirine hydrochloride / tenofovir disoproxil fumarate / emtricitabine combination tablet |
| 2015-700014 (○) | JP4173202 | Name of sale: Complera combination tablet Common name: rilpivirine hydrochloride / tenofovir Disoproxil fumarate / Emtricitabine combination tablet |
| 2015-700014 (■) | JP4173202 | Name of sale: Complera combination tablet Common name: rilpivirine hydrochloride / tenofovir disoproxil fumarate / emtricitabine combination tablet |
| 2015-700013 (○) | JP4033494 | Name of sale: Complera combination tablet Common name: rilpivirine hydrochloride / tenofovir Disoproxil fumarate / Emtricitabine combination tablet |
| 2015-700013 (■) | JP4033494 | Name of sale: Complera combination tablet Common name: rilpivirine hydrochloride / tenofovir disoproxil fumarate / emtricitabine combination tablet |
| 2015-700012 (○) | JP5507791 | Drugs targeted for disposal (brand name) Complera combination tablets Active ingredients for pharmaceuticals targeted for disposal (general name) Rilpivirine hydrochloride Emtricitabine Tenofovir < br> Disoproxil fumarate |
| 2015-700012 (■) | JP5507791 | Drugs subject to disposal (brand name) Complera combination tablet Active ingredient of medications subject to disposal (general name) Rilpivirine hydrochloride Emtricitabine Tenofovir Diso Proxil fumarate |
| 2015-700011 (○) | JP4912309 | Drugs subject to disposal (brand name) Complera-blended tablets active ingredients of drug subject to disposal (general name) rilpiviline hydrochloride emtricitabine tenofovir disoproxil fumarate |
| 2015-700011 (■) | JP4912309 | Drugs subject to disposal (brand name) Complera combination tablet Active ingredient of medications subject to disposal (general name) Rilpivirine hydrochloride Emtricitabine Tenofovir Diso Proxil fumarate |
| 2015-700010 (○) | JP4838396 | Drugs subject to disposal (brand name) Complera-blended tablets active ingredients of drug subject to disposal (general name) rilpiviline hydrochloride emtricitabine tenofovir disoproxil fumarate |
| 2015-700010 (■) | JP4838396 | Drugs subject to disposal (brand name) Complera combination tablet Active ingredient of medications subject to disposal (general name) Rilpivirine hydrochloride Emtricitabine Tenofovir Diso Proxil fumarate |
| 2015-700009 (○) | JP5216002 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2015-700009 (■) | JP5216002 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2015-700008 (○) | JP5216002 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2015-700008 (■) | JP5216002 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2015-700007 (○) | JP5273746 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2015-700007 (■) | JP5273746 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2015-700006 (○) | JP5273746 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2015-700006 (■) | JP5273746 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2015-700005 (○) | JP4723140 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2015-700005 (■) | JP4723140 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2015-700004 (○) | JP4723140 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2015-700004 (■) | JP4723140 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2015-700003 (○) | JP4344135 | Spidera 2.5 micro g repimat 60 inhalation (active ingredient: tiotropium bromide hydrate) |
| 2015-700003 (■) | JP4344135 | Spidera 2.5 μg respimat 60 inhalation (active ingredient: tiotropium bromide hydrate) |
| 2015-700002 (○) | JP5324091 | Osurnia |
| 2015-700002 (■) | JP5324091 | Osurnia |
| 2015-700001 (○) | JP4991530 | Osurnia |
| 2015-700001 (■) | JP4991530 | Osurnia |
| 2014-700301 (○) | JP4141156 | Glaster subcutaneous injection 3.6 mg pegfilgrastim (genetically modified) |
| 2014-700301 (■) | JP4141156 | Glaster subcutaneous injection 3.6 mg pegfilgrastim (genetically modified) |
| 2014-700300 (○) | JP3117251 | Glaster subcutaneous injection 3.6 mg pegfilgrastim (genetically modified) |
| 2014-700300 (■) | JP3117251 | Glaster subcutaneous injection 3.6 mg pegfilgrastim (genetically modified) |
| 2014-700299 (○) | JP4890657 | Name of Sale: Prorenal Tablet 5μg Active Ingredient: Limaprost Alphadex |
| 2014-700299 (■) | JP4890657 | Name of Sale: Prorenal Tablet 5μg Active Ingredient: Limaprost Alphadex |
| 2014-700298 (○) | JP4890657 | Name of Sale: Opalmon Tablets 5μg Active Ingredients: Limaprost Alphadex |
| 2014-700298 (■) | JP4890657 | Name of Sale: Opalmon Tablets 5μg Active Ingredients: Limaprost Alphadex |
| 2014-700297 (○) | JP4537582 | Boschliffe Tablets 100 mg Active Ingredient: Bosutinib hydrate |
| 2014-700297 (■) | JP4537582 | A Name of sale: Boschliffe Tablet 100 mg Active ingredient: Bostinib hydrate |
| 2014-700296 (○) | JP4537500 | Name of sale: BOSCHRIF Tablet 100 mg Active ingredient: Bostinib hydrate |
| 2014-700296 (■) | JP4537500 | A Name of sale: Boschliffe Tablet 100 mg Active ingredient: Bostinib hydrate |
| 2014-700295 (○) | JP4168071 | Lipasdil hydrochloride hydrate |
| 2014-700295 (■) | JP4168071 | Lipasdil hydrochloride hydrate |
| 2014-700294 (○) | JP4099201 | Lipasdil hydrochloride hydrate |
| 2014-700294 (■) | JP4099201 | Lipasdil hydrochloride hydrate |
| 2014-700293 (○) | JP40101600 | Lipasdil hydrochloride hydrate |
| 2014-700293 (■) | JP40101600 | Lipasdil hydrochloride hydrate |
| 2014-700292 (○) | JP4316794 | Lipasdil hydrochloride hydrate |
| 2014-700292 (■) | JP4316794 | Lipasdil hydrochloride hydrate |
| 2014-700291 (○) | JP3834663 | Lipasdil hydrochloride hydrate |
| 2014-700291 (■) | JP3834663 | Lipasdil hydrochloride hydrate |
| 2014-700290 (○) | JP4299483 | Types of pesticides: pyraclonyl, pyrimisulfan, phenoxasulfone agents Pesticide names: Yabu-shabu 250 Active ingredients: (general name) pyraclonyl, pyrimisulfan, fenoxasulfone chemical name : 1- (3-Chloro-4,5,6,7-tetrahydropyrazolo [1,5-a] pyridin-2-yl) -5- [methyl (prop-2-ynyl) amino] pyrazole-4 -Carbonitrile, (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) (hydroxy) methyl] -1,1-difluoro-6'-(methoxymethyl) methanesulfonanilide, 3- [ (2,5-Dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700290 (■) | JP4299483 | Types of pesticides: pyraclonyl, pyrimisulfan, phenoxasulfone agents Pesticide names: Yabu-shabu 250 Active ingredients: (general name) pyraclonyl, pyrimisulfan, fenoxasulfone chemical name : 1- (3-Chloro-4,5,6,7-tetrahydropyrazolo [1,5-a] pyridin-2-yl) -5- [methyl (prop-2-ynyl) amino] pyrazole-4 -Carbonitrile, (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) (hydroxy) methyl] -1,1-difluoro-6'-(methoxymethyl) methanesulfonanilide, 3- [ (2,5-Dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700289 (○) | JP4299483 | Types of pesticides: pyrimisulfan ・ phenoxasulfone ・ benzobicyclon granules Name of pesticide: Benkei 1 kg granules Active ingredients: (general name) pyrimisulfan, phenoxasulfone ・ benzobicyclo Chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) (hydroxy) methyl] -1,1-difluoro-6'-(methoxymethyl) methanesulfonanilide, 3-[(2,5-Dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, 3- (2-chloro-4-mesylbenzoyl) -2 -Fernithiobicyclo [3.2.1] octa-2-en-4-one |
| 2014-700289 (■) | JP4299483 | Types of pesticides: pyrimisulfan ・ phenoxasulfone ・ benzobicyclo granules Name of pesticide: Benkei 1 kg granules Active ingredients: (general name) pyrimisulfan ・ phenoxasulfone ・ benzobicyclo Chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) (hydroxy) methyl] -1,1-difluoro-6'-(methoxymethyl) methanesulfonanilide, 3-[(2,5-Dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, 3- (2-chloro-4-mesylbenzoyl) -2 -Fernithiobicyclo [3.2.1] octa-2-en-4-one |
| 2014-700288 (○) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl wettable powder Name of pesticide: Cumister L flowable Active ingredient: (general name) fenoxasulfone, bromobutide, bensulfuron methyl chemistry Name: 3-[(2,5-dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, (RS) -2-bromo-N- (α , Α-Dimethylbenzyl) -3,3-dimethylbutylamide, methyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2014-700288 (■) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl wettable powder Name of pesticide: Cumister L flowable Active ingredient: (general name) fenoxasulfone, bromobutide, bensulfuron methyl chemistry Name: 3-[(2,5-dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, (RS) -2-bromo-N- (α , Α-Dimethylbenzyl) -3,3-dimethylbutylamide, methyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2014-700287 (○) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl wettable powder Name of pesticide: Cumister flowable Active ingredient: (general name) fenoxasulfone, bromobutide, bensulfuron menthyl chemistry Name: 3-[(2,5-dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, (RS) -2-bromo-N- (α , Α-Dimethylbenzyl) -3,3-dimethylbutylamide, methyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2014-700287 (■) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl wettable powder Name of pesticide: Cumister flowable Active ingredient: (general name) fenoxasulfone, bromobutide, bensulfuron menthyl chemistry Name: 3-[(2,5-dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, (RS) -2-bromo-N- (α , Α-Dimethylbenzyl) -3,3-dimethylbutylamide, methyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2014-700286 (○) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl agent Name of pesticide: Cumister L jumbo Active ingredient: (general name) fenoxasulfone, bromobutide, bensulfuron menthyl chemical name: 3-[(2,5-dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, (RS) -2-bromo-N- (α, α -Dimethylbenzyl) -3,3-dimethylbutylamide, methyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2014-700286 (■) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl agent Name of pesticide: Cumister L jumbo Active ingredient: (general name) fenoxasulfone, bromobutide, bensulfuron menthyl chemical name: 3-[(2,5-dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, (RS) -2-bromo-N- (α, α -Dimethylbenzyl) -3,3-dimethylbutylamide, methyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2014-700285 (○) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl agent Name of pesticide: Cumister Jumbo Active ingredient: (general name) fenoxasulfone, bromobutide, bensulfuron menthyl chemical name: 3-[(2,5-dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, (RS) -2-bromo-N- (α, α -Dimethylbenzyl) -3,3-dimethylbutylamide, methyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2014-700285 (■) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl agent Name of pesticide: Cumister Jumbo Active ingredient: (general name) fenoxasulfone, bromobutide, bensulfuron menthyl chemical name: 3-[(2,5-dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, (RS) -2-bromo-N- (α, α -Dimethylbenzyl) -3,3-dimethylbutylamide, methyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2014-700284 (○) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl agent Name of pesticide: Cumister L bean crush 250 Active ingredient: (general name) fenoxasulfone, bromobutide, bensulfuron menthyl chemistry Name: 3-[(2,5-dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, (RS) -2-bromo-N- (α , Α-Dimethylbenzyl) -3,3-dimethylbutylamide, methyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2014-700284 (■) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl agent Name of pesticide: Cumister L bean crush 250 Active ingredient: (general name) fenoxasulfone, bromobutide, bensulfuron menthyl chemistry Name: 3-[(2,5-dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, (RS) -2-bromo-N- (α , Α-Dimethylbenzyl) -3,3-dimethylbutylamide, methyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2014-700283 (○) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl agent Name of pesticide: Cumister mash 250 Active ingredient: (general name) fenoxasulfone, bromobutide, bensulfuron menthyl chemical name : 3-[(2,5-dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, (RS) -2-bromo-N- (α, α, α-Dimethylbenzyl) -3,3-dimethylbutylamide, methyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2014-700283 (■) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl agent Name of pesticide: Cumister mash 250 Active ingredient: (general name) fenoxasulfone, bromobutide, bensulfuron menthyl chemical name : 3-[(2,5-dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, (RS) -2-bromo-N- (α, α, α-Dimethylbenzyl) -3,3-dimethylbutylamide, methyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2014-700282 (○) | JP4299483 | Types of pesticides: pyrimisulfan ・ phenoxasulfone granules Name of pesticides: gungan 1 kg granules active ingredients: (general name) pyrimisulfan, phenoxasulfone chemical name: ( RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) (hydroxy) methyl] -1,1-difluoro-6'-(methoxymethyl) methanesulfonanilide, 3-[(2,5- Dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700282 (■) | JP4299483 | Types of pesticides: pyrimisulfan ・ phenoxasulfone granules Name of pesticides: gungan 1 kg granules active ingredients: (general name) pyrimisulfan, phenoxasulfone chemical name: ( RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) (hydroxy) methyl] -1,1-difluoro-6'-(methoxymethyl) methanesulfonanilide, 3-[(2,5- Dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700281 (○) | JP4299483 | Types of pesticides: pyrimisulfan / phenoxasulfone agents Pesticide names: Gangan Jumbo Active ingredients: (general name) pyrimisulfan, fenoxasulfone Chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) (hydroxy) methyl] -1,1-difluoro-6'-(methoxymethyl) methanesulfonanilide, 3-[(2,5-dichloro-4- Ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700281 (■) | JP4299483 | Types of pesticides: pyrimisulfan / phenoxasulfone agents Pesticide names: Gangan Jumbo Active ingredients: (general name) pyrimisulfan, fenoxasulfone Chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) (hydroxy) methyl] -1,1-difluoro-6'-(methoxymethyl) methanesulfonanilide, 3-[(2,5-dichloro-4- Ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700280 (○) | JP4299483 | Types of pesticides: pyrimisulfan phenomisulsulfone agents pesticide names: pounding bean 250 active ingredients: (general name) pyrimisulfan, fenoxasulfone chemical name: (RS) -2 '-[(4,6-Dimethoxypyrimidin-2-yl) (hydroxy) methyl] -1,1-difluoro-6'-(methoxymethyl) methanesulfonanilide, 3-[(2,5-dichloro- 4-Ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700280 (■) | JP4299483 | Types of pesticides: pyrimisulfan / phenoxasulfone agents Pesticide names: pounding bean 250 Active ingredients: (general name) pyrimisulfan, phenoxasulfone chemical name: (RS) -2 '-[(4,6-Dimethoxypyrimidin-2-yl) (hydroxy) methyl] -1,1-difluoro-6'-(methoxymethyl) methanesulfonanilide, 3-[(2,5-dichloro- 4-Ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700279 (○) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl granules Pesticide name: Kmister 1 kg granules 75 Active ingredient: General name fenoxasulfone, bromobutide, bensulfuron methyl chemical name : 3-[(2,5-dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole, (RS) -2-bromo-N- (α, α, α-Dimethylbenzyl) -3,3-dimethylbutylamide, methyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2014-700279 (■) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl granules Name of pesticide: Kumister 1 kg granules 75 Active ingredient: (general name) fenoxasulfone, bromobutide, bensulfuron methyl |
| 2014-700278 (○) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl granules Name of pesticides: Kmister 1 kg granules 51 Active ingredients: (general name) fenoxasulfone, bromobutide, bensulfuron methyl |
| 2014-700278 (■) | JP4299483 | Types of pesticides: fenoxasulfone, bromobutide, bensulfuron methyl granules Name of pesticides: Kmister 1 kg granules 51 Active ingredients: (general name) fenoxasulfone, bromobutide, bensulfuron methyl |
| 2014-700277 (○) | JP4299483 | Types of pesticides: fenoxasulfone granules Name of pesticides: Hiecat 1 kg granules Active ingredients: General name: fenoxasulfones Chemical name: 3- [(2,5-dichloro- 4-Ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700277 (■) | JP4299483 | Types of pesticides: fenoxasulfone granules Name of pesticides: Hiecat 1 kg granules Active ingredients: (general name) fenoxasulfones chemical name: 3- [(2,5-dichloro -4-Ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700276 (○) | JP5216002 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2014-700276 (■) | JP5216002 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2014-700275 (○) | JP5216002 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2014-700275 (■) | JP5216002 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2014-700274 (○) | JP5273746 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2014-700274 (■) | JP5273746 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2014-700273 (○) | JP5273746 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2014-700273 (■) | JP5273746 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2014-700272 (○) | JP4723140 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2014-700272 (■) | JP4723140 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2014-700271 (○) | JP4723140 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2014-700271 (■) | JP4723140 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2014-700270 (○) | JP4675427 | General name: Suvorexant Name: Bersomula Tablet 20 mg Active Ingredient: Suvorexant |
| 2014-700270 (■) | JP4675427 | General name: Suvorexant Name: Bersomula Tablet 20 mg Active Ingredient: Suvorexant |
| 2014-700269 (○) | JP4675427 | Common Name: Suvorexant Name: Bersomula Tablet 15 mg |
| 2014-700269 (■) | JP4675427 | Common Name: Suvorexant Name: Bersomula Tablet 15 mg |
| 2014-700268 (○) | JP4621282 | Common Name: Vanip Level Name of Sales: Bani Hepple Capsule 150 mg Active Ingredient: Vaniprevir |
| 2014-700268 (■) | JP4621282 | Common Name: Vanipreville Name: Vanipep Capsule 150 mg Active Ingredient: Vaniprevir |
| 2014-700267 (○) | JP5390014 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700267 (■) | JP5390014 | Name of sale: Lixiana Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700266 (○) | JP5390014 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700266 (■) | JP5390014 | Name of sale: Lixiana Tablets 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700265 (○) | JP5390014 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700265 (■) | JP5390014 | Name of sale: Lixiana Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700264 (○) | JP5390014 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700264 (■) | JP5390014 | Name of sale: Lixiana Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700263 (○) | JP5390014 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700263 (■) | JP5390014 | Name of sale: Lixiana Tablets 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700262 (○) | JP5390014 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700262 (■) | JP5390014 | Name of sale: Lixiana Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700261 (○) | JP5305421 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700261 (■) | JP5305421 | Name of sale: Lixiana Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700260 (○) | JP5305421 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700260 (■) | JP5305421 | Name of sale: Lixiana Tablets 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700259 (○) | JP5305421 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700259 (■) | JP5305421 | Name of sale: Lixiana Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700258 (○) | JP5305421 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700258 (■) | JP5305421 | Name of sale: Lixiana Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700257 (○) | JP5305421 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700257 (■) | JP5305421 | Name of sale: Lixiana Tablets 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700256 (○) | JP5305421 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700256 (■) | JP5305421 | Name of sale: Lixiana Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700255 (○) | JP4463875 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700255 (■) | JP4463875 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700254 (○) | JP4463875 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700254 (■) | JP4463875 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700253 (○) | JP4463875 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700253 (■) | JP4463875 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700252 (○) | JP4463875 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700252 (■) | JP4463875 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700251 (○) | JP4463875 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700251 (■) | JP4463875 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700250 (○) | JP4463875 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700250 (■) | JP4463875 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700249 (○) | JP4510088 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700249 (■) | JP4510088 | Name of sale: Lixiana Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700248 (○) | JP4510088 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700248 (■) | JP4510088 | Name of sale: Lixiana Tablets 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700247 (○) | JP4510088 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700247 (■) | JP4510088 | Name of sale: Lixiana Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700246 (○) | JP4510088 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700246 (■) | JP4510088 | Name of sale: Lixiana Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700245 (○) | JP4510088 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700245 (■) | JP4510088 | Name of sale: Lixiana Tablets 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700244 (○) | JP4510088 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700244 (■) | JP4510088 | Name of sale: Lixiana Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700243 (○) | JP4109288 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700243 (■) | JP4109288 | Name of sale: Lixiana Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700242 (○) | JP4109288 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700242 (■) | JP4109288 | Name of sale: Lixiana Tablets 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700241 (○) | JP4109288 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700241 (■) | JP4109288 | Name of sale: Lixiana Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700240 (○) | JP4109288 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700240 (■) | JP4109288 | Name of sale: Lixiana Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700239 (○) | JP4109288 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700239 (■) | JP4109288 | Name of sale: Lixiana Tablets 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700238 (○) | JP4109288 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700238 (■) | JP4109288 | Name of sale: Lixiana Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700237 (○) | JP4128138 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700237 (■) | JP4128138 | Name of sale: Lixiana Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700236 (○) | JP4128138 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700236 (■) | JP4128138 | Name of sale: Lixiana Tablets 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700235 (○) | JP4128138 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700235 (■) | JP4128138 | Name of sale: Lixiana Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700234 (○) | JP4128138 | Name of Sale: Liciana Tablets 60mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2014-700234 (■) | JP4128138 | Name of sale: Lixiana Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700233 (○) | JP4128138 | Name of Sale: Riciana Tablets 30mg Active Ingredients: Edoxaban tosylate Hydrate Hydrate |
| 2014-700233 (■) | JP4128138 | Name of sale: Lixiana Tablets 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700232 (○) | JP4128138 | Name of Sale: Lixiana Tablet 15mg Active Ingredient: Edoxaban tosylate Hydrate |
| 2014-700232 (■) | JP4128138 | Name of sale: Lixiana Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2014-700231 (○) | JP4154326 | Name of sale; Marine dip (active ingredient: methyl pyruvate) |
| 2014-700231 (■) | JP4154326 | Name of sale; Marine dip (active ingredient: methyl pyruvate) |
| 2014-700230 (○) | JP3364481 | Zonisamide (brand name: Torelief OD tablet 25 mg) |
| 2014-700230 (■) | JP3364481 | Zonisamide (brand name: Torelief OD tablet 25 mg) |
| 2014-700228 (○) | JP5324574 | Name of Sales: Dakul In The Tablets 60mg Active Ingredient: General Name: Daclatasvir Hydrochloride |
| 2014-700228 (■) | JP5324574 | Name of sale: Dakul in the tablet 60 mg active ingredient General name: daclatasvir hydrochloride |
| 2014-700227 (○) | JP5244179 | Name of Sales: Dakul In The Tablets 60mg Active Ingredient: General Name: Daclatasvir Hydrochloride |
| 2014-700227 (■) | JP5244179 | Name of Sales: Dakul In The Tablets 60 mg Active Ingredients General Name: Daclatasvir Hydrochloride |
| 2014-700226 (○) | JP5091480 | Name of Sales: Orprolix Intravenous Injection 3000 Common Name: Eftrenonacog Alpha (genetically modified) |
| 2014-700226 (■) | JP5091480 | Name of Sales: Orprolix Intravenous Injection 3000 Common Name: Eftrenonacog Alpha (genetically modified) |
| 2014-700225 (○) | JP5091480 | Sales name: Orprolix for intravenous injection 2000 Common name: Eftrenonacog alpha (genetically modified) |
| 2014-700225 (■) | JP5091480 | Sales name: Orprolix for intravenous injection 2000 Common name: Eftrenonacog alpha (genetically modified) |
| 2014-700224 (○) | JP5091480 | Name of Sales: Orprolix Intravenous Injection 1000 Common Name: Eftrenonacog Alpha (Genetic Recombination) |
| 2014-700224 (■) | JP5091480 | Name of Sales: Orprolix Intravenous Injection 1000 Common Name: Eftrenonacog Alpha (Genetic Recombination) |
| 2014-700223 (○) | JP5091480 | Name of sale: Orprolix for intravenous injection 500 Common name: Eftrenonacog alpha (genetically modified) |
| 2014-700223 (■) | JP5091480 | Name of sale: Orprolix for intravenous injection 500 Common name: Eftrenonacog alpha (genetically modified) |
| 2014-700222 (○) | JP5091480 | Name of sale: Orprolix for intravenous injection 250 Common name: Eftenonacog alpha (genetically modified) |
| 2014-700222 (■) | JP5091480 | Name of sale: Orprolix for intravenous injection 250 Common name: Eftrenona cog Alpha (genetically modified) |
| 2014-700221 (○) | JP5475653 | Name of Sale: JAKAVI Mold Tablet 5mg Active Ingredient: Luxolitinib phosphate |
| 2014-700221 (■) | JP5475653 | Name of sale: JAKAVI Tablets 5mg Active ingredient: Ruxolitinib phosphate |
| 2014-700220 (○) | JP5017278 | Name of Sale: JAKAVI Mold Tablet 5mg Active Ingredient: Luxolitinib phosphate |
| 2014-700220 (■) | JP5017278 | Name of sale: JAKAVI Tablets 5mg Active ingredient: Ruxolitinib phosphate |
| 2014-700219 (○) | JP4885896 | Active ingredient (general name) of medicines targeted for disposal of Stalebo combination tablets L100 (i) levodopa carbidopa hydrate entakapon |
| 2014-700219 (■) | JP4885896 | Active ingredient (general name) of medicines targeted for disposal of Stalebo combination tablets L100 (i) levodopa carbidopa hydrate entakapon |
| 2014-700218 (○) | JP4885896 | Active ingredient (general name) of pharmaceuticals targeted for disposal of Stalebo combination tablets L50 (i) Levodopa carbidopa hydrate ・ entakapon |
| 2014-700218 (■) | JP4885896 | Active ingredient (general name) of pharmaceuticals targeted for disposal of Stalebo combination tablets L50 (i) Levodopa carbidopa hydrate ・ entakapon |
| 2014-700217 (○) | JP4204783 | Active ingredient (general name) of medicines targeted for disposal of Stalebo combination tablets L100 (i) levodopa carbidopa hydrate entakapon |
| 2014-700217 (■) | JP4204783 | Active ingredient (general name) of medicines targeted for disposal of Stalebo combination tablets L100 (i) levodopa carbidopa hydrate entakapon |
| 2014-700216 (○) | JP4204783 | Active ingredient (general name) of pharmaceuticals targeted for disposal of Stalebo combination tablets L50 (i) Levodopa carbidopa hydrate ・ entakapon |
| 2014-700216 (■) | JP4204783 | Active ingredient (general name) of pharmaceuticals targeted for disposal of Stalebo combination tablets L50 (i) Levodopa carbidopa hydrate ・ entakapon |
| 2014-700215 (○) | JP5159788 | Name of Sale: Kanagru Tablet 100 mg Active Ingredient: Canagliflozin Hydrate |
| 2014-700215 (■) | JP5159788 | Name of Sale: Kanagru Tablet 100 mg Active Ingredient: Canagliflozin Hydrate |
| 2014-700214 (○) | JP4496174 | Name of Sale: Kanagru Tablet 100 mg Active Ingredient: Canagliflozin Hydrate |
| 2014-700214 (■) | JP4496174 | Name of Sale: Kanagru Tablet 100 mg Active Ingredient: Canagliflozin Hydrate |
| 2014-700213 (○) | JP4130466 | Name of Sale: Kanagru Tablet 100 mg Active Ingredient: Canagliflozin Hydrate |
| 2014-700213 (■) | JP4130466 | Name of Sale: Kanagru Tablet 100 mg Active Ingredient: Canagliflozin Hydrate |
| 2014-700212 (○) | JP5199667 | Zytiga Tablet 250 mg (Active Ingredient: "Abiraterone Acetate") |
| 2014-700212 (■) | JP5199667 | Zytiga Tablet 250 mg (active ingredient "abiraterone acetate") |
| 2014-700211 (○) | JP5069561 | Zytiga Tablet 250 mg (Active Ingredient: "Abiraterone Acetate") |
| 2014-700211 (■) | JP5069561 | Zytiga Tablet 250 mg (Active Ingredient: "Abiraterone Acetate") |
| 2014-700210 (○) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2014-700210 (■) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2014-700209 (○) | JP4361545 | Name of sale: Opdivo IV infusion 20 mg Active ingredient name: nivolumab (genetically modified) |
| 2014-700209 (■) | JP4361545 | Name of sale: Opdivo IV infusion 20 mg Active ingredient name: nivolumab (genetically modified) |
| 2014-700208 (○) | JP4813017 | (Sales name) for bike lot combination intravenous injection |
| 2014-700208 (■) | JP4813017 | Name of Sale: Bike Lot Combination Intravenous Injection Active Ingredients: General Name: Dry Concentrated Human Blood Coagulation Factor X-activated Factor VII |
| 2014-700207 (○) | JP4676585 | (Sales name) for bike lot combination intravenous injection |
| 2014-700207 (■) | JP4676585 | Name of Sale: Bike Lot Combination Intravenous Injection Active Ingredients: General Name: Dry Concentrated Human Blood Coagulation Factor X-activated Factor VII |
| 2014-700206 (○) | JP4613133 | (Sales name) for bike lot combination intravenous injection |
| 2014-700206 (■) | JP4613133 | Name of Sale: Bike Lot Combination Intravenous Injection Active Ingredients: General Name: Dry Concentrated Human Blood Coagulation Factor X-activated Factor VII |
| 2014-700205 (○) | JP4046377 | (Sales name) for bike lot combination intravenous injection |
| 2014-700205 (■) | JP4046377 | Name of Sale: Bike Lot Combination Intravenous Injection Active Ingredients: General Name: Dry Concentrated Human Blood Coagulation Factor X-activated Factor VII |
| 2014-700204 (○) | JP5235882 | Name of Sales: Dakul In The Tablets 60mg Active Ingredient: General Name: Daclatasvir Hydrochloride |
| 2014-700204 (■) | JP5235882 | Name of sale: Dakul in the tablet 60 mg active ingredient General name: daclatasvir hydrochloride |
| 2014-700203 (○) | JP4312710 | Name of Sale: Sunbepra Capsule 100mg Active Ingredient: General Name: Asunaprevir |
| 2014-700203 (■) | JP4312710 | Name of Sale: Sunbepra Capsule 100mg Active Ingredient Common Name: Asuna Prebil |
| 2014-700202 (○) | JP3977420 | Type of medicine: precipitated and purified pertussis diphtheria tetanus inactivated polio (Sork vaccine) combination vaccine Name of medicine: Square Kids hypodermic syringe |
| 2014-700201 (○) | JP3280675 | Type of medicine: precipitated and purified pertussis diphtheria tetanus inactivated polio (Sork vaccine) combination vaccine Name of medicine: Square Kids hypodermic syringe |
| 2014-700201 (■) | JP3280675 | Type of medicine: precipitated and purified pertussis diphtheria tetanus inactivated polio (Sork vaccine) combination vaccine Name of medicine: Square Kids hypodermic syringe |
| 2014-700200 (○) | JP4409430 | Name of sale: Opdivo IV 100 mg Active ingredient: Nivolumab (genetically modified) |
| 2014-700200 (■) | JP4409430 | Name of sale: Opdivo IV 100 mg Active ingredient: Nivolumab (genetically modified) |
| 2014-700199 (○) | JP4409430 | Name of sale: Opdivo Intravenous Drip Injection 20 mg Active Ingredient: Nivolumab (genetically modified) |
| 2014-700199 (■) | JP4409430 | Name of sale: Opdivo Intravenous Drip Injection 20 mg Active Ingredient: Nivolumab (genetically modified) |
| 2014-700198 (○) | JP5345174 | Deltiva Tablets 50 mg (General name: Dela Manido) |
| 2014-700198 (■) | JP5345174 | Deltiva Tablets 50 mg (General name: Dela Manido) |
| 2014-700197 (○) | JP5105818 | Deltiva Tablets 50 mg (General name: Dela Manido) |
| 2014-700197 (■) | JP5105818 | Deltiva Tablets 50 mg (General name: Dela Manido) |
| 2014-700196 (○) | JP5006987 | Name of sale: AleSensa Capsule 40mg Active ingredient: Alectinib hydrochloride |
| 2014-700196 (■) | JP5006987 | Name of sale: AleSensa Capsule 40mg Active ingredient: Alectinib hydrochloride |
| 2014-700195 (○) | JP5006987 | Name of sale: AleSensa Capsule 20mg Active ingredient: Alectinib hydrochloride |
| 2014-700195 (■) | JP5006987 | Name of sale: AleSensa Capsule 20mg Active ingredient: Alectinib hydrochloride |
| 2014-700194 (○) | JP4971343 | Deltiva Tablets 50 mg (General name: Dela Manido) |
| 2014-700194 (■) | JP4971343 | Deltiva Tablets 50 mg (General name: Dela Manido) |
| 2014-700193 (○) | JP4918630 | Name of sale: AleSensa Capsule 40mg Active ingredient: Alectinib hydrochloride |
| 2014-700193 (■) | JP4918630 | Name of sale: AleSensa Capsule 40mg Active ingredient: Alectinib hydrochloride |
| 2014-700192 (○) | JP4918630 | Name of sale: AleSensa Capsule 20mg Active ingredient: Alectinib hydrochloride |
| 2014-700192 (■) | JP4918630 | Name of sale: AleSensa Capsule 20mg Active ingredient: Alectinib hydrochloride |
| 2014-700191 (○) | JP4808246 | Deltiva Tablets 50 mg (General name: Dela Manido) |
| 2014-700191 (■) | JP4808246 | Deltiva Tablets 50 mg (General name: Dela Manido) |
| 2014-700190 (○) | JP4787529 | Deltiva Tablets 50 mg (General name: Dela Manido) |
| 2014-700190 (■) | JP4787529 | Deltiva Tablets 50 mg (General name: Dela Manido) |
| 2014-700189 (○) | JP4588121 | Name of sale: AleSensa Capsule 40mg Active ingredient: Alectinib hydrochloride |
| 2014-700189 (■) | JP4588121 | Name of sale: AleSensa Capsule 40mg Active ingredient: Alectinib hydrochloride |
| 2014-700188 (○) | JP4588121 | Name of sale: AleSensa Capsule 20mg Active ingredient: Alectinib hydrochloride |
| 2014-700188 (■) | JP4588121 | Name of sale: AleSensa Capsule 20mg Active ingredient: Alectinib hydrochloride |
| 2014-700187 (○) | JP4186065 | Deltiva Tablets 50 mg (General name: Dela Manido) |
| 2014-700187 (■) | JP4186065 | Deltiva Tablets 50 mg (General name: Dela Manido) |
| 2014-700186 (○) | JP501411 | Name of sale: Anoloellipta 30 for inhalation Active ingredient: Umeclidinium bromide Active ingredient: Billanterol triphenyl acetate |
| 2014-700186 (■) | JP501411 | Name of sale: Anoloellipta 30 for inhalation Active ingredient: Umeclidinium bromide Active ingredient: Billanterol triphenyl acetate |
| 2014-700185 (○) | JP501411 | Name of sale: Anoloellipta 7 for inhalation Active ingredient: Umeclidinium bromide Active ingredient: Billanterol triphenyl acetate |
| 2014-700185 (■) | JP501411 | Name of sale: Anoloellipta 7 for inhalation Active ingredient: Umeclidinium bromide Active ingredient: Billanterol triphenyl acetate |
| 2014-700184 (○) | JP4191034 | Name of sale: Anoloellipta 30 for inhalation Active ingredient: Umeclidinium bromide Active ingredient: Billanterol triphenyl acetate |
| 2014-700184 (■) | JP4191034 | Name of sale: Anoloellipta 30 for inhalation Active ingredient: Umeclidinium bromide Active ingredient: Billanterol triphenyl acetate |
| 2014-700183 (○) | JP4191034 | Name of sale: Anoloellipta 7 for inhalation Active ingredient: Umeclidinium bromide Active ingredient: Billanterol triphenyl acetate |
| 2014-700183 (■) | JP4191034 | Name of sale: Anoloellipta 7 for inhalation Active ingredient: Umeclidinium bromide Active ingredient: Billanterol triphenyl acetate |
| 2014-700182 (○) | JP5566466 | Name (sold name) Djevana Intravenous Drip Injection 60 mg Active Ingredient Name: Kabazitaxel Acetone adduct |
| 2014-700182 (■) | JP5566466 | Name (sold name) Djevana Intravenous Drip Injection 60 mg Active Ingredient Name: Kabazitaxel Acetone adduct |
| 2014-700181 (○) | JP5010279 | Name (sold name) Djevana Intravenous Drip Injection 60 mg Active Ingredient Name: Kabazitaxel Acetone adduct |
| 2014-700181 (■) | JP5010279 | Name (sold name) Djevana Intravenous Drip Injection 60 mg Active Ingredient Name: Kabazitaxel Acetone adduct |
| 2014-700180 (○) | JP4359386 | Name (sold name) Djevana Intravenous Drip Injection 60 mg Active Ingredient Name: Kabazitaxel Acetone adduct |
| 2014-700180 (■) | JP4359386 | Name (sold name) Djevana Intravenous Drip Injection 60 mg Active Ingredient Name: Kabazitaxel Acetone adduct |
| 2014-700179 (○) | JP2941951 | Name (sold name) Djevana Intravenous Drip Injection 60 mg Active Ingredient Name: Kabazitaxel Acetone adduct |
| 2014-700179 (■) | JP2941951 | Name (sold name) Djevana Intravenous Drip Injection 60 mg Active Ingredient Name: Kabazitaxel Acetone adduct |
| 2014-700178 (○) | JP4484023 | Types of pesticides: amiculblom hydrate Name of pesticides: Lymei flowable Types of active ingredients: 3- (3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N -Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2014-700178 (■) | JP4484023 | Pesticide type: amiculblom hydrate Pesticide name: Lymei flowable Active ingredient type: 3- (3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N -Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2014-700177 (○) | JP5173920 | General name: Precipitated 13-valent pneumococcal conjugate vaccine (nontoxic mutant diphtheria toxin conjugate) Product name: Prevena 13 aqueous suspension Active ingredient: Pneumococcal capsular polysaccharide (serotype 1) -CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 3)-CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 4)-CRM 197 conjugate pneumococcal capsule Polysaccharide (serotype 5) -CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 6A) -CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 6B) -CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 7F)-CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 9V)-CRM 197 conjugate pneumococcal capsular polysaccharide (Serotype 14) -CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 18C) -CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 19A) -CRM 197 conjugated Body Streptococcus pneumoniae capsular polysaccharide (serum 19F) -CRM 197 conjugate Streptococcus pneumoniae capsular polysaccharide (serotype 23F) -CRM <197 junction |
| 2014-700177 (■) | JP5173920 | General name: Precipitated 13-valent pneumococcal conjugate vaccine (non-toxic mutant diphtheria toxin conjugate) Product name: Prevener 13 aqueous suspension Active ingredient Pneumococcal capsular polysaccharide (serotype) 1)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 3)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 4)-CRM 197 conjugate Streptococcus pneumoniae poly Saccharide (serotype 5)-CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 6A)-CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 6B)-CRM 197 conjugate pneumonia Streptococcus capsular polysaccharide (serotype 7F) -CRM197 conjugate pneumococcal capsular polysaccharide (serotype 9V) -CRM197 conjugate pneumococcal capsular polysaccharide ( Pure 14)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 18C)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 19 A)-CRM 197 conjugate Streptococcus pneumoniae Membrane polysaccharide (serotype 19F) -CRM197 conjugate Pneumococcal capsular polysaccharide (serotype 23F) -CRM197 conjugate |
| 2014-700176 (○) | JP4472770 | General name: Precipitated 13-valent pneumococcal conjugate vaccine (nontoxic mutant diphtheria toxin conjugate) Product name: Prevena 13 aqueous suspension Active ingredient: Pneumococcal capsular polysaccharide (serotype 1) -CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 3)-CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 4)-CRM 197 conjugate pneumococcal capsule Polysaccharide (serotype 5) -CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 6A) -CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 6B) -CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 7F)-CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 9V)-CRM 197 conjugate pneumococcal capsular polysaccharide (Serotype 14) -CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 18C) -CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 19A) -CRM 197 conjugated Body Streptococcus pneumoniae capsular polysaccharide (serotype 19F) -CRM 197 conjugate Streptococcus pneumoniae capsular polysaccharide (serotype 23F) -CRM <197 junction |
| 2014-700176 (■) | JP4472770 | General name: Precipitated 13-valent pneumococcal conjugate vaccine (non-toxic mutant diphtheria toxin conjugate) Product name: Prevener 13 aqueous suspension Active ingredient Pneumococcal capsular polysaccharide (serotype) 1)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 3)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 4)-CRM 197 conjugate Streptococcus pneumoniae poly Saccharide (serotype 5)-CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 6A)-CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 6B)-CRM 197 conjugate pneumonia Streptococcus capsular polysaccharide (serotype 7F) -CRM197 conjugate pneumococcal capsular polysaccharide (serotype 9V) -CRM197 conjugate pneumococcal capsular polysaccharide ( Pure 14)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 18C)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 19 A)-CRM 197 conjugate Streptococcus pneumoniae Membrane polysaccharide (serotype 19F) -CRM197 conjugate Pneumococcal capsular polysaccharide (serotype 23F) -CRM197 conjugate |
| 2014-700175 (○) | JP5215666 | Sorafenib tosylate (brand name: Nexavar Tablet 200 mg) |
| 2014-700175 (■) | JP5215666 | Sorafenib tosylate |
| 2014-700174 (○) | JP5304241 | Sorafenib tosylate (brand name: Nexavar Tablet 200 mg) |
| 2014-700174 (■) | JP5304241 | Sorafenib tosylate (brand name: Nexavar Tablet 200 mg) |
| 2014-700173 (○) | JP3845792 | Sorafenib tosylate (brand name: Nexavar Tablet 200 mg) |
| 2014-700173 (■) | JP3845792 | Sorafenib tosylate (brand name: Nexavar tablet 200 mg) |
| 2014-700172 (○) | JP4426729 | Name of sale: Dovobet Ointment Common name: calcipotriol hydrate / betamethasone dipropionate combination drug |
| 2014-700172 (■) | JP4426729 | Name of sale: Dovobet Ointment Common name: calcipotriol hydrate / betamethasone dipropionate combination drug |
| 2014-700171 (○) | JP4465133 | Types of pesticides: piroxasulfone water dispersible powder Name of pesticides: solist powder water dispersible powder active ingredient: (general name) piroxasulfone Chemical name: 3- [5- (difluoromethoxy) -1 -Methyl-3- (trifluoromethyl) pyrazol-4-ylmethylsulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700171 (■) | JP4465133 | Types of pesticides: piroxasulfone water dispersible powder Name of pesticides: Soristo water dispersible powder active ingredients: (general name) piroxasulfone Chemical name: 3- [5- (difluoromethoxy ) -1-Methyl-3- (trifluoromethyl) pyrazol-4-ylmethylsulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700170 (○) | JP4401613 | Name of sale: Lanmark subcutaneous injection 120 mg Common name of active ingredient: Denosumab (genetically modified) |
| 2014-700170 (■) | JP4401613 | Name of sale: Lanmark subcutaneous injection 120 mg Common name of active ingredient: Denosumab (genetically modified) |
| 2014-700169 (○) | JP5065529 | Name of sale: Lanmark subcutaneous injection 120 mg Common name of active ingredient: Denosumab (genetically modified) |
| 2014-700169 (■) | JP5065529 | Name of sale: Lanmark subcutaneous injection 120 mg Common name of active ingredient: Denosumab (genetically modified) |
| 2014-700168 (○) | JP4358282 | Name of sale: Lanmark subcutaneous injection 120 mg Common name of active ingredient: Denosumab (genetically modified) |
| 2014-700168 (■) | JP4358282 | Name of sale: Lanmark subcutaneous injection 120 mg Common name of active ingredient: Denosumab (genetically modified) |
| 2014-700167 (○) | JP4212470 | Name of sale: Lanmark subcutaneous injection 120 mg Common name of active ingredient: Denosumab (genetically modified) |
| 2014-700167 (■) | JP4212470 | Name of sale: Lanmark subcutaneous injection 120 mg Common name of active ingredient: Denosumab (genetically modified) |
| 2014-700166 (○) | JP3895349 | Name of Sale: Nesina Tablets 25 mg Active Ingredient: Alogliptin Benzoate |
| 2014-700166 (■) | JP3895349 | Name of Sale: Nesina Tablets 25 mg Active Ingredient: Alogliptin Benzoate |
| 2014-700165 (○) | JP3895349 | Name: Nesina Tablets 12.5 mg Active Ingredient: Alogliptin Benzoate |
| 2014-700165 (■) | JP3895349 | Name: Nesina Tablets 12.5 mg Active Ingredient: Alogliptin Benzoate |
| 2014-700164 (○) | JP3895349 | Name of sale: Nesina Tablet 6.25mg Active ingredient: Alogliptin benzoate |
| 2014-700164 (■) | JP3895349 | Name of sale: Nesina Tablet 6.25mg Active ingredient: Alogliptin benzoate |
| 2014-700163 (○) | JP3836566 | Fentostape 8mg (active ingredient: fentanyl citrate) |
| 2014-700163 (■) | JP3836566 | Fentostape 8mg (active ingredient: fentanyl citrate) |
| 2014-700162 (○) | JP3836566 | Fentostape 6 mg (active ingredient: fentanyl citrate) |
| 2014-700162 (■) | JP3836566 | Fentostape 6 mg (active ingredient: fentanyl citrate) |
| 2014-700161 (○) | JP3836566 | Fentostape 4mg (active ingredient: fentanyl citrate) |
| 2014-700161 (■) | JP3836566 | Fentostape 4mg (active ingredient: fentanyl citrate) |
| 2014-700160 (○) | JP3836566 | Fentostape 2 mg (active ingredient: fentanyl citrate) |
| 2014-700160 (■) | JP3836566 | Fentostape 2 mg (active ingredient: fentanyl citrate) |
| 2014-700159 (○) | JP3836566 | Fentostape 1 mg (active ingredient: fentanyl citrate) |
| 2014-700159 (■) | JP3836566 | Fentostape 1 mg (active ingredient: fentanyl citrate) |
| 2014-700158 (○) | JP4414623 | Common Name: Efinaconazole |
| 2014-700158 (■) | JP4414623 | Common Name: Efinaconazole |
| 2014-700157 (○) | JP4463768 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 100 mg |
| 2014-700156 (○) | JP4463768 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia tablet 50 mg |
| 2014-700156 (■) | JP4463768 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia tablet 50 mg |
| 2014-700155 (○) | JP4463768 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 25 mg |
| 2014-700155 (■) | JP4463768 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 25 mg |
| 2014-700154 (○) | JP4463768 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia tablet 12.5 mg |
| 2014-700154 (■) | JP4463768 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia tablet 12.5 mg |
| 2014-700153 (○) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 100 mg |
| 2014-700153 (■) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 100 mg |
| 2014-700152 (○) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia tablet 50 mg |
| 2014-700152 (■) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia tablet 50 mg |
| 2014-700151 (○) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 25 mg |
| 2014-700151 (■) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 25 mg |
| 2014-700150 (○) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia tablet 12.5 mg |
| 2014-700150 (■) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia tablet 12.5 mg |
| 2014-700149 (○) | JP5069676 | Imidacloprid chlorantraniliprole isotianil penflufen box granules |
| 2014-700149 (■) | JP5069676 | Imidacloprid chlorantraniliprole isotianil penflufen box granules |
| 2014-700148 (○) | JP4550412 | Imidacloprid chlorantraniliprole isotianil penflufen box granules |
| 2014-700148 (■) | JP4550412 | Imidacloprid chlorantraniliprole isotianil penflufen box granules |
| 2014-700147 (○) | JP4557131 | Types of Pesticides: Chlorantranililiprole / Amisulblom Water Hydrating Agent Name of Pesticides: Head Water Hydrating Agent Type of Active Ingredients: 3- (3-Bromo-6-fluoro-2-methylindole- 1-ylsulfonyl) -N, N-dimethyl-1,2,4-triazole-1-sulfonamide |
| 2014-700147 (■) | JP4557131 | Types of Pesticides: Chlorantranililiprole / Amisulblom Water Hydrating Agent Name of Pesticides: Head Water Hydrating Agent Type of Active Ingredients: 3- (3-Bromo-6-fluoro-2-methylindole- 1-ylsulfonyl) -N, N-dimethyl-1,2,4-triazole-1-sulfonamide |
| 2014-700146 (○) | JP4299483 | Types of pesticides: fenoxasulfone water dispersible powder Name of pesticides: Spada water dispersible powder active ingredients: (general name) fenoxa sulfone chemical name: 3- [(2,5- Dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700146 (■) | JP4299483 | Types of pesticides: fenoxasulfone water dispersible powder Name of pesticides: Spada water dispersible powder active ingredients: (general name) fenoxa sulfone chemical name: 3- [(2,5- Dichloro-4-ethoxybenzyl) sulfonyl] -4,5-dihydro-5,5-dimethyl-1,2-oxazole |
| 2014-700145 (○) | JP5289338 | Tolvaptan (brand name: Samska Tablets 30 mg) |
| 2014-700145 (■) | JP5289338 | Tolvaptan (brand name: Samsca 30 mg) |
| 2014-700144 (○) | JP5289338 | Tolvaptan (brand name: Samska Tablet 15 mg) |
| 2014-700144 (■) | JP5289338 | Tolvaptan (brand name: Samsca Tablet 15 mg) |
| 2014-700143 (○) | JP5289338 | Tolvaptan (brand name: Samsca Tablet 7.5 mg) |
| 2014-700143 (■) | JP5289338 | Tolvaptan (brand name: Samsca Tablet 7.5 mg) |
| 2014-700142 (○) | JP4210355 | Tolvaptan (brand name: Samska Tablets 30 mg) |
| 2014-700142 (■) | JP4210355 | Tolvaptan (brand name: Samsca 30 mg) |
| 2014-700141 (○) | JP4210355 | Tolvaptan (brand name: Samska Tablet 15 mg) |
| 2014-700141 (■) | JP4210355 | Tolvaptan (brand name: Samsca Tablet 15 mg) |
| 2014-700140 (○) | JP4210355 | Tolvaptan (brand name: Samsca Tablet 7.5 mg) |
| 2014-700140 (■) | JP4210355 | Tolvaptan (brand name: Samsca Tablet 7.5 mg) |
| 2014-700139 (○) | JP4059916 | Valsartan cilnidipine |
| 2014-700139 (■) | JP4059916 | Valsartan silnidipine |
| 2014-700138 (○) | JP5086478 | Name of sale: Tobikei Tablet 50 mg Active Ingredient General Name: Doltegravyl Sodium |
| 2014-700138 (■) | JP5086478 | Name of sale: Tobikei Tablet 50 mg Active Ingredient General Name: Doltegravyl Sodium |
| 2014-700137 (○) | JP4295353 | Name of sale: Tobikei Tablet 50 mg Active Ingredient General Name: Doltegravyl Sodium |
| 2014-700137 (■) | JP4295353 | Name of sale: Tobikei Tablet 50 mg Active Ingredient General Name: Doltegravyl Sodium |
| 2014-700136 (○) | JP4173202 | Name of Sale: Tenoset Tablet 300mg Active Ingredient: Tenofovir Disoproxil Fumarate |
| 2014-700136 (■) | JP4173202 | Name of Sale: Tenoset Tablet 300mg Active Ingredient: Tenofovir Disoproxil Fumarate |
| 2014-700135 (○) | JP4033494 | Name of Sale: Tenoset Tablet 300mg Active Ingredient: Tenofovir Disoproxil Fumarate |
| 2014-700135 (■) | JP4033494 | Name of Sale: Tenoset Tablet 300mg Active Ingredient: Tenofovir Disoproxil Fumarate |
| 2014-700134 (○) | JP5138753 | Name of Sale: Extane Capsule 40mg Active Ingredient: Enzalutamide |
| 2014-700134 (■) | JP5138753 | Name of Sale: Extane Capsule 40mg Active Ingredient: Enzalutamide |
| 2014-700133 (○) | JP4644737 | Name of Sale: Extane Capsule 40mg Active Ingredient: Enzalutamide |
| 2014-700133 (■) | JP4644737 | Name of Sale: Extane Capsule 40mg Active Ingredient: Enzalutamide |
| 2014-700132 (○) | JP5313889 | Product Name: Fosiga Tablets 10 mg Common Name: Dapagliflozin Propylene Glycol Hydrate |
| 2014-700132 (■) | JP5313889 | Product Name: Fosiga Tablets 10 mg Common Name: Dapagliflozin Propylene Glycol Hydrate |
| 2014-700131 (○) | JP5313889 | Product Name: Fosiga Tablets 5 mg Common Name: Dapagliflozin Propylene Glycol Hydrate |
| 2014-700131 (■) | JP5313889 | Product Name: Fosiga Tablets 5 mg Common Name: Dapagliflozin Propylene Glycol Hydrate |
| 2014-700130 (○) | JP5090621 | Product Name: Fosiga Tablets 10 mg Common Name: Dapagliflozin Propylene Glycol Hydrate |
| 2014-700130 (■) | JP5090621 | Product Name: Fosiga Tablets 10 mg Common Name: Dapagliflozin Propylene Glycol Hydrate |
| 2014-700129 (○) | JP5090621 | Product Name: Fosiga Tablets 5 mg Common Name: Dapagliflozin Propylene Glycol Hydrate |
| 2014-700129 (■) | JP5090621 | Product Name: Fosiga Tablets 5 mg Common Name: Dapagliflozin Propylene Glycol Hydrate |
| 2014-700128 (○) | JP4365554 | Product Name: Fosiga Tablets 10 mg Common Name: Dapagliflozin Propylene Glycol Hydrate |
| 2014-700128 (■) | JP4365554 | Product Name: Fosiga Tablets 10 mg Common Name: Dapagliflozin Propylene Glycol Hydrate |
| 2014-700127 (○) | JP4365554 | Product Name: Fosiga Tablets 5 mg Common Name: Dapagliflozin Propylene Glycol Hydrate |
| 2014-700127 (■) | JP4365554 | Product Name: Fosiga Tablets 5 mg Common Name: Dapagliflozin Propylene Glycol Hydrate |
| 2014-700126 (○) | JP4126067 | Name of sale: Emulsion cell culture influenza HA vaccine H5N1 for intramuscular injection "Chokken" Active ingredient name: Inactivated split type A influenza virus |
| 2014-700126 (■) | JP4126067 | Name of sale: Emulsion cell culture influenza HA vaccine H5N1 for intramuscular injection "Chokken" Active ingredient name: Inactivated split type A influenza virus |
| 2014-700125 (○) | JP5485237 | Tofogliflozin hydrate |
| 2014-700125 (■) | JP5485237 | Tofogliflozin hydrate |
| 2014-700124 (○) | JP5485237 | Tofogliflozin hydrate |
| 2014-700124 (■) | JP5485237 | Tofogliflozin hydrate |
| 2014-700123 (○) | JP4823385 | Tofogliflozin hydrate |
| 2014-700123 (■) | JP4823385 | Tofogliflozin hydrate |
| 2014-700122 (○) | JP4823385 | Tofogliflozin hydrate |
| 2014-700122 (■) | JP4823385 | Tofogliflozin hydrate |
| 2014-700121 (○) | JP4093587 | Tofogliflozin hydrate |
| 2014-700121 (■) | JP4093587 | Tofogliflozin hydrate |
| 2014-700120 (○) | JP4093587 | Tofogliflozin hydrate |
| 2014-700120 (■) | JP4093587 | Tofogliflozin hydrate |
| 2014-700119 (○) | JP4143034 | Bimatoprost |
| 2014-700119 (■) | JP4143034 | Glush Vista topical liquid preparation 0.03% 5 mL (active ingredient: bimatoprost) |
| 2014-700118 (○) | JP4143034 | Bimatoprost |
| 2014-700118 (■) | JP4143034 | Grush Vista External solution 0.03% 3 mL (active ingredient: Bimatoprost) |
| 2014-700117 (○) | JP4728948 | Name of sale: Taisaburi Intravenous Drip Injection 300 mg General name: natalizumab (genetically modified) |
| 2014-700117 (■) | JP4728948 | Name of sale: Taisaburi Intravenous Drip Injection 300 mg General name: natalizumab (genetically modified) |
| 2014-700116 (○) | JP4115517 | Name of sale: Taisaburi Intravenous Drip Injection 300 mg General name: natalizumab (genetically modified) |
| 2014-700116 (■) | JP4115517 | Name of sale: Taisaburi Intravenous Drip Injection 300 mg General name: natalizumab (genetically modified) |
| 2014-700115 (○) | JP3717053 | Treprost Injection 200 mg (Treprostinil) |
| 2014-700115 (■) | JP3717053 | Treprost Injection 200 mg (Treprostinil) |
| 2014-700114 (○) | JP3717053 | Treprost Injection 100 mg (Treprostinil) |
| 2014-700114 (■) | JP3717053 | Treprost Injection 100 mg (Treprostinil) |
| 2014-700113 (○) | JP3717053 | Treprost Injection 50 mg (Treprostinil) |
| 2014-700113 (■) | JP3717053 | Treprost Injection 50 mg (Treprostinil) |
| 2014-700112 (○) | JP3717053 | Treprost Injection 20 mg (Treprostinil) |
| 2014-700112 (■) | JP3717053 | Treprost Injection 20 mg (Treprostinil) |
| 2014-700111 (○) | JP5363307 | Name: Effient Tablets 5mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700111 (■) | JP5363307 | Name: Effient Tablets 5mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700110 (○) | JP5363307 | Name: Effient Tablet 3.75mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700110 (■) | JP5363307 | Name: Effient Tablet 3.75mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700109 (○) | JP5274261 | Name: Effient Tablets 5mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700109 (■) | JP5274261 | Name: Effient Tablets 5mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700108 (○) | JP5274261 | Name: Effient Tablet 3.75mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700108 (■) | JP5274261 | Name: Effient Tablet 3.75mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700107 (○) | JP5289975 | Name: Effient Tablets 5mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700107 (■) | JP5289975 | Name: Effient Tablets 5mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700106 (○) | JP5289975 | Name: Effient Tablet 3.75mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700106 (■) | JP5289975 | Name: Effient Tablet 3.75mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700105 (○) | JP5289940 | Name: Effient Tablets 5mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700104 (○) | JP5289940 | Name: Effient Tablet 3.75mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700103 (○) | JP4029974 | Name of product: Effient Tablets 5 mg Active ingredient Prasugrel hydrochloride |
| 2014-700103 (■) | JP4029974 | Name of product: Effient Tablets 5 mg Active ingredient Prasugrel hydrochloride |
| 2014-700102 (○) | JP4029974 | Name of product: Effient Tablet 3.75mg Active ingredient Prasugrel hydrochloride |
| 2014-700102 (■) | JP4029974 | Name of product: Effient Tablet 3.75mg Active ingredient Prasugrel hydrochloride |
| 2014-700101 (○) | JP4874482 | Name: Effient Tablets 5mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700101 (■) | JP4874482 | Name: Effient Tablets 5mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700100 (○) | JP4874482 | Name: Effient Tablet 3.75mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700100 (■) | JP4874482 | Name: Effient Tablet 3.75mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700099 (○) | JP4001199 | Name: Effient Tablets 5mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700099 (■) | JP4001199 | Name: Effient Tablets 5mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700098 (○) | JP4001199 | Name: Effient Tablet 3.75mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700098 (■) | JP4001199 | Name: Effient Tablet 3.75mg Active Ingredient: Prasugrel Hydrochloride |
| 2014-700097 (○) | JP3088757 | Name of sale: Ronsurf combination tablet T20 Active ingredient: Trifluridine and tipiracil hydrochloride |
| 2014-700097 (■) | JP3088757 | Name of sale: Ronsurf combination tablet T20 Active ingredient: Trifluridine and tipiracil hydrochloride |
| 2014-700096 (○) | JP3088757 | Name of sale: Ronsurf combination tablet T15 Active ingredient: Trifluridine and tipiracil hydrochloride |
| 2014-700096 (■) | JP3088757 | Name of sale: Ronsurf combination tablet T15 Active ingredient: Trifluridine and tipiracil hydrochloride |
| 2014-700095 (○) | JP4047363 | Name of sale: Semi-solid agent for enteral with lacor NF Ingredients: Milk casein, isolated soy protein, tricaprylin, soybean oil, perilla oil, palm oil, maltodextrin, refined sucrose, sodium citrate hydrate , Potassium carbonate, magnesium chloride, calcium chloride hydrate, tripotassium citrate, calcium citrate, potassium dihydrogen phosphate, potassium chloride, ferrous gluconate, zinc sulfate hydrate, manganese (II) sulfate, pentahydrate Hydrate, copper sulfate, vitamin A oil (containing 200,000 IU in 1 g), cholecalciferol, tocopherol acetate, phytonadione, thiamine chloride hydrochloride, riboflavin phosphate sodium, pyridoxine hydrochloride, cyanocobalamin, sodium ascorbate, Nicotinamide, calcium pantothenate, folic acid, biotin Additives: alginate, agar powder, etc. |
| 2014-700095 (■) | JP4047363 | Name of sale: Semi-solid agent for enteral with lacor NF Ingredients: Milk casein, isolated soy protein, tricaprylin, soy oil, perilla oil, palm oil, maltodextrin, refined sucrose, sodium citrate hydrate , Potassium carbonate, magnesium chloride, calcium chloride hydrate, tripotassium citrate, calcium citrate, potassium dihydrogen phosphate, potassium chloride, ferrous gluconate, zinc sulfate hydrate, manganese (II) sulfate, pentahydrate Hydrate, copper sulfate, vitamin A oil (containing 200,000 IU in 1 g), cholecalciferol, tocopherol acetate, phytonadione, thiamine chloride hydrochloride, riboflavin phosphate sodium, pyridoxine hydrochloride, cyanocobalamin, sodium ascorbate, Nicotinamide, calcium pantothenate, folic acid, biotin Additives: Alginic acid, agar powder, etc. |
| 2014-700094 (○) | JP4253188 | Name of sale: Vorient Tablet 200 mg General name of active ingredient: Pazopanib hydrochloride |
| 2014-700094 (■) | JP4253188 | Name of sale: Vorient Tablet 200 mg General name of active ingredient: Pazopanib hydrochloride |
| 2014-700093 (○) | JP4939217 | Tapenta tablet 100 mg |
| 2014-700093 (■) | JP4939217 | Tapenta tablet 100 mg |
| 2014-700092 (○) | JP4939217 | Tapenta tablet 50 mg |
| 2014-700092 (■) | JP4939217 | Tapenta tablet 50 mg |
| 2014-700091 (○) | JP4939217 | Tapenta tablet 25 mg |
| 2014-700091 (■) | JP4939217 | Tapenta tablet 25 mg |
| 2014-700090 (○) | JP4034366 | Tapenta tablet 100 mg (General name: tapentadol hydrochloride) |
| 2014-700090 (■) | JP4034366 | Tapenta tablet 100 mg (General name: tapentadol hydrochloride) |
| 2014-700089 (○) | JP4034366 | Tapenta tablet 50 mg (General name: tapentadol hydrochloride) |
| 2014-700089 (■) | JP4034366 | Tapenta tablet 50 mg (General name: tapentadol hydrochloride) |
| 2014-700088 (○) | JP4034366 | Tapenta tablet 25 mg (General name: tapentadol hydrochloride) |
| 2014-700088 (■) | JP4034366 | Tapenta tablet 25 mg (General name: tapentadol hydrochloride) |
| 2014-700087 (○) | JP4219932 | Potelligio IV infusion 20 mg mogamulizumab (genetically modified) |
| 2014-700087 (■) | JP4219932 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2014-700086 (○) | JP4052515 | Potelligio IV infusion 20 mg mogamulizumab (genetically modified) |
| 2014-700086 (■) | JP4052515 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2014-700085 (○) | JP3926153 | Potelligio IV infusion 20 mg mogamulizumab (genetically modified) |
| 2014-700085 (■) | JP3926153 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2014-700084 (○) | JP2882882 | Cinacalcet Hydrochloride (trade name: Regpara Tablet 25 mg) |
| 2014-700084 (■) | JP2882882 | Cinacalcet hydrochloride (trade name: Regpara Tablet 25 mg) |
| 2014-700083 (○) | JP2882882 | Cinacalcet Hydrochloride (trade name: Regpara Tablet 75 mg) |
| 2014-700083 (■) | JP2882882 | Cinacalcet hydrochloride (trade name: Regpara Tablet 75 mg) |
| 2014-700082 (○) | JP3957765 | Name of sale: Lucentis intravitreal injection 2.3 mg / 0.23 mL Common name: ranibizumab (genetically modified) |
| 2014-700082 (■) | JP3957765 | Name of sale: Lucentis intravitreal injection 2.3 mg / 0.23 mL Common name: ranibizumab (genetically modified) |
| 2014-700081 (○) | JP4785987 | Meptin swing heller 10 μg inhalation 100 times |
| 2014-700081 (■) | JP4785987 | Meptin swing heller 10 μg inhalation 100 times |
| 2014-700080 (○) | JP5242413 | Name (trade name) Nexguard 136 Active ingredient name: Afoxolanel |
| 2014-700080 (■) | JP5242413 | Name (trade name) Nexguard 136 Active ingredient name: Afoxolanel |
| 2014-700079 (○) | JP5242413 | Name (trade name) Nexguard 68 Active ingredient name: Afoxoranel |
| 2014-700079 (■) | JP5242413 | Name (trade name) Nexguard 68 Active ingredient name: Afoxoranel |
| 2014-700078 (○) | JP5242413 | Name (brand name) Nexguard 28.3 Active ingredient name: Afoxolanel |
| 2014-700078 (■) | JP5242413 | Name (brand name) Nexguard 28.3 Active ingredient name: Afoxolanel |
| 2014-700077 (○) | JP5242413 | Name (trade name) Nexguard 11.3 Active ingredient name: Afoxoranel |
| 2014-700077 (■) | JP5242413 | Name (trade name) Nexguard 11.3 Active ingredient name: Afoxoranel |
| 2014-700076 (○) | JP5077786 | Active ingredients of pharmaceuticals subject to disposal (general name): ruseogliflozin hydrate |
| 2014-700076 (■) | JP5077786 | Active ingredient of generic drug subject to disposal (general name): Ruseogliflozin hydrate |
| 2014-700075 (○) | JP5077786 | (I) Drugs subject to disposal (brand name): Lucefi Tablet 5 mg (ii) Active ingredients of drug subject to disposal (General name): Luceogliflozin hydrate object |
| 2014-700075 (■) | JP5077786 | (I) Drugs subject to disposal (brand name): Lucefi Tablet 5 mg (ii) Active ingredient of the drug subject to disposition (general name): ruseogliflozin hydrate |
| 2014-700074 (○) | JP5077786 | (I) Drugs subject to disposal (brand name): Lucefi tablet 2.5 mg (ii) Active ingredients of drug subject to disposal (General name): ruseogliflozin Hydrate |
| 2014-700074 (■) | JP5077786 | (I) Drugs subject to disposal (brand name): Lucefi Tablet 2.5 mg (ii) Active ingredient of the drug subject to disposal (general name): ruseogliflozin hydrate |
| 2014-700073 (○) | JP4492968 | Active ingredients of pharmaceuticals subject to disposal (general name): ruseogliflozin hydrate |
| 2014-700073 (■) | JP4492968 | Active ingredient of generic drug subject to disposal (general name): Ruseogliflozin hydrate |
| 2014-700072 (○) | JP4492968 | (I) Drugs subject to disposal (brand name): Lucefi Tablet 5 mg (ii) Active ingredients of drug subject to disposal (General name): Luceogliflozin hydrate object |
| 2014-700072 (■) | JP4492968 | Drugs targeted for disposal (brand name): Lucefi tablet 5 mg Active ingredient for medications targeted for disposal (general name): Ruseogliflozin hydrate |
| 2014-700071 (○) | JP4492968 | (I) Drugs subject to disposal (brand name): Lucefi tablet 2.5 mg (ii) Active ingredients of drug subject to disposal (General name): ruseogliflozin Hydrate |
| 2014-700071 (■) | JP4492968 | Drugs targeted for disposal (brand name): Lucefi tablet 2.5 mg Active ingredient for medications targeted for disposal (general name): Ruseogliflozin hydrate |
| 2014-700070 (○) | JP3453362 | Name of Sale: Avigan Tablet 200 mg Active Ingredient: favipiravir |
| 2014-700070 (■) | JP3453362 | Name of Sale: Avigan Tablet 200 mg Active Ingredient: favipiravir |
| 2014-700069 (○) | JP3808095 | Name of sale: Zaltia Tablet 5 mg Common name: Tadalafil Chemical name: (6R, 12aR) -6- (1, 3-benzodioxol-5-yl) -2-methyl-2, 3, 6,7,12,12a-hexahydropyrazino [1 ′, 2 ′: 1,6] pyrido [3,4-b] indole-1,4-dione |
| 2014-700069 (■) | JP3808095 | Name of sale: Zaltia Tablet 5 mg Common name: Tadalafil Chemical name: (6R, 12aR) -6- (1, 3-benzodioxol-5-yl) -2-methyl-2, 3, 6,7,12,12a-hexahydropyrazino [1 ′, 2 ′: 1,6] pyrido [3,4-b] indole-1,4-dione |
| 2014-700068 (○) | JP3808095 | Product Name: Zaltia Tablet 2.5 mg Common Name: Tadalafil Chemical Name: (6R, 12aR) -6- (1,3-benzodioxol-5-yl) -2-methyl-2, 3,6,7,12,12a-hexahydropyrazino [1 ′, 2 ′: 1,6] pyrido [3,4-b] indole-1,4-dione |
| 2014-700068 (■) | JP3808095 | Product Name: Zaltia Tablet 2.5 mg Common Name: Tadalafil Chemical Name: (6R, 12aR) -6- (1,3-benzodioxol-5-yl) -2-methyl-2, 3,6,7,12,12a-hexahydropyrazino [1 ′, 2 ′: 1,6] pyrido [3,4-b] indole-1,4-dione |
| 2014-700067 (○) | JP4456788 | Name of sale: Zaltia Tablet 5 mg Common name: Tadalafil Chemical name: (6R, 12aR) -6- (1, 3-benzodioxol-5-yl) -2-methyl-2, 3, 6,7,12,12a-hexahydropyrazino [1 ′, 2 ′: 1,6] pyrido [3,4-b] indole-1,4-dione |
| 2014-700067 (■) | JP4456788 | Name of sale: Zaltia Tablet 5 mg Common name: Tadalafil Chemical name: (6R, 12aR) -6- (1, 3-benzodioxol-5-yl) -2-methyl-2, 3, 6,7,12,12a-hexahydropyrazino [1 ′, 2 ′: 1,6] pyrido [3,4-b] indole-1,4-dione |
| 2014-700066 (○) | JP4456788 | Product Name: Zaltia Tablet 2.5 mg Common Name: Tadalafil Chemical Name: (6R, 12aR) -6- (1,3-benzodioxol-5-yl) -2-methyl-2, 3,6,7,12,12a-hexahydropyrazino [1 ′, 2 ′: 1,6] pyrido [3,4-b] indole-1,4-dione |
| 2014-700066 (■) | JP4456788 | Product Name: Zaltia Tablet 2.5 mg Common Name: Tadalafil Chemical Name: (6R, 12aR) -6- (1,3-benzodioxol-5-yl) -2-methyl-2, 3,6,7,12,12a-hexahydropyrazino [1 ′, 2 ′: 1,6] pyrido [3,4-b] indole-1,4-dione |
| 2014-700065 (○) | JP4594317 | Giotrif Tablets 50 mg (active ingredient: afatinib maleate) |
| 2014-700064 (○) | JP4594317 | Giotrif Tablet 40mg (Active Ingredient: Afatinib Maleate) |
| 2014-700063 (○) | JP4594317 | Giotrif Tablets 30mg (Active Ingredient: Afatinib Maleate) |
| 2014-700062 (○) | JP4594317 | Giotrif Tablets 20 mg (active ingredient: afatinib maleate) |
| 2014-700061 (○) | JP5264830 | Giotrif Tablets 50 mg (active ingredient: afatinib maleate) |
| 2014-700061 (■) | JP5264830 | Giotrif Tablets 50 mg (active ingredient: afatinib maleate) |
| 2014-700060 (○) | JP5264830 | Giotrif Tablet 40mg (Active Ingredient: Afatinib Maleate) |
| 2014-700060 (■) | JP5264830 | Giotrif Tablet 40mg (Active Ingredient: Afatinib Maleate) |
| 2014-700059 (○) | JP5264830 | Giotrif Tablets 30mg (Active Ingredient: Afatinib Maleate) |
| 2014-700059 (■) | JP5264830 | Giotrif Tablets 30mg (Active Ingredient: Afatinib Maleate) |
| 2014-700058 (○) | JP5264830 | Giotrif Tablets 20 mg (active ingredient: afatinib maleate) |
| 2014-700058 (■) | JP5264830 | Giotrif Tablets 20 mg (active ingredient: afatinib maleate) |
| 2014-700057 (○) | JP4095444 | Name of sale: Adcetris 50 mg for intravenous drip infusion Active ingredient: Brentuximab Bedotin (genetically modified) |
| 2014-700056 (○) | JP4303964 | Name of sale: Adcetris 50 mg for intravenous drip infusion Active ingredient: Brentuximab Bedotin (genetically modified) |
| 2014-700056 (■) | JP4303964 | Name of sale: Adcetris for intravenous injection 50mg Active ingredient: Brentuximab bedotin (genetically modified) |
| 2014-700055 (○) | JP4741838 | Name of sale: Adcetris 50 mg for intravenous drip infusion Active ingredient: Brentuximab Bedotin (genetically modified) |
| 2014-700055 (■) | JP4741838 | Name of sale: Adcetris for intravenous injection 50mg Active ingredient: Brentuximab bedotin (genetically modified) |
| 2014-700054 (○) | JP3827641 | Giotrif Tablet 50 mg (active ingredient: afatinib maleate) |
| 2014-700054 (■) | JP3827641 | Giotrif Tablets 50 mg (active ingredient: afatinib maleate) |
| 2014-700053 (○) | JP3827641 | Giotrif Tablets 40 mg (active ingredient: afatinib maleate) |
| 2014-700053 (■) | JP3827641 | Giotrif Tablet 40mg (Active Ingredient: Afatinib Maleate) |
| 2014-700052 (○) | JP3827641 | Giotrif Tablets 30mg (Active Ingredient: Afatinib Maleate) |
| 2014-700052 (■) | JP3827641 | Giotrif Tablets 30mg (Active Ingredient: Afatinib Maleate) |
| 2014-700051 (○) | JP3827641 | Giotrif Tablet 20 mg (active ingredient: afatinib maleate) |
| 2014-700051 (■) | JP3827641 | Giotrif Tablets 20 mg (active ingredient: afatinib maleate) |
| 2014-700050 (○) | JP3686610 | Giotrif Tablet 50 mg (active ingredient: afatinib maleate) |
| 2014-700050 (■) | JP3686610 | Giotrif Tablets 50 mg (active ingredient: afatinib maleate) |
| 2014-700049 (○) | JP3686610 | Giotrif Tablets 40 mg (active ingredient: afatinib maleate) |
| 2014-700049 (■) | JP3686610 | Giotrif Tablet 40mg (Active Ingredient: Afatinib Maleate) |
| 2014-700048 (○) | JP3686610 | Giotrif Tablets 30mg (Active Ingredient: Afatinib Maleate) |
| 2014-700048 (■) | JP3686610 | Giotrif Tablets 30mg (Active Ingredient: Afatinib Maleate) |
| 2014-700047 (○) | JP3686610 | Giotrifu Tablet 20 mg (active ingredient: afatinib maleate) |
| 2014-700047 (■) | JP3686610 | Giotrif Tablets 20 mg (active ingredient: afatinib maleate) |
| 2014-700046 (○) | JP4173553 | Name of sale: Liona Tablet 250 mg Active ingredient: Ferric acid citric acid hydrate |
| 2014-700046 (■) | JP4173553 | Name of sale: Liona Tablet 250 mg Active ingredient: Ferric acid citric acid hydrate |
| 2014-700045 (○) | JP4964585 | Name of sale: Liona Tablet 250 mg Active ingredient: Ferric acid citric acid hydrate |
| 2014-700045 (■) | JP4964585 | Name of sale: Liona Tablet 250 mg Active ingredient: Ferric acid citric acid hydrate |
| 2014-700044 (○) | JP4803686 | (A) Active ingredient: Topiramate (B) Sales name: Topina fine grains 10% |
| 2014-700044 (■) | JP4803686 | (A) Active ingredient: Topiramate (B) Sales name: Topina fine grains 10% |
| 2014-700043 (○) | JP5167389 | Name of sale: Liona Tablet 250 mg Active ingredient: Ferric acid citric acid hydrate |
| 2014-700043 (■) | JP5167389 | Name of sale: Liona Tablet 250 mg Active ingredient: Ferric acid citric acid hydrate |
| 2014-700042 (○) | JP4455321 | Name of Sale: Adempass Tablet 2.5 mg General name: Rio Siguat |
| 2014-700042 (■) | JP4455321 | Name of Sale: Adempass Tablet 2.5 mg General name: Rio Siguat |
| 2014-700041 (○) | JP4455321 | Name of sale: Adempas Tablet 1.0 mg General name: Rio Siguat |
| 2014-700041 (■) | JP4455321 | Name of sale: Adempas Tablet 1.0 mg General name: Rio Siguat |
| 2014-700040 (○) | JP4455321 | Name of sale: Adempass Tablet 0.5 mg General name: Rio Siguat |
| 2014-700040 (■) | JP4455321 | Name of sale: Adempass Tablet 0.5 mg General name: Rio Siguat |
| 2014-700039 (○) | JP4759102 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700039 (■) | JP4759102 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700038 (○) | JP4759102 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700038 (■) | JP4759102 | Sugla Maru R Tablets 25 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700037 (○) | JP5210154 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700037 (■) | JP5210154 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700036 (○) | JP5210154 | Sugler Maru R Tablets 25 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700036 (■) | JP5210154 | Sugla Maru R Tablets 25 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700035 (○) | JP4913104 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700035 (■) | JP4913104 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700034 (○) | JP4913104 | Sugler Maru R Tablets 25 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700034 (■) | JP4913104 | Sugler Maru R Tablets 25 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700033 (○) | JP4222450 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700033 (■) | JP4222450 | Sugla Maru R Tablet 50 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700032 (○) | JP4222450 | Sugler Maru R Tablets 25 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700032 (■) | JP4222450 | Sugler Maru R Tablets 25 mg (Ipragliflozin L-Proline as Active Ingredient) |
| 2014-700031 (○) | JP3547755 | Name of Sale: ELPLAT Intravenous Drip Solution 200mg Active Ingredient: Oxaliplatin |
| 2014-700031 (■) | JP3547755 | Name of Sale: ELPLAT Intravenous Drip Solution 200mg Active Ingredient: Oxaliplatin |
| 2014-700030 (○) | JP3547755 | Name of Sale: ELPLAT Intravenous Drip Solution 100mg Active Ingredient: Oxaliplatin |
| 2014-700030 (■) | JP3547755 | Name of Sale: ELPLAT Intravenous Drip Solution 100mg Active Ingredient: Oxaliplatin |
| 2014-700029 (○) | JP3547755 | Name of sale: ELPLAT Intravenous Drip Solution 50mg Active Ingredient: Oxaliplatin |
| 2014-700029 (■) | JP3547755 | Name of sale: ELPLAT Intravenous Drip Solution 50mg Active Ingredient: Oxaliplatin |
| 2014-700028 (○) | JP4865427 | Name of Sale: ELPLAT Intravenous Drip Solution 200mg Active Ingredient: Oxaliplatin |
| 2014-700027 (○) | JP4865427 | Name of Sale: ELPLAT Intravenous Drip Solution 100mg Active Ingredient: Oxaliplatin |
| 2014-700026 (○) | JP4865427 | Name of sale: ELPLAT Intravenous Drip Solution 50mg Active Ingredient: Oxaliplatin |
| 2014-700025 (○) | JP4208938 | Tenelia Tablets 20 mg Tenelligliptin hydrobromide hydrate |
| 2014-700025 (■) | JP4208938 | Tenelia Tablets 20 mg Tenelligliptin hydrobromide hydrate |
| 2014-700024 (○) | JP4101053 | Tenelia Tablets 20 mg Tenelligliptin hydrobromide hydrate |
| 2014-700024 (■) | JP4101053 | Tenelia Tablets 20 mg Tenelligliptin hydrobromide hydrate |
| 2014-700023 (○) | JP5249947 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2014-700023 (■) | JP5249947 | General name: Raninamivir octanoate hydrate Name (brand name) Inavil inhalation powder 20 mg |
| 2014-700022 (○) | JP4205314 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2014-700022 (■) | JP4205314 | General name: Raninamivir octanoate hydrate Name (brand name) Inavil inhalation powder 20 mg |
| 2014-700021 (○) | JP3920041 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2014-700021 (■) | JP3920041 | General name: Raninamivir octanoate hydrate Name (brand name) Inavil inhalation powder 20 mg |
| 2014-700020 (○) | JP3209946 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2014-700020 (■) | JP3209946 | General name: Raninamivir octanoate hydrate Name (brand name) Inavil inhalation powder 20 mg |
| 2014-700019 (○) | JP5216002 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2014-700019 (■) | JP5216002 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2014-700018 (○) | JP5216002 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2014-700018 (■) | JP5216002 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2014-700017 (○) | JP5273746 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2014-700017 (■) | JP5273746 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2014-700016 (○) | JP5273746 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2014-700016 (■) | JP5273746 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2014-700015 (○) | JP4723140 | Airia intravitreal injection kit 40 mg / mL aflibercept (genetically modified) |
| 2014-700015 (■) | JP4723140 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2014-700014 (○) | JP4723140 | Airia Intravitreal Injection 40 mg / mL Aflibercept (genetically modified) |
| 2014-700014 (■) | JP4723140 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2014-700013 (○) | JP4685035 | (3-1) Active ingredient (i) General name: tebuconazole Chemical name: (RS) -1-p-chlorophenyl-4,4-dimethyl-3- (1H-1,2,4-triazole-1 -Ylmethyl) pentan-3-ol, and (ii) General name fluopyram chemical name N- {2- [3-chloro-5- (trifluoromethyl) -2-pyridyl] ethyl} -α, α, α-triyl Fluoro-o-toluamide (3-2) Pesticide type: tebuconazole / fluopyram wettable powder (3-3) Pesticide name Orphine plus flowable |
| 2014-700013 (■) | JP4685035 | (3-1) Active ingredient (i) General name: tebuconazole Chemical name: (RS) -1-p-chlorophenyl-4,4-dimethyl-3- (1H-1,2,4- Triazol-1-ylmethyl) pentan-3-ol, and (ii) common name: fluopyram chemical name: N- {2- [3-chloro-5- (trifluoromethyl) -2-pyridyl ] Ethyl α-α, α, α-Trifluoro-o-toluamide (3-2) Pesticide type: tebuconazole / fluopyram wettable powder (3-3) Pesticide name: orphine plus flowable |
| 2014-700012 (○) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 400 mg / 16 mL Common name: bevacizumab (genetically modified) |
| 2014-700012 (■) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 400 mg / 16 mL Common name: bevacizumab (genetically modified) |
| 2014-700011 (○) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 100 mg / 4 mL Common name: bevacizumab (genetically modified) |
| 2014-700011 (■) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 100 mg / 4 mL Common name: bevacizumab (genetically modified) |
| 2014-700010 (○) | JP4608140 | Pyrophenon |
| 2014-700010 (■) | JP4608140 | Pyrophenon |
| 2014-700009 (○) | JP5004392 | Toceranibulinate (brand name: Paradia Tablets 50) |
| 2014-700009 (■) | JP5004392 | Toceranibulinate (brand name: Paradia Tablets 50) |
| 2014-700008 (○) | JP5004392 | Toceranibulinate (brand name: Paradia Tablets 15) |
| 2014-700008 (■) | JP5004392 | Toceranibulinate (brand name: Paradia Tablets 15) |
| 2014-700007 (○) | JP5004392 | Toceranibulinate (brand name: Paradia Tablet 10) |
| 2014-700007 (■) | JP5004392 | Toceranibulinate (brand name: Paradia Tablet 10) |
| 2014-700006 (○) | JP4519114 | Toceranibulinate (brand name: Paradia Tablets 50) |
| 2014-700006 (■) | JP4519114 | Toceranibulinate (brand name: Palladia Tablet 50) |
| 2014-700005 (○) | JP4519114 | Toceranibulinate (brand name: Paradia Tablets 15) |
| 2014-700005 (■) | JP4519114 | Toceranibulinate (brand name: Paladia Tablet 15) |
| 2014-700004 (○) | JP4519114 | Toceranibulinate (brand name: Paradia Tablet 10) |
| 2014-700004 (■) | JP4519114 | Toceraniburine acid salt (brand name: PARADIA Tablet 10) |
| 2014-700003 (○) | JP3663382 | Toceranibulinate (brand name: Paradia Tablets 50) |
| 2014-700003 (■) | JP3663382 | Toceranibulinate (brand name: Paradia Tablets 50) |
| 2014-700002 (○) | JP3663382 | Toceranibulinate (brand name: Paradia Tablets 15) |
| 2014-700002 (■) | JP3663382 | Toceranibulinate (brand name: Paradia Tablets 15) |
| 2014-700001 (○) | JP3663382 | Toceranibulinate (brand name: Paradia Tablet 10) |
| 2014-700001 (■) | JP3663382 | Toceranibulinate (brand name: Paradia Tablet 10) |
| 2013-700299 (○) | JP5350792 | (I) Name of sale: 160mg for intravenous injection of Kadcyra (ii) Active ingredient: Trastuzumab Emtancin (genetically modified) |
| 2013-700299 (■) | JP5350792 | (I) Name of sale: 160mg for intravenous injection of Kadcyra (ii) Active ingredient: Trastuzumab Emtancin (genetically modified) |
| 2013-700298 (○) | JP5350792 | (I) Name of sale: 100mg for intravenous injection of Kadcyra (ii) Active ingredient: Trastuzumab Emtancin (genetically modified) |
| 2013-700298 (■) | JP5350792 | (I) Name of sale: 100mg for intravenous injection of Kadcyra (ii) Active ingredient: Trastuzumab Emtancin (genetically modified) |
| 2013-700297 (○) | JP4780633 | (I) Name of sale: 160mg for intravenous injection of Kadcyra (ii) Active ingredient: Trastuzumab Emtancin (genetically modified) |
| 2013-700297 (■) | JP4780633 | (I) Name of sale: 160mg for intravenous injection of Kadcyra (ii) Active ingredient: Trastuzumab Emtancin (genetically modified) |
| 2013-700296 (○) | JP4780633 | (I) Name of sale: 100mg for intravenous injection of Kadcyra (ii) Active ingredient: Trastuzumab Emtancin (genetically modified) |
| 2013-700296 (■) | JP4780633 | (I) Name of sale: 100mg for intravenous injection of Kadcyra (ii) Active ingredient: Trastuzumab Emtancin (genetically modified) |
| 2013-700295 (○) | JP4778101 | (I) Name of sale: 160 mg for IV infusion of Cadosilla (ii) Active ingredient: Trastuzumab Emtancin (genetically modified) |
| 2013-700295 (■) | JP4778101 | (I) Name of sale: 160mg for intravenous injection of Kadcyra (ii) Active ingredient: Trastuzumab Emtancin (genetically modified) |
| 2013-700294 (○) | JP4778101 | (I) Name of sale: 100 mg for Kadcyra intravenous drip (ii) Active ingredient: Trastuzumab Emtancin (genetically modified) |
| 2013-700294 (■) | JP4778101 | (I) Name of sale: 100mg for intravenous injection of Kadcyra (ii) Active ingredient: Trastuzumab Emtancin (genetically modified) |
| 2013-700293 (○) | JP3876355 | Name of sale: Tapcom combination eye drops Active ingredient: Tafluprost, timolol maleate |
| 2013-700293 (■) | JP3876355 | Name of sale: Tapcom combination eye drops Active ingredient: Tafluprost, timolol maleate |
| 2013-700292 (○) | JP3822439 | Obrine Tablet 120 mg |
| 2013-700292 (■) | JP3822439 | Obrine Tablet 120 mg |
| 2013-700291 (○) | JP4902361 | (Brand name) Sobriard capsule 100 mg (common name) simeprevir sodium |
| 2013-700291 (■) | JP4902361 | (Brand name) Sobriard capsule 100 mg (general name) simeprevir sodium |
| 2013-700290 (○) | JP4797067 | (Brand name) Sobriard capsule 100 mg (common name) simeprevir sodium |
| 2013-700290 (■) | JP4797067 | (Brand name) Sobriard capsule 100 mg (general name) simeprevir sodium |
| 2013-700289 (○) | JP4914345 | Name of sale: Ultivuro capsule for inhalation Common name: indacaterol maleate and copironium bromide |
| 2013-700289 (■) | JP4914345 | Name of sale: Ultivuro capsule for inhalation Common name: indacaterol maleate and glycopyrronium bromide |
| 2013-700288 (○) | JP3785365 | Name of sale: Ultivuro capsule for inhalation Common name: indacaterol maleate and glycopyrronium bromide |
| 2013-700288 (■) | JP3785365 | Name of sale: Ultivuro capsule for inhalation Common name: indacaterol maleate and glycopyrronium bromide |
| 2013-700287 (○) | JP4478512 | (A) Active ingredient: Fentanyl citrate (B) Sales name: Abstral sublingual tablet 400 μg |
| 2013-700287 (■) | JP4478512 | (A) Active ingredient: Fentanyl citrate (B) Sales name: Abstral sublingual tablet 400 μg |
| 2013-700286 (○) | JP4478512 | (A) Active ingredient: Fentanyl citrate (b) Name of sale: Abstral sublingual tablet 200 μg |
| 2013-700286 (■) | JP4478512 | (A) Active ingredient: Fentanyl citrate (b) Name of sale: Abstral sublingual tablet 200 μg |
| 2013-700285 (○) | JP4478512 | (A) Active ingredient: Fentanyl citrate (b) Name of sale: Abstrall sublingual tablet 100 μg |
| 2013-700285 (■) | JP4478512 | (A) Active ingredient: Fentanyl citrate (b) Name of sale: Abstrall sublingual tablet 100 μg |
| 2013-700284 (○) | JP3381220 | (A) Active ingredient: Fentanyl citrate (B) Sales name: Abstral sublingual tablet 400 μg |
| 2013-700284 (■) | JP3381220 | (A) Active ingredient: Fentanyl citrate (B) Sales name: Abstral sublingual tablet 400 μg |
| 2013-700283 (○) | JP3381220 | (A) Active ingredient: Fentanyl citrate (b) Name of sale: Abstral sublingual tablet 200 μg |
| 2013-700283 (■) | JP3381220 | (A) Active ingredient: Fentanyl citrate (b) Name of sale: Abstral sublingual tablet 200 μg |
| 2013-700282 (○) | JP3381220 | (A) Active ingredient: Fentanyl citrate (b) Name of sale: Abstrall sublingual tablet 100 μg |
| 2013-700282 (■) | JP3381220 | (A) Active ingredient: Fentanyl citrate (b) Name of sale: Abstrall sublingual tablet 100 μg |
| 2013-700281 (○) | JP5124718 | Ultivuro capsule for inhalation |
| 2013-700281 (■) | JP5124718 | Ultivuro capsule for inhalation |
| 2013-700280 (○) | JP3662028 | Name (brand name) Complavin combination tablet Active ingredient name: clopidogrel, aspirin |
| 2013-700280 (■) | JP3662028 | Name (brand name) Complavin combination tablet Active ingredient name: clopidogrel, aspirin |
| 2013-700279 (○) | JP5042426 | (Name) Ultivuro Capsule for inhalation (Active ingredient) Glycopyronium bromide and Indacaterol maleate |
| 2013-700278 (○) | JP4211965 | (Brand name) Zeprion water suspension injection 150 mg syringe (general name) paliperidone palmitate ester |
| 2013-700278 (■) | JP4211965 | (Brand name) Zeprion water suspension injection 150 mg syringe (general name) paliperidone palmitate ester |
| 2013-700277 (○) | JP4211965 | (Brand name) Zeprion water suspension injection 100 mg syringe (general name) paliperidone palmitate ester |
| 2013-700277 (■) | JP4211965 | (Brand name) Zeprion water suspension injection 100 mg syringe (general name) paliperidone palmitate ester |
| 2013-700276 (○) | JP4211965 | (Brand name) Zeprion water suspension muscle injection 75 mg syringe (general name) paliperidone palmitate ester |
| 2013-700276 (■) | JP4211965 | (Brand name) Zeprion water suspension muscle injection 75 mg syringe (general name) paliperidone palmitate ester |
| 2013-700275 (○) | JP4211965 | (Sales name) Drugs subject to disposal (sales name) Zeprion water suspension injection 50 mg syringe active ingredient of drug subject to disposal (general name) paliperidone palmitate ester |
| 2013-700275 (■) | JP4211965 | (Brand name) Zeprion water suspension injection 50 mg syringe (general name) paliperidone palmitate ester |
| 2013-700274 (○) | JP4211965 | (Brand name) Zeprion water suspension injection 25 mg syringe (general name) paliperidone palmitate ester |
| 2013-700274 (■) | JP4211965 | Zeprion water suspension injection 25 mg syringe (general name) paliperidone palmitate ester |
| 2013-700273 (○) | JP4436041 | Name of sale: Relvar 200 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700273 (■) | JP4436041 | Name of sale: Relvar 200 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700272 (○) | JP4436041 | Name of sale: Relvar 200 Elipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700272 (■) | JP4436041 | Name of sale: Relvar 200 Elipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700271 (○) | JP4436041 | Name of sale: Relvar 100 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700271 (■) | JP4436041 | Name of sale: Relvar 100 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700270 (○) | JP4436041 | Name of sale: Relvar 100 Ellipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700270 (■) | JP4436041 | Name of sale: Relvar 100 Ellipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700269 (○) | JP4191034 | Name of sale: Relvar 200 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700269 (■) | JP4191034 | Name of sale: Relvar 200 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700268 (○) | JP4191034 | Name of sale: Relvar 200 Elipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700268 (■) | JP4191034 | Name of sale: Relvar 200 Elipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700267 (○) | JP4191034 | Name of sale: Relvar 100 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700267 (■) | JP4191034 | Name of sale: Relvar 100 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700266 (○) | JP4191034 | Name of sale: Relvar 100 Ellipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700266 (■) | JP4191034 | Name of sale: Relvar 100 Ellipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700265 (○) | JP5150607 | Name of sale: Relvar 200 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700265 (■) | JP5150607 | Name of sale: Relvar 200 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700264 (○) | JP5150607 | Name of sale: Relvar 200 Elipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700264 (■) | JP5150607 | Name of sale: Relvar 200 Elipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700263 (○) | JP5150607 | Name of sale: Relvar 100 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700263 (■) | JP5150607 | Name of sale: Relvar 100 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700262 (○) | JP5150607 | Name of sale: Relvar 100 Ellipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700262 (■) | JP5150607 | Name of sale: Relvar 100 Ellipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2013-700261 (○) | JP4672143 | Active Ingredients: Fluticasone Propionate formoterol fumarate hydrate Name: Fultiform 125 Aerosol 120 for inhalation |
| 2013-700261 (■) | JP4672143 | Active ingredient: fluticasone propionate ester formoterol fumarate hydrate Name of sale: Flutiform 125 aerosol 120 for inhalation |
| 2013-700260 (○) | JP4672143 | Active Ingredients: Fluticasone Propionate formoterol fumarate hydrate Name: Flutiform 50 Aerosol 120 for inhalation |
| 2013-700260 (■) | JP4672143 | Active ingredient: fluticasone propionate ester formoterol fumarate hydrate Name of sale: Flutiform 50 aerosol 120 for inhalation |
| 2013-700259 (○) | JP4672143 | Active Ingredients: Fluticasone Propionate formoterol fumarate hydrate Name: Fultiform 125 Aerosol 56 for inhalation |
| 2013-700259 (■) | JP4672143 | Active ingredient: fluticasone propionate ester formoterol fumarate hydrate Name of sale: Flutiform 125 aerosol 56 for inhalation |
| 2013-700258 (○) | JP4672143 | Active Ingredients: Fluticasone Propionate formoterol fumarate hydrate Name: Flutiform 50 Aerosol 56 for inhalation |
| 2013-700258 (■) | JP4672143 | Active ingredient: fluticasone propionate ester formoterol fumarate hydrate Name of sale: Flutiform 50 aerosol 56 for inhalation |
| 2013-700257 (○) | JP4550412 | About Feintable |
| 2013-700257 (■) | JP4550412 | About Feintable |
| 2013-700256 (○) | JP4665076 | Tafami dissmegulmin (brand name: bindaker capsule 20 mg) |
| 2013-700256 (■) | JP4665076 | Tafami dissmegulmin (brand name: bindaker capsule 20 mg) |
| 2013-700255 (○) | JP5289338 | Tolvaptan (brand name: Samsca Tablet 7.5 mg) |
| 2013-700255 (■) | JP5289338 | Tolvaptan (brand name: Samsca Tablet 7.5 mg) |
| 2013-700254 (○) | JP4210355 | Tolvaptan (brand name: Samsca Tablet 7.5 mg) |
| 2013-700254 (■) | JP4210355 | Tolvaptan (brand name: Samsca Tablet 7.5 mg) |
| 2013-700253 (○) | JP5005699 | Interface flowable |
| 2013-700253 (■) | JP5005699 | Interface flowable |
| 2013-700252 (○) | JP5044398 | Name of Sale: Obreen Tablet 120 mg Common Name: Setilistat |
| 2013-700252 (■) | JP5044398 | Name of Sale: Obreen Tablet 120 mg Common Name: Setilistat |
| 2013-700251 (○) | JP3957765 | Name of sale: Lucentis intravitreal injection 2.3 mg / 0.23 mL Common name: ranibizumab (genetically modified) |
| 2013-700251 (■) | JP3957765 | Name of sale: Lucentis intravitreal injection 2.3 mg / 0.23 mL Common name: ranibizumab (genetically modified) |
| 2013-700250 (○) | JP3957765 | Name of sale: Lucentis intravitreal injection 2.3 mg / 0.23 mL Common name: ranibizumab (genetically modified) |
| 2013-700250 (■) | JP3957765 | Name of sale: Lucentis intravitreal injection 2.3 mg / 0.23 mL Common name: ranibizumab (genetically modified) |
| 2013-700249 (○) | JP5017115 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2013-700249 (■) | JP5017115 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2013-700248 (○) | JP4777887 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2013-700248 (■) | JP4777887 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2013-700247 (○) | JP4472669 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2013-700247 (■) | JP4472669 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2013-700246 (○) | JP3274687 | Medicinal product targeted for disposal (brand name) Zeprion water suspension injection 150 mg syringe Active ingredient for medicinal product targeted for disposal (general name) Paliperidone palmitate ester |
| 2013-700246 (■) | JP3274687 | Drugs subject to disposal (brand name) Zeprion suspension in water 150 mg syringe active ingredient of drug subject to disposal (general name) paliperidone palmitate ester |
| 2013-700245 (○) | JP3274687 | Medicinal product targeted for disposal (brand name) Zeprion water suspension injection 100 mg syringe Active ingredient for medicinal product targeted for disposal (general name) Paliperidone palmitate ester |
| 2013-700245 (■) | JP3274687 | Drugs subject to disposal (brand name) Zeprion suspension in water 100 mg syringe active ingredient of medications subject to disposal (general name) paliperidone palmitate ester |
| 2013-700244 (○) | JP3274687 | Medicinal product targeted for disposal (brand name) Zeprion water suspension injection 75 mg syringe Active ingredient for medicinal product targeted for disposal (general name) Paliperidone palmitate ester |
| 2013-700244 (■) | JP3274687 | Drugs subject to disposal (brand name) Zeprion suspension in water 75 mg syringe active ingredients of drug subject to disposal (general name) paliperidone palmitate ester |
| 2013-700243 (○) | JP3274687 | Medicinal product targeted for disposal (brand name) Zeprion water suspension injection 50 mg syringe Active ingredient for medicinal product targeted for disposal (general name) Paliperidone palmitic acid ester |
| 2013-700243 (■) | JP3274687 | Drugs subject to disposal (brand name) Zeprion suspension 50 mg syringe active ingredient of medications subject to disposal (general name) paliperidone palmitate ester |
| 2013-700242 (○) | JP3274687 | Medicinal product targeted for disposal (brand name) Zeprion water suspension injection 25 mg syringe active ingredient for medicinal product targeted for disposal (general name) Paliperidone palmitate ester |
| 2013-700242 (■) | JP3274687 | Drugs subject to disposal (brand name) Zeprion water suspension injection 25 mg syringe active ingredient of medications subject to disposal (general name) paliperidone palmitate ester |
| 2013-700241 (○) | JP4202423 | Movent Floorable |
| 2013-700241 (■) | JP4202423 | Movent Floorable |
| 2013-700240 (○) | JP4216297 | (Active ingredient) Palivizumab (brand name: Synagis for intramuscular injection 100 mg) |
| 2013-700239 (○) | JP4216297 | (Active ingredient) Palivizumab (brand name: 50 mg for injection and synagis) |
| 2013-700238 (○) | JP4216297 | (Active ingredient) Palivizumab (brand name: Synagis muscle injection 100 mg) |
| 2013-700237 (○) | JP4216297 | (Active ingredient) Palivizumab (brand name: Synagis muscle injection 50 mg) |
| 2013-700236 (○) | JP3896160 | (Active ingredient) Palivizumab (brand name: Synagis for intramuscular injection 100 mg) |
| 2013-700236 (■) | JP3896160 | Palivizumab (brand name: 100 mg for Synagis intramuscular injection) |
| 2013-700235 (○) | JP3896160 | (Active ingredient) Palivizumab (brand name: 50 mg for injection and synagis) |
| 2013-700235 (■) | JP3896160 | Palivizumab (brand name: 50 mg for Synagis intramuscular injection) |
| 2013-700234 (○) | JP3896160 | (Active ingredient) Palivizumab (brand name: Synagis muscle injection 100 mg) |
| 2013-700234 (■) | JP3896160 | Palivizumab (brand name: Synagis muscle injection 100 mg) |
| 2013-700233 (○) | JP3896160 | (Active ingredient) Palivizumab (brand name: Synagis muscle injection 50 mg) |
| 2013-700233 (■) | JP3896160 | Palivizumab (brand name: Cinadis muscle injection 50 mg) |
| 2013-700232 (○) | JP4896719 | Lanthanum carbonate hydrate (brand name: Hosurenol chewable tablet 500 mg) |
| 2013-700232 (■) | JP4896719 | Lanthanum carbonate hydrate (brand name: Hosurenol chewable tablet 500 mg) |
| 2013-700231 (○) | JP4896719 | Lanthanum carbonate hydrate (brand name: Hosurenol chewable tablet 250 mg) |
| 2013-700231 (■) | JP4896719 | Lanthanum carbonate hydrate (brand name: Hosurenol chewable tablet 250 mg) |
| 2013-700230 (○) | JP3224544 | Lanthanum carbonate hydrate (brand name: hosurenol granule package 500 mg) |
| 2013-700230 (■) | JP3224544 | Lanthanum carbonate hydrate (brand name: Hosurenol granule package 500 mg) |
| 2013-700229 (○) | JP3224544 | Lanthanum carbonate hydrate (brand name: Hosurenol Granule package 250 mg) |
| 2013-700229 (■) | JP3224544 | Lanthanum carbonate hydrate (brand name: Hosurenol Granule package 250 mg) |
| 2013-700228 (○) | JP3224544 | Lanthanum carbonate hydrate (brand name: Hosurenol chewable tablet 500 mg) |
| 2013-700228 (■) | JP3224544 | Lanthanum carbonate hydrate (brand name: Hosurenol chewable tablet 500 mg) |
| 2013-700227 (○) | JP3224544 | Lanthanum carbonate hydrate (brand name: Hosurenol chewable tablet 250 mg) |
| 2013-700227 (■) | JP3224544 | Lanthanum carbonate hydrate (brand name: Hosurenol chewable tablet 250 mg) |
| 2013-700226 (○) | JP4964587 | Name of sale: Biopten granules 10% Common name of active ingredient: Sapropterin hydrochloride |
| 2013-700226 (■) | JP4964587 | Name of sale: Biopten granules 10% Common name of active ingredient: Sapropterin hydrochloride |
| 2013-700225 (○) | JP3122141 | Iribomaru ROD tablet 2.5 μg (lamosetron hydrochloride as active ingredient) |
| 2013-700225 (■) | JP3122141 | Iribomaru ROD tablet 2.5 μg (lamosetron hydrochloride as active ingredient) |
| 2013-700224 (○) | JP3122141 | Iribomaru ROD tablet 5 μg (lamosetron hydrochloride as active ingredient) |
| 2013-700224 (■) | JP3122141 | Iribomaru ROD tablet 5 μg (lamosetron hydrochloride as active ingredient) |
| 2013-700223 (○) | JP3728324 | Pesticide name: Winner 1 kg Granule 75 Active ingredient: 1- (2,4-Dichlorophenyl) -2 ', 4'-difluoro-1,5-dihydro-N-isopropyl-5-oxo-4H -1,2,4-Triazole-4-carboxanilide (RS) -2-bromo-N- (α, α-dimethylbenzyl) -3,3-dimethylbutyramido methyl = α- (4,6-dimethoxysilane Pyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2013-700223 (■) | JP3728324 | Pesticide name: Winner 1 kg Granule 75 Active ingredient: 1- (2,4-Dichlorophenyl) -2 ', 4'-difluoro-1,5-dihydro-N-isopropyl-5-oxo-4H -1,2,4-Triazole-4-carboxanilide · (RS) -2-bromo-N- (α, α-dimethylbenzyl) -3,3-dimethylbutyramide · methyl = α- (4,6-Dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2013-700222 (○) | JP3728324 | Pesticide name: Fighter 1 kg granules Active ingredient: 1- (2,4-Dichlorophenyl) -2 ', 4'-difluoro-1,5-dihydro-N-isopropyl-5-oxo-4H-1 , 2,4-Triazole-4-carboxanilide |
| 2013-700222 (■) | JP3728324 | Pesticide name: Fighter 1 kg granules Active ingredient: 1- (2,4-Dichlorophenyl) -2 ', 4'-difluoro-1,5-dihydro-N-isopropyl-5-oxo-4H-1 , 2,4-Triazole-4-carboxanilide |
| 2013-700221 (○) | JP2614700 | Types of Pesticides: Etaboxam Water Repellent Name of Pesticides: Etofin Frouble Active Ingredients: (RS) -N- (α-cyano-2-tenyl) -4-ethyl-2- (ethylamino) 1,3-thiazole-5-carboxamide |
| 2013-700221 (■) | JP2614700 | Types of Pesticides: Etaboxam Water Repellent Name of Pesticides: Etofin Frouble Active Ingredients: (RS) -N- (α-cyano-2-tenyl) -4-ethyl-2- (ethylamino) 1,3-thiazole-5-carboxamide |
| 2013-700220 (○) | JP5142608 | Pesticide name: Winner L. F. Bull Bull Active ingredient (chemical name): 1- (2,4-dichlorophenyl) -2 ', 4'-difluoro-1,5-dihydro-N-isopropyl-5-oxo-4H -1,2,4-Triazole-4-carboxanilide (RS) -2-bromo-N- (α, α-dimethylbenzyl) -3,3-dimethylbutylamide methyl = α- (4,6-dimethoxypyrimidine -2-ylcarbamoylsulfamoyl) -o-tolu ate |
| 2013-700220 (■) | JP5142608 | Types of pesticides: Ipphencarbazone, Bromobutide, Bensulfuron methyl wettable powder Name of agrochemical: Winner L. Flowable Active ingredient (chemical name): 1- (2,4-dichlorophenyl) -2 ', 4'-Difluoro-1,5-dihydro-N-isopropyl-5-oxo-4H-1,2,4-triazole-4-carboxanilide (RS) -2-bromo-N- (α, α-dimethylbenzyl) -3,3-Dimethylbutylamidomethyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2013-700219 (○) | JP5142608 | Pesticide name: Winner's flowable Active ingredient (chemical name): 1- (2,4-dichlorophenyl) -2 ', 4'-difluoro-1,5-dihydro-N-isopropyl-5-oxo-4H- 1,2,4-Triazole-4-carboxanilide (RS) -2-bromo-N- (α, α-dimethylbenzyl) -3,3-dimethylbutylamide methyl = α-(4,6-dimethoxypyrimidine- 2-ylcarbamoylsulfamoyl) -o-tolu ate |
| 2013-700219 (■) | JP5142608 | Types of pesticides: Ipphencarbazone, Bromobutide, Bensulfuron methyl water-dispersible powder Name of pesticide: Winner's floor Active ingredient (chemical name): 1- (2,4-Dichlorophenyl) -2 ', 4 '-Difluoro-1,5-dihydro-N-isopropyl-5-oxo-4H-1,2,4-triazole-4-carboxanilide (RS) -2-bromo-N- (α, α-dimethylbenzyl)- 3,3-Dimethylbutyramidomethyl = α- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -o-toluate |
| 2013-700218 (○) | JP4219987 | (Sale name) Oil bags 7R |
| 2013-700217 (○) | JP4484023 | Type of pesticide: amisulblom water dispersible powder Name of pesticide: Vortex FS Active ingredient Chemical name: 3- (3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N -Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2013-700216 (○) | JP4438919 | Types of Pesticide: Amisulbrom Powder Name of Pesticide: Oracle Powder Type of Active Ingredient: 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N-dimethyl -1,2,4-Triazole-1-sulfonamide |
| 2013-700215 (○) | JP3665339 | Active ingredient compound: 1- (4,6-dimethoxypyrimidin-2-yl) -3- [2- (dimethylcarbamoyl) -5-formamidophenylsulfonyl] urea Pesticide type: Foramsulfuron hydrate < Name of pesticide: tribute OD |
| 2013-700215 (■) | JP3665339 | Active ingredient compound: 1- (4,6-dimethoxypyrimidin-2-yl) -3- [2- (dimethylcarbamoyl) -5-formamidophenylsulfonyl] urea Pesticide type: phoramsulfuron hydrate < Name of pesticide: tribute OD |
| 2013-700214 (○) | JP4395912 | Fenpyrazamine Water Repellent Pesticide Name: Pixio DF Active Ingredient: S-Allyl 5-amino-2,3-dihydro-2-isopropyl-3-oxo-4- (o-tolyl) pyrazole 1- Carbothioate |
| 2013-700214 (■) | JP4395912 | Fenpyrazamine Water Repellent Pesticide Name: Pixio DF Active Ingredient: S-Allyl 5-amino-2,3-dihydro-2-isopropyl-3-oxo-4- (o-tolyl) pyrazole 1- Carbothioate |
| 2013-700213 (○) | JP4557131 | Types of Pesticides: Amisulbrom · Shimoxanil Hydrating Agent Name of Pesticides: Dynamo Water Hydrating Agent Types of Active Ingredients: 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl ) -N, N-Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2013-700213 (■) | JP4557131 | Types of Pesticides: Amisulbrom · Shimoxanil Hydrating Agent Name of Pesticide: Dynamo Water Hydrating Agent Type of Active Ingredients: 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl ) -N, N-Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2013-700212 (○) | JP4557131 | Types of Pesticides: Amisulblom Water Hydrate Name of Pesticide: Oracle Granule Water Repellent Active Ingredient Chemical Name: 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl)- N, N-Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2013-700212 (■) | JP4557131 | Types of Pesticides: Amisulblom Hydrating Agent Name of Pesticide: Oracle Granulating Water Repellent Active Ingredient Chemical Name: 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl)- N, N-Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2013-700211 (○) | JP4782418 | Common Name: Fluopyram Chemical Name: Ν- {2- [3-Chloro-5- (trifluoromethyl) -2-pyridyl] ethyl} -α, α, α-trifluoro-ο-toluamide Type of pesticide: Fluopyram wettable powder Name of pesticide: Orphine flowable |
| 2013-700211 (■) | JP4782418 | Common Name: Fluopyram Chemical Name: Ν- {2- [3-Chloro-5- (trifluoromethyl) -2-pyridyl] ethyl} -α, α, α-trifluoro-ο-toluamide Type of pesticide: Fluopyram wettable powder Name of pesticide: Orphine flowable |
| 2013-700210 (○) | JP5244318 | Efenbacal Tablet 800 μg |
| 2013-700210 (■) | JP5244318 | Efenbacal Tablet 800 μg |
| 2013-700209 (○) | JP5244318 | Efenbacal Tablet 600 μg |
| 2013-700209 (■) | JP5244318 | Efenbacal Tablet 600 μg |
| 2013-700208 (○) | JP5244318 | Efenbaccal Tablet 400 μg |
| 2013-700208 (■) | JP5244318 | Efenbaccal Tablet 400 μg |
| 2013-700207 (○) | JP5244318 | Efenbachal Tablet 200 μg |
| 2013-700207 (■) | JP5244318 | Efenbachal Tablet 200 μg |
| 2013-700206 (○) | JP5244318 | Efenbacal Tablet 100 μg |
| 2013-700206 (■) | JP5244318 | Efenbacal Tablet 100 μg |
| 2013-700205 (○) | JP5244318 | Efenbachal tablet 50 μg |
| 2013-700205 (■) | JP5244318 | Efenbachal tablet 50 μg |
| 2013-700204 (○) | JP4954170 | Name of Sale: Efenbacal Tablet 800 μg Active Ingredient: Fentanyl Citrate |
| 2013-700204 (■) | JP4954170 | Name of Sale: Efenbacal Tablet 800 μg Active Ingredient: Fentanyl Citrate |
| 2013-700203 (○) | JP4954170 | Name of Sale: Efenbacal Tablet 600μg Active Ingredient: Fentanyl Citrate |
| 2013-700203 (■) | JP4954170 | Name of Sale: Efenbacal Tablet 600μg Active Ingredient: Fentanyl Citrate |
| 2013-700202 (○) | JP4954170 | Name of Sale: Efenbacal Tablet 400 μg Active Ingredient: Fentanyl Citrate |
| 2013-700202 (■) | JP4954170 | Name of Sale: Efenbacal Tablet 400 μg Active Ingredient: Fentanyl Citrate |
| 2013-700201 (○) | JP4954170 | Name of Sale: Efenbacal Tablet 200μg Active Ingredient: Fentanyl Citrate |
| 2013-700201 (■) | JP4954170 | Name of Sale: Efenbacal Tablet 200μg Active Ingredient: Fentanyl Citrate |
| 2013-700200 (○) | JP4954170 | Name of Sale: Efenbacal Tablet 100μg Active Ingredient: Fentanyl Citrate |
| 2013-700200 (■) | JP4954170 | Name of Sale: Efenbacal Tablet 100μg Active Ingredient: Fentanyl Citrate |
| 2013-700199 (○) | JP4954170 | Name of Sale: Efenbacal Tablet 50μg Active Ingredient: Fentanyl Citrate |
| 2013-700199 (■) | JP4954170 | Name of Sale: Efenbacal Tablet 50μg Active Ingredient: Fentanyl Citrate |
| 2013-700198 (○) | JP4789324 | Name of Sale: Efenbacal Tablet 800 μg Active Ingredient: Fentanyl Citrate |
| 2013-700198 (■) | JP4789324 | Name of Sale: Efenbacal Tablet 800 μg Active Ingredient: Fentanyl Citrate |
| 2013-700197 (○) | JP4789324 | Name of Sale: Efenbacal Tablet 600μg Active Ingredient: Fentanyl Citrate |
| 2013-700197 (■) | JP4789324 | Name of Sale: Efenbacal Tablet 600μg Active Ingredient: Fentanyl Citrate |
| 2013-700196 (○) | JP4789324 | Name of Sale: Efenbacal Tablet 400 μg Active Ingredient: Fentanyl Citrate |
| 2013-700196 (■) | JP4789324 | Name of Sale: Efenbacal Tablet 400 μg Active Ingredient: Fentanyl Citrate |
| 2013-700195 (○) | JP4789324 | Name of Sale: Efenbacal Tablet 200μg Active Ingredient: Fentanyl Citrate |
| 2013-700195 (■) | JP4789324 | Name of Sale: Efenbacal Tablet 200μg Active Ingredient: Fentanyl Citrate |
| 2013-700194 (○) | JP4789324 | Name of Sale: Efenbacal Tablet 100μg Active Ingredient: Fentanyl Citrate |
| 2013-700194 (■) | JP4789324 | Name of Sale: Efenbacal Tablet 100μg Active Ingredient: Fentanyl Citrate |
| 2013-700193 (○) | JP4789324 | Name of Sale: Efenbacal Tablet 50μg Active Ingredient: Fentanyl Citrate |
| 2013-700193 (■) | JP4789324 | Name of Sale: Efenbacal Tablet 50μg Active Ingredient: Fentanyl Citrate |
| 2013-700192 (○) | JP5058531 | Bisonotape 8 mg Bisoprolol |
| 2013-700192 (■) | JP5058531 | Bisonotape 8 mg Bisoprolol |
| 2013-700191 (○) | JP5058531 | Bisonotape 4 mg Bisoprolol |
| 2013-700191 (■) | JP5058531 | Bisonotape 4 mg Bisoprolol |
| 2013-700190 (○) | JP4392016 | Bisonotape 8 mg Bisoprolol |
| 2013-700190 (■) | JP4392016 | Bisonotape 8 mg Bisoprolol |
| 2013-700189 (○) | JP4392016 | Bisonotape 4 mg Bisoprolol |
| 2013-700189 (■) | JP4392016 | Bisonotape 4 mg Bisoprolol |
| 2013-700188 (○) | JP5069843 | (I) Name of sale: PERJETA IV infusion 420 mg / 14 mL (ii) Active ingredient: Pertuzumab (genetically modified) |
| 2013-700188 (■) | JP5069843 | (I) Sales name Pergeta IV infusion 420 mg / 14 mL (ii) Active ingredient Pertuzumab (genetically modified) |
| 2013-700187 (○) | JP4283474 | (I) Name of sale: PERJETA IV infusion 420 mg / 14 mL (ii) Active ingredient: Pertuzumab (genetically modified) |
| 2013-700187 (■) | JP4283474 | (I) Sales name Pergeta IV infusion 420 mg / 14 mL (ii) Active ingredient Pertuzumab (genetically modified) |
| 2013-700186 (○) | JP4974255 | Name of sale: Iltra combination tablet HD (active ingredient: irbesartan and trichlormethiazide) |
| 2013-700186 (■) | JP4974255 | Name of sale: Iltra combination tablet HD (active ingredient: irbesartan and trichlormethiazide) |
| 2013-700185 (○) | JP4974255 | Name of sale: Iltra combination tablet LD (active ingredient: irbesartan and trichlormethiazide) |
| 2013-700185 (■) | JP4974255 | Name of sale: Iltra combination tablet LD (active ingredient: irbesartan and trichlormethiazide) |
| 2013-700184 (○) | JP4741463 | Name (brand name) Liquismia subcutaneous injection 300 μg Active ingredient name: Lixisenatide |
| 2013-700183 (○) | JP4741462 | Name (brand name) Liquismia subcutaneous injection 300 μg Active ingredient name: Lixisenatide |
| 2013-700182 (○) | JP5025482 | i) Common name: Pertuzumab (genetically modified) ii) Sales name: Perjeta IV infusion 420 mg / 14 mL |
| 2013-700182 (■) | JP5025482 | (I) General name: Pertuzumab (genetically modified) (ii) Name of sale: Perjeta IV infusion 420 mg / 14 mL |
| 2013-700181 (○) | JP5021000 | Cell culture influenza vaccine H5N1 "Baxter" (general name: cell culture influenza vaccine (H5N1 strain)) |
| 2013-700181 (■) | JP5021000 | Cell culture influenza vaccine H5N1 "Baxter" (general name: cell culture inactivated influenza vaccine (H5N1 strain)) |
| 2013-700180 (○) | JP4902945 | ABILIFY OD tablet 12 mg (General name: aripiprazole) |
| 2013-700180 (■) | JP4902945 | ABILIFY OD Tablet 12 mg (General name: aripiprazole) |
| 2013-700179 (○) | JP4902945 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2013-700179 (■) | JP4902945 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2013-700178 (○) | JP4902945 | ABILIFY powder 1% (common name: aripiprazole) |
| 2013-700178 (■) | JP4902945 | ABILIFY powder 1% (common name: aripiprazole) |
| 2013-700177 (○) | JP4902945 | ABILIFY Tablet 12 mg (General name: aripiprazole) |
| 2013-700177 (■) | JP4902945 | ABILIFY Tablet 12 mg (General name: aripiprazole) |
| 2013-700176 (○) | JP4284524 | ABILIFY OD tablet 12 mg (General name: aripiprazole) |
| 2013-700176 (■) | JP4284524 | ABILIFY OD tablet 12 mg (General name: aripiprazole) |
| 2013-700175 (○) | JP4284524 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2013-700175 (■) | JP4284524 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2013-700174 (○) | JP4284524 | ABILIFY powder 1% (General name: aripiprazole) |
| 2013-700174 (■) | JP4284524 | ABILIFY powder 1% (General name: aripiprazole) |
| 2013-700173 (○) | JP4284524 | ABILIFY Tablet 12 mg (General name: aripiprazole) |
| 2013-700173 (■) | JP4284524 | ABILIFY Tablet 12 mg (General name: aripiprazole) |
| 2013-700172 (○) | JP4401077 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2013-700172 (■) | JP4401077 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2013-700171 (○) | JP4178032 | ABILIFY OD tablet 12 mg (General name: aripiprazole) |
| 2013-700171 (■) | JP4178032 | ABILIFY OD Tablet 12 mg (General name: aripiprazole) |
| 2013-700170 (○) | JP4178032 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2013-700170 (■) | JP4178032 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2013-700169 (○) | JP4178032 | ABILIFY powder 1% (General name: aripiprazole) |
| 2013-700169 (■) | JP4178032 | ABILIFY powder 1% (common name: aripiprazole) |
| 2013-700168 (○) | JP4178032 | ABILIFY Tablet 12 mg (General name: aripiprazole) |
| 2013-700168 (■) | JP4178032 | ABILIFY Tablet 12 mg (General name: aripiprazole) |
| 2013-700167 (○) | JP3760264 | ABILIFY OD tablet 12 mg (General name: aripiprazole) |
| 2013-700167 (■) | JP3760264 | ABILIFY OD Tablet 12 mg (General name: aripiprazole) |
| 2013-700166 (○) | JP3760264 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2013-700166 (■) | JP3760264 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2013-700165 (○) | JP3760264 | ABILIFY powder 1% (General name: aripiprazole) |
| 2013-700165 (■) | JP3760264 | ABILIFY powder 1% (common name: aripiprazole) |
| 2013-700164 (○) | JP3760264 | ABILIFY Tablet 12 mg (General name: aripiprazole) |
| 2013-700164 (■) | JP3760264 | ABILIFY Tablet 12 mg (Common name: aripiprazole) |
| 2013-700163 (○) | JP5173920 | General name: Precipitated 13-valent pneumococcal conjugate vaccine (nontoxic mutant diphtheria toxin conjugate) Product name: Prevena 13 aqueous suspension Active ingredient: Pneumococcal capsular polysaccharide (serotype 1) -CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 3)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 4)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide ( Serotype 5)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 6A)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 6B)-CRM 197 conjugate Streptococcus pneumoniae Membrane polysaccharide (serotype 7F) -CRM197 conjugate pneumococcal capsular polysaccharide (serotype 9V) -CRM197 conjugate pneumococcal capsular polysaccharide (blood Pure 14)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 18C)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 19 A)-CRM 197 conjugate Streptococcus pneumoniae Membrane polysaccharide (serotype 19F) -CRM197 conjugate Pneumococcal capsular polysaccharide (serotype 23F) -CRM197 conjugate |
| 2013-700163 (■) | JP5173920 | General name: Precipitated 13-valent pneumococcal conjugate vaccine (non-toxic mutant diphtheria toxin conjugate) Product name: Prevener 13 aqueous suspension Active ingredient Pneumococcal capsular polysaccharide (serotype) 1)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 3)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 4)-CRM 197 conjugate Streptococcus pneumoniae poly Saccharide (serotype 5)-CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 6A)-CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 6B)-CRM 197 conjugate pneumonia Streptococcus capsular polysaccharide (serotype 7F) -CRM197 conjugate pneumococcal capsular polysaccharide (serotype 9V) -CRM197 conjugate pneumococcal capsular polysaccharide ( Pure 14)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 18C)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 19 A)-CRM 197 conjugate Streptococcus pneumoniae Membrane polysaccharide (serotype 19F) -CRM197 conjugate Pneumococcal capsular polysaccharide (serotype 23F) -CRM197 conjugate |
| 2013-700162 (○) | JP4472770 | General name: Precipitated 13-valent pneumococcal conjugate vaccine (nontoxic mutant diphtheria toxin conjugate) Product name: Prevena 13 aqueous suspension Active ingredient: Pneumococcal capsular polysaccharide (serotype 1) -CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 3)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 4)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide ( Serotype 5)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 6A)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 6B)-CRM 197 conjugate Streptococcus pneumoniae Membrane polysaccharide (serotype 7F) -CRM197 conjugate pneumococcal capsular polysaccharide (serotype 9V) -CRM197 conjugate pneumococcal capsular polysaccharide (blood Pure 14)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 18C)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 19 A)-CRM 197 conjugate Streptococcus pneumoniae Membrane polysaccharide (serotype 19F) -CRM197 conjugate Pneumococcal capsular polysaccharide (serotype 23F) -CRM197 conjugate |
| 2013-700162 (■) | JP4472770 | General name: Precipitated 13-valent pneumococcal conjugate vaccine (non-toxic mutant diphtheria toxin conjugate) Product name: Prevener 13 aqueous suspension Active ingredient Pneumococcal capsular polysaccharide (serotype) 1)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 3)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 4)-CRM 197 conjugate Streptococcus pneumoniae poly Saccharide (serotype 5)-CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 6A)-CRM 197 conjugate pneumococcal capsular polysaccharide (serotype 6B)-CRM 197 conjugate pneumonia Streptococcus capsular polysaccharide (serotype 7F) -CRM197 conjugate pneumococcal capsular polysaccharide (serotype 9V) -CRM197 conjugate pneumococcal capsular polysaccharide ( Pure 14)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 18C)-CRM 197 conjugate Streptococcus pneumoniae polysaccharide (serotype 19 A)-CRM 197 conjugate Streptococcus pneumoniae Membrane polysaccharide (serotype 19F) -CRM197 conjugate Pneumococcal capsular polysaccharide (serotype 23F) -CRM197 conjugate |
| 2013-700161 (○) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 400 mg / 16 mL Common name: bevacizumab (genetically modified) |
| 2013-700161 (■) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 400 mg / 16 mL Common name: bevacizumab (genetically modified) |
| 2013-700160 (○) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 100 mg / 4 mL Common name: bevacizumab (genetically modified) |
| 2013-700160 (■) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 100 mg / 4 mL Common name: bevacizumab (genetically modified) |
| 2013-700159 (○) | JP4332314 | Name of sale: Liquismia subcutaneous injection 300 μg Active ingredient: Lixisenatide |
| 2013-700159 (■) | JP4332314 | Name of sale: Liquismia subcutaneous injection 300 μg Active ingredient: Lixisenatide |
| 2013-700158 (○) | JP4689916 | Name of sale: Tarceva Tablet 150 mg Active Ingredient: Erlotinib Hydrochloride |
| 2013-700158 (■) | JP4689916 | Name of sale: Tarceva Tablet 150 mg Active Ingredient: Erlotinib Hydrochloride |
| 2013-700157 (○) | JP4689916 | Name of sale: Tarceva Tablet 100 mg Active ingredient: Erlotinib hydrochloride |
| 2013-700157 (■) | JP4689916 | Name of sale: Tarceva Tablet 100 mg Active ingredient: Erlotinib hydrochloride |
| 2013-700156 (○) | JP4689916 | Name of sale: Tarceva Tablet 25 mg Active ingredient: Erlotinib hydrochloride |
| 2013-700156 (■) | JP4689916 | Name of sale: Tarceva Tablet 25 mg Active ingredient: Erlotinib hydrochloride |
| 2013-700155 (○) | JP3088018 | Name of sale: Tarceva Tablet 150 mg Active Ingredient: Erlotinib Hydrochloride |
| 2013-700155 (■) | JP3088018 | Name of sale: Tarceva Tablet 150 mg Active Ingredient: Erlotinib Hydrochloride |
| 2013-700154 (○) | JP3088018 | Name of sale: Tarceva Tablet 100 mg Active ingredient: Erlotinib hydrochloride |
| 2013-700154 (■) | JP3088018 | Name of sale: Tarceva Tablet 100 mg Active ingredient: Erlotinib hydrochloride |
| 2013-700153 (○) | JP3088018 | Name of sale: Tarceva Tablet 25 mg Active ingredient: Erlotinib hydrochloride |
| 2013-700153 (■) | JP3088018 | Name of sale: Tarceva Tablet 25 mg Active ingredient: Erlotinib hydrochloride |
| 2013-700152 (○) | JP5247467 | Name of sale: Orensea subcutaneous injection 125 mg syringe 1 mL Active ingredient: General name: Abatacept (genetically modified) |
| 2013-700152 (■) | JP5247467 | Name of sale: Orensea subcutaneous injection 125 mg syringe 1 mL active ingredient General name: abatacept (genetically modified) |
| 2013-700151 (○) | JP4903900 | Levetiracetam |
| 2013-700151 (■) | JP4903900 | Name of product: E-Kepra dry syrup 50% Active ingredient: Levetiracetam |
| 2013-700150 (○) | JP4925582 | (Active ingredient) Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700150 (■) | JP4925582 | Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700149 (○) | JP4890997 | (Active ingredient) Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700149 (■) | JP4890997 | Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700148 (○) | JP4404181 | (Active ingredient) Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700148 (■) | JP4404181 | Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700147 (○) | JP3861118 | (Active ingredient) Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700147 (■) | JP3861118 | Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700146 (○) | JP4925582 | (Active ingredient) Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700146 (■) | JP4925582 | Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700145 (○) | JP4890997 | (Active ingredient) Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700145 (■) | JP4890997 | Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700144 (○) | JP4404181 | (Active ingredient) Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700144 (■) | JP4404181 | Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700143 (○) | JP3861118 | (Active ingredient) Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700143 (■) | JP3861118 | Adalimumab (genetically modified) (brand name: Humira subcutaneous injection 40 mg syringe 0.8 mL) |
| 2013-700142 (○) | JP3600832 | Name of sale: Toporrik tablet 60 mg Common name: topiroxostat |
| 2013-700142 (■) | JP3600832 | Name of sale: Toporrik tablet 60 mg Common name: topiroxostat |
| 2013-700141 (○) | JP3600832 | Name of sale: Toporrik tablet 40 mg Common name: topiroxostat |
| 2013-700141 (■) | JP3600832 | Name of sale: Toporrik tablet 40 mg Common name: topiroxostat |
| 2013-700140 (○) | JP3600832 | Name of sale: Toporrik tablet 20 mg Common name: topiroxostat |
| 2013-700140 (■) | JP3600832 | Name of sale: Toporrik tablet 20 mg Common name: topiroxostat |
| 2013-700139 (○) | JP3118258 | Name of sale: Bonviva IV injection 1 mg syringe Active ingredient: Ibandronate sodium hydrate |
| 2013-700139 (■) | JP3118258 | Name of sale: Bonviva IV injection 1 mg syringe Active ingredient: Ibandronate sodium hydrate |
| 2013-700138 (○) | JP5221544 | Name of sale: Stalibuild combination tablets Active ingredients: Erbitegravir, Covisitastat / Silicon dioxide mixture, Emtricitabine, and Tenofovir disoproxil fumarate |
| 2013-700137 (○) | JP5202635 | Name of sale: Stalibuild combination tablets Active ingredients: Erbitegravir, Covisitastat / Silicon dioxide mixture, Emtricitabine, and Tenofovir disoproxil fumarate |
| 2013-700136 (○) | JP4996241 | Name of sale: Stalibuild combination tablets Active ingredients: Erbitegravir, Covisitastat / Silicon dioxide mixture, Emtricitabine, and Tenofovir disoproxil fumarate |
| 2013-700136 (■) | JP4996241 | Name of sale: Stalibuild combination tablets Active ingredients: Erbitegravir, Covisitastat / Silicon dioxide mixture, Emtricitabine, and Tenofovir Disoproxil fumarate |
| 2013-700135 (○) | JP4881446 | Name of sale: Stalibuild combination tablets Active ingredients: Erbitegravir, Covisitastat / Silicon dioxide mixture, Emtricitabine, and Tenofovir disoproxil fumarate |
| 2013-700135 (■) | JP4881446 | Name of sale: Stalibuild combination tablets Active ingredients: Erbitegravir, Covisitastat / Silicon dioxide mixture, Emtricitabine, and Tenofovir Disoproxil fumarate |
| 2013-700134 (○) | JP4173202 | Name of sale: Stalibuild combination tablets Active ingredients: Erbitegravir, Covisitastat / Silicon dioxide mixture, Emtricitabine, and Tenofovir disoproxil fumarate |
| 2013-700134 (■) | JP4173202 | Name of sale: Stalibuild combination tablets Active ingredients: Erbitegravir, Covisitastat / Silicon dioxide mixture, Emtricitabine, and Tenofovir Disoproxil fumarate |
| 2013-700133 (○) | JP4173195 | Name of sale: Stalibuild combination tablets Active ingredients: Erbitegravir, Covisitastat / Silicon dioxide mixture, Emtricitabine, and Tenofovir disoproxil fumarate |
| 2013-700132 (○) | JP4033494 | Name of sale: Stalibuild combination tablets Active ingredients: Erbitegravir, Covisitastat / Silicon dioxide mixture, Emtricitabine, and Tenofovir disoproxil fumarate |
| 2013-700132 (■) | JP4033494 | Name of sale: Stalibuild combination tablets Active ingredients: Erbitegravir, Covisitastat / Silicon dioxide mixture, Emtricitabine, and Tenofovir Disoproxil fumarate |
| 2013-700131 (○) | JP4869064 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: Tocilizumab (genetically modified) |
| 2013-700131 (■) | JP4869064 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: Tocilizumab (genetically modified) |
| 2013-700130 (○) | JP4869064 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2013-700130 (■) | JP4869064 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2013-700129 (○) | JP4340062 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: Tocilizumab (genetically modified) |
| 2013-700129 (■) | JP4340062 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: Tocilizumab (genetically modified) |
| 2013-700128 (○) | JP4340062 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2013-700128 (■) | JP4340062 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2013-700127 (○) | JP4669040 | Name of sale: Stalibuild combination tablets Active ingredient: (General name) Erbitegravir, (Common name) Cobicistat / Silicon dioxide mixture, (Common name) Emtricitabine, (Common name) Tenofovir disoproxil fumarate |
| 2013-700127 (■) | JP4669040 | Name of sale: Stalibuild combination tablets Active ingredient: (Organic name) Erbitegravir, (Organic name) covisistat / silicon dioxide mixture, (Organic name) Emtricitabine, (Organic name) tenofovir disoproxil fumarate |
| 2013-700126 (○) | JP4629104 | Name of sale: Stalibuild combination tablets Active ingredient: (General name) Erbitegravir, (Common name) Cobicistat / Silicon dioxide mixture, (Common name) Emtricitabine, (Common name) Tenofovir disoproxil fumarate |
| 2013-700126 (■) | JP4629104 | Name of sale: Stalibuild combination tablets Active ingredient: (Organic name) Erbitegravir, (Organic name) covisistat / silicon dioxide mixture, (Organic name) Emtricitabine, (Organic name) tenofovir disoproxil fumarate |
| 2013-700125 (○) | JP3754064 | Name of sale: Stalibuild combination tablets Active ingredient: (General name) Erbitegravir, (Common name) Cobicistat / Silicon dioxide mixture, (Common name) Emtricitabine, (Common name) Tenofovir disoproxil fumarate |
| 2013-700125 (■) | JP3754064 | Name of sale: Stalibuild combination tablets Active ingredient: (Organic name) Erbitegravir, (Organic name) covisistat / silicon dioxide mixture, (Organic name) Emtricitabine, (Organic name) tenofovir disoproxil fumarate |
| 2013-700124 (○) | JP3567162 | Name of sale: Stalibuild combination tablets Active ingredient: (General name) Erbitegravir, (General name) Cobicistat / Silicon Dioxide mixture, (General name) Emtricitabine, (General name) Tenofovir Disopro xyl fumarate |
| 2013-700124 (■) | JP3567162 | Name of sale: Stalibuild combination tablets Active ingredient: (Organic name) Erbitegravir, (Organic name) covisistat / silicon dioxide mixture, (Organic name) Emtricitabine, (Organic name) tenofovir disoproxil fumarate |
| 2013-700123 (○) | JP4901727 | Name of Sale: Onglyza Tablets 5mg Active Ingredient Common Name: Saxagliptin Hydrate |
| 2013-700123 (■) | JP4901727 | Name of Sale: Onglyza Tablets 5mg Active Ingredient Common Name: Saxagliptin Hydrate |
| 2013-700122 (○) | JP4901727 | Name of sale: Onglyza Tablets 2.5mg Active Ingredient Common name: Saxagliptin hydrate |
| 2013-700122 (■) | JP4901727 | Name of sale: Onglyza Tablets 2.5mg Active Ingredient Common name: Saxagliptin hydrate |
| 2013-700121 (○) | JP4886193 | Name of Sale: Onglyza Tablets 5mg Active Ingredient Common Name: Saxagliptin Hydrate |
| 2013-700121 (■) | JP4886193 | Name of Sale: Onglyza Tablets 5mg Active Ingredient Common Name: Saxagliptin Hydrate |
| 2013-700120 (○) | JP4886193 | Name of sale: Onglyza Tablets 2.5mg Active Ingredient Common name: Saxagliptin hydrate |
| 2013-700120 (■) | JP4886193 | Name of sale: Onglyza Tablets 2.5mg Active Ingredient Common name: Saxagliptin hydrate |
| 2013-700119 (○) | JP4460205 | Name of Sale: Onglyza Tablets 5mg Active Ingredient Common Name: Saxagliptin Hydrate |
| 2013-700119 (■) | JP4460205 | Name of Sale: Onglyza Tablets 5mg Active Ingredient Common Name: Saxagliptin Hydrate |
| 2013-700118 (○) | JP4460205 | Name of sale: Onglyza Tablets 2.5mg Active Ingredient Common name: Saxagliptin hydrate |
| 2013-700118 (■) | JP4460205 | Name of sale: Onglyza Tablets 2.5mg Active Ingredient Common name: Saxagliptin hydrate |
| 2013-700117 (○) | JP4937358 | Actemra subcutaneous injection 162 mg auto injector |
| 2013-700117 (■) | JP4937358 | Actemra subcutaneous injection 162 mg auto injector |
| 2013-700116 (○) | JP4937358 | Actemra subcutaneous injection 162 mg syringe |
| 2013-700116 (■) | JP4937358 | Actemra subcutaneous injection 162 mg syringe |
| 2013-700115 (○) | JP4472669 | Legorafenib Hydrate (brand name: Stivarga tablet 40 mg) |
| 2013-700115 (■) | JP4472669 | Legorafenib Hydrate (brand name: Stivarga tablet 40 mg) |
| 2013-700114 (○) | JP5017115 | Legorafenib Hydrate (brand name: Stivarga tablet 40 mg) |
| 2013-700114 (■) | JP5017115 | Legorafenib Hydrate (brand name: Stivarga tablet 40 mg) |
| 2013-700113 (○) | JP4777887 | Legorafenib Hydrate (brand name: Stivarga tablet 40 mg) |
| 2013-700113 (■) | JP4777887 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2013-700112 (○) | JP3672574 | Name: Innovaron Tablets 200 mg General name: Rufinamide |
| 2013-700112 (■) | JP3672574 | Name: Innovaron Tablets 200 mg General name: Rufinamide |
| 2013-700111 (○) | JP3672574 | Name: Innovaron Tablets 100 mg General name: Rufinamide |
| 2013-700111 (■) | JP3672574 | Name: Innovaron Tablets 100 mg General name: Rufinamide |
| 2013-700110 (○) | JP4606326 | Istra de Filin |
| 2013-700110 (■) | JP4606326 | Nouriast Tablets 20 mg (Active Ingredient: Istradefilin) |
| 2013-700109 (○) | JP4413866 | Istra de Filin |
| 2013-700109 (■) | JP4413866 | Nouriast Tablets 20 mg (Active ingredient: Istradefilin) |
| 2013-700108 (○) | JP4673745 | Istra de Filin |
| 2013-700108 (■) | JP4673745 | Istra de Filin |
| 2013-700107 (○) | JP4376630 | Istra de Filin |
| 2013-700107 (■) | JP4376630 | Istra de Filin |
| 2013-700106 (○) | JP2613355 | Istra de Filin |
| 2013-700106 (■) | JP2613355 | Istra de Filin |
| 2013-700105 (○) | JP4593917 | Drugs subject to disposal (brand name): Evotra intravenous drip 20 mg active ingredients of drug subject to disposal (General name): clofarabine |
| 2013-700105 (■) | JP4593917 | Drugs subject to disposal (brand name): Evorla IV drip 20 mg active ingredient of medications subject to disposal (General name): clofarabine |
| 2013-700104 (○) | JP4662473 | Name of sale: Zeera Intravenous Drip Injection 1000 mg Active ingredient name: Ofatumumab (genetically modified) |
| 2013-700104 (■) | JP4662473 | Name of sale: Zeera Intravenous Drip Injection 1000 mg Active ingredient name: Ofatumumab (genetically modified) |
| 2013-700103 (○) | JP4401613 | Common name: Denosumab (genetically modified) Name of sale: Praria subcutaneous injection 60 mg syringe |
| 2013-700103 (■) | JP4401613 | Common name: Denosumab (genetically modified) Name of sale: Praria subcutaneous injection 60 mg syringe |
| 2013-700102 (○) | JP4212470 | Common name: Denosumab (genetically modified) Name of sale: Praria subcutaneous injection 60 mg syringe |
| 2013-700102 (■) | JP4212470 | Common name: Denosumab (genetically modified) Name of sale: Praria subcutaneous injection 60 mg syringe |
| 2013-700101 (○) | JP4358282 | Name of sale: PRARIA subcutaneous injection 60 mg syringe Common name of active ingredient: Denosumab (genetically modified) |
| 2013-700101 (■) | JP4358282 | Name of sale: PRARIA subcutaneous injection 60 mg syringe Common name of active ingredient: Denosumab (genetically modified) |
| 2013-700100 (○) | JP4749542 | (I) Common Name: Fluopicolide Chemical Name: 2,6-Dichloro-N- [3-chloro-5- (trifluoromethyl) -2-pyridylmethyl] benzamide, and (ii) Common Name: Bencia Varicarb Isopropyl Chemical Name: Isopropyl = [(S) -1-[{(R) -1- (6-Fluoro-1,3-benzothiazol-2-yl) ethyl} carbamoyl] -2-methyl [Propyl] CarbaMart Type of pesticide: Fluopicolide ・ Bencha Varyca Isopropyl wettable powder Name of pesticide: Just fit flowable |
| 2013-700100 (■) | JP4749542 | (I) Common Name: Fluopicolide Chemical Name: 2,6-Dichloro-N- [3-chloro-5- (trifluoromethyl) -2-pyridylmethyl] benzamide, and (ii) Common Name : Bencha Vialica Isopropyl Chemical Name: Isopropyl = [(S) -1-[{(R) -1- (6-Fluoro-1,3-benzothiazol-2-yl) ethyl} carbamoyl]- 2-Methyl Propyl] Carbamate Pesticide Type: Fluopicolide / Bench Avaliculum Isopropyl Wettable Powder Name of Pesticide: Just Fit Flowable |
| 2013-700099 (○) | JP5132303 | Pesticide name: Try 2 J powder DL active ingredient name: tebufloquine, silafluophene active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate , 4-Ethoxyphenyl [3- (4-fluoro-3-phenoxyphenyl) propyl] dimethylsilane |
| 2013-700098 (○) | JP5132303 | Pesticide name: Tri-2 mazine powder DL active ingredient name: tebufloquin, clothianidin, validamycin A active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4 -Quinolyl acetate, (E) -1- (2-chloro-1,3-thiazol-5-ylmethyl) -3-methyl-2-nitroguanidine, validamycin A |
| 2013-700097 (○) | JP5132303 | Pesticide name: Try 2 K powder DL active ingredient name: tebufloquine, ethiprole active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate , 5-Amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2013-700096 (○) | JP5132303 | Pesticide name: Tri 2 Star crumb powder DL active ingredient name: tebufloquine, dinotefuran active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl = Acetate, (RS) -1-Methyl-2-nitro-3- (tetrahydro-3-furylmethyl) guanidine |
| 2013-700095 (○) | JP5132303 | Pesticide Name: Tri-2 Trebon Powder DL Active Ingredient Name: Tephfloquin, Etofenprox Active Ingredient Name: 6-tert-Butyl-8-fluoro-2,3-dimethyl-4- Quinolyl acetate, 2- (4-ethoxyphenyl) -2-methylpropyl 3-phenoxybenzyl ether |
| 2013-700094 (○) | JP5132303 | Pesticide name: Tri-2 powder DL active ingredient name: tebufloquin active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate |
| 2013-700093 (○) | JP4152742 | Pesticide name: Try 2 J powder DL active ingredient name: tebufloquine, silafluophene active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate , 4-Ethoxyphenyl [3- (4-fluoro-3-phenoxyphenyl) propyl] dimethylsilane |
| 2013-700093 (■) | JP4152742 | Pesticide name: Try 2 J powder DL active ingredient name: tebufloquine, silafluophene active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate , 4-Ethoxyphenyl [3- (4-fluoro-3-phenoxyphenyl) propyl] dimethylsilane |
| 2013-700092 (○) | JP4152742 | Pesticide name: Tri-2 mazine powder DL active ingredient name: tebufloquin, clothianidin, validamycin A active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4 -Quinolyl acetate, (E) -1- (2-chloro-1,3-thiazol-5-ylmethyl) -3-methyl-2-nitroguanidine, validamycin A |
| 2013-700092 (■) | JP4152742 | Pesticide name: TRI-2 mazine powder DL active ingredient name: tebufloquin, clothianidin, validamycin A active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4 -Quinolyl acetate, (E) -1- (2-chloro-1,3-thiazol-5-ylmethyl) -3-methyl-2-nitroguanidine, validamycin A |
| 2013-700091 (○) | JP4152742 | Pesticide name: Try 2 K powder DL active ingredient name: tebufloquine, ethiprole active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate , 5-Amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2013-700091 (■) | JP4152742 | Pesticide name: Try 2 K powder DL active ingredient name: tebfloquine, ethiprole active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate 5-Amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2013-700090 (○) | JP4152742 | Pesticide name: Tri 2 Star crumb powder DL active ingredient name: tebufloquine, dinotefuran active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl = Acetate, (RS) -1-Methyl-2-nitro-3- (tetrahydro-3-furylmethyl) guanidine |
| 2013-700090 (■) | JP4152742 | Pesticide name: Tri 2 Star crumb powder DL active ingredient name: tebufloquine, dinotefuran active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl = Acetate, (RS) -1-Methyl-2-nitro-3- (tetrahydro-3-furylmethyl) guanidine |
| 2013-700089 (○) | JP4152742 | Pesticide Name: Tri-2 Trebon Powder DL Active Ingredient Name: Tephfloquin, Etofenprox Active Ingredient Name: 6-tert-Butyl-8-fluoro-2,3-dimethyl-4- Quinolyl acetate, 2- (4-ethoxyphenyl) -2-methylpropyl 3-phenoxybenzyl ether |
| 2013-700089 (■) | JP4152742 | Pesticide Name: Tri-2 Trebon Powder DL Active Ingredient Name: Tephfloquin, Etophenprox Active Ingredient Chemical Name: 6-tert-Butyl-8-Fluoro-2,3-dimethyl-4- Quinolyl acetate, 2- (4-ethoxyphenyl) -2-methylpropyl 3-phenoxybenzyl ether |
| 2013-700088 (○) | JP4152742 | Pesticide name: Tri 2 water dispersible granules active ingredient name: tebufloquine active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate |
| 2013-700088 (■) | JP4152742 | Pesticide name: Tri 2 water dispersible powder active ingredient name: tebufloquine active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate |
| 2013-700087 (○) | JP4152742 | Pesticide name: Tri-2 powder DL active ingredient name: tebufloquin active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate |
| 2013-700087 (■) | JP4152742 | Pesticide Name: Tri-2 Powder DL Active Ingredient Name: Tephfloquin Active Ingredient Chemical Name: 6-tert-Butyl-8-Fluoro-2,3-dimethyl-4-quinolyl acetate |
| 2013-700086 (○) | JP3934164 | Pesticide name: Try 2 J powder DL active ingredient name: tebufloquine, silafluophene active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate , 4-Ethoxyphenyl [3- (4-fluoro-3-phenoxyphenyl) propyl] dimethylsilane |
| 2013-700086 (■) | JP3934164 | Pesticide name: Try 2 J powder DL active ingredient name: tebufloquine, silafluophene active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate , 4-Ethoxyphenyl [3- (4-fluoro-3-phenoxyphenyl) propyl] dimethylsilane |
| 2013-700085 (○) | JP3934164 | Pesticide name: Tri-2 mazine powder DL active ingredient name: tebufloquin, clothianidin, validamycin A active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4 -Quinolyl acetate, (E) -1- (2-chloro-1,3-thiazol-5-ylmethyl) -3-methyl-2-nitroguanidine, validamycin A |
| 2013-700085 (■) | JP3934164 | Pesticide name: TRI-2 mazine powder DL active ingredient name: tebufloquin, clothianidin, validamycin A active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4 -Quinolyl acetate, (E) -1- (2-chloro-1,3-thiazol-5-ylmethyl) -3-methyl-2-nitroguanidine, validamycin A |
| 2013-700084 (○) | JP3934164 | Pesticide name: Try 2 K powder DL active ingredient name: tebufloquine, ethiprole active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate , 5-Amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2013-700084 (■) | JP3934164 | Pesticide name: Try 2 K powder DL active ingredient name: tebfloquine, ethiprole active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate 5-Amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2013-700083 (○) | JP3934164 | Pesticide name: Tri 2 Star crumb powder DL active ingredient name: tebufloquine, dinotefuran active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl = Acetate, (RS) -1-Methyl-2-nitro-3- (tetrahydro-3-furylmethyl) guanidine |
| 2013-700083 (■) | JP3934164 | Pesticide name: Tri 2 Star crumb powder DL active ingredient name: tebufloquine, dinotefuran active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl = Acetate, (RS) -1-Methyl-2-nitro-3- (tetrahydro-3-furylmethyl) guanidine |
| 2013-700082 (○) | JP3934164 | Pesticide Name: Tri-2 Trebon Powder DL Active Ingredient Name: Tephfloquin, Etofenprox Active Ingredient Name: 6-tert-Butyl-8-fluoro-2,3-dimethyl-4- Quinolyl acetate, 2- (4-ethoxyphenyl) -2-methylpropyl = 3-phenoxybenzyl ether |
| 2013-700082 (■) | JP3934164 | Pesticide Name: Tri-2 Trebon Powder DL Active Ingredient Name: Tephfloquin, Etophenprox Active Ingredient Chemical Name: 6-tert-Butyl-8-Fluoro-2,3-dimethyl-4- Quinolyl acetate, 2- (4-ethoxyphenyl) -2-methylpropyl 3-phenoxybenzyl ether |
| 2013-700081 (○) | JP3934164 | Pesticide name: Tri 2 water dispersible powder active ingredient name: tebufloquine active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate |
| 2013-700081 (■) | JP3934164 | Pesticide name: Tri 2 water dispersible powder active ingredient name: tebufloquine active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate |
| 2013-700080 (○) | JP3934164 | Pesticide name: Tri-2 powder DL active ingredient name: tebufloquin active ingredient chemical name: 6-tert-butyl-8-fluoro-2,3-dimethyl-4-quinolyl acetate |
| 2013-700080 (■) | JP3934164 | Pesticide Name: Tri-2 Powder DL Active Ingredient Name: Tephfloquin Active Ingredient Chemical Name: 6-tert-Butyl-8-Fluoro-2,3-dimethyl-4-quinolyl acetate |
| 2013-700079 (○) | JP4242913 | Praria subcutaneous injection 60 mg (active ingredient: "denosumab") |
| 2013-700079 (■) | JP4242913 | Praria subcutaneous injection 60 mg (active ingredient: "denosumab") |
| 2013-700078 (○) | JP5122144 | Name of sale: Equa Tablet 50 mg General name: vildagliptin |
| 2013-700078 (■) | JP5122144 | Name of sale: Equa Tablet 50 mg General name: vildagliptin |
| 2013-700077 (○) | JP3681110 | Sales name: Equa Tablet 50 mg Common name: vildagliptin |
| 2013-700077 (■) | JP3681110 | Name of sale: Equa Tablet 50 mg General name: vildagliptin |
| 2013-700076 (○) | JP4837809 | Abraxane 100 mg for intravenous infusion (General name: paclitaxel) |
| 2013-700076 (■) | JP4837809 | Abraxane 100 mg for intravenous infusion (common name: paclitaxel) |
| 2013-700075 (○) | JP4865937 | Abraxane 100 mg for intravenous infusion (General name: paclitaxel) |
| 2013-700075 (■) | JP4865937 | Abraxane 100 mg for intravenous infusion (common name: paclitaxel) |
| 2013-700074 (○) | JP3746293 | Abraxane 100 mg for intravenous infusion (General name: paclitaxel) |
| 2013-700074 (■) | JP3746293 | Abraxane 100 mg for intravenous infusion (common name: paclitaxel) |
| 2013-700073 (○) | JP3746293 | Abraxane 100 mg for intravenous infusion (General name: paclitaxel) |
| 2013-700073 (■) | JP3746293 | Abraxane 100 mg for intravenous infusion (common name: paclitaxel) |
| 2013-700072 (○) | JP3935861 | Denosumab (genetically modified) |
| 2013-700072 (■) | JP3935861 | Denosumab (genetically modified) |
| 2013-700071 (○) | JP3523650 | Denosumab (genetically modified) |
| 2013-700071 (■) | JP3523650 | Denosumab (genetically modified) |
| 2013-700070 (○) | JP4703075 | Neoxy tape 73.5 mg (active ingredient: oxybutynin hydrochloride) |
| 2013-700070 (■) | JP4703075 | Neoxy tape 73.5mg (active ingredient: oxybutynin hydrochloride) |
| 2013-700069 (○) | JP4354678 | Neoxy tape 73.5 mg (active ingredient: oxybutynin hydrochloride) |
| 2013-700069 (■) | JP4354678 | Neoxy tape 73.5mg (active ingredient: oxybutynin hydrochloride) |
| 2013-700068 (○) | JP4261911 | Neoxy tape 73.5 mg (active ingredient: oxybutynin hydrochloride) |
| 2013-700068 (■) | JP4261911 | Neoxy tape 73.5mg (active ingredient: oxybutynin hydrochloride) |
| 2013-700067 (○) | JP4205778 | Neoxy tape 73.5 mg (active ingredient: oxybutynin hydrochloride) |
| 2013-700067 (■) | JP4205778 | Neoxy tape 73.5mg (active ingredient: oxybutynin hydrochloride) |
| 2013-700066 (○) | JP4844395 | Name of Sales: Acofide Tablet 100 mg Active Ingredient: Acotiamide Hydrochloride Hydrate Hydrate |
| 2013-700066 (■) | JP4844395 | Name of Sales: Acofide Tablet 100 mg Active Ingredient: Acotiamide Hydrochloride Hydrate Hydrate |
| 2013-700065 (○) | JP3181919 | Name of Sales: Acofide Tablet 100 mg Active Ingredient: Acotiamide Hydrochloride Hydrate Hydrate |
| 2013-700065 (■) | JP3181919 | Name of Sales: Acofide Tablet 100mg Active Ingredient: Acotiamide Hydrochloride Hydrate Hydrate |
| 2013-700064 (○) | JP3693258 | Pregabalin (brand name: Lyrica Capsule 150 mg) |
| 2013-700064 (■) | JP3693258 | Pregabalin (brand name: Lyrica Capsule 150 mg) |
| 2013-700063 (○) | JP3693258 | Pregabalin (brand name: Lilyca Capsule 75 mg) |
| 2013-700063 (■) | JP3693258 | Pregabalin (brand name: Lilyca Capsule 75 mg) |
| 2013-700062 (○) | JP3693258 | Pregabalin (brand name: Lyrica Capsule 25 mg) |
| 2013-700062 (■) | JP3693258 | Pregabalin (brand name: Lyrica Capsule 25 mg) |
| 2013-700061 (○) | JP3795917 | Name of Sale: Nexium Capsule 20 mg Active Ingredient (Common Name): Esomeprazole Magnesium Hydrate |
| 2013-700061 (■) | JP3795917 | Name of Sale: Nexium Capsule 20 mg Active Ingredient (Common Name): Esomeprazole Magnesium Hydrate |
| 2013-700060 (○) | JP3959056 | Name of Sale: Nexium Capsule 20 mg Active Ingredient (Common Name): Esomeprazole Magnesium Hydrate |
| 2013-700060 (■) | JP3959056 | Name of Sale: Nexium Capsule 20 mg Active Ingredient (Common Name): Esomeprazole Magnesium Hydrate |
| 2013-700059 (○) | JP3795917 | Name of sale: Nexium capsule 10 mg Active ingredient (general name): Esomeprazole magnesium hydrate |
| 2013-700059 (■) | JP3795917 | Name of sale: Nexium capsule 10 mg Active ingredient (general name): Esomeprazole magnesium hydrate |
| 2013-700058 (○) | JP3959056 | Name of sale: Nexium capsule 10 mg Active ingredient (general name): Esomeprazole magnesium hydrate |
| 2013-700058 (■) | JP3959056 | Name of sale: Nexium capsule 10 mg Active ingredient (general name): Esomeprazole magnesium hydrate |
| 2013-700057 (○) | JP4381137 | Name of sale: Zellantz 5 mg (active ingredient: tofacitinib citrate) |
| 2013-700057 (■) | JP4381137 | Name of sale: Zellantz 5 mg (active ingredient: tofacitinib citrate) |
| 2013-700056 (○) | JP4201135 | Name of sale: Zellantz 5 mg (active ingredient: tofacitinib citrate) |
| 2013-700056 (■) | JP4201135 | Name of sale: Zellantz 5 mg (active ingredient: tofacitinib citrate) |
| 2013-700055 (○) | JP4078074 | Name of sale: Zellantz 5 mg (active ingredient: tofacitinib citrate) |
| 2013-700055 (■) | JP4078074 | Name of sale: Zellantz 5 mg (active ingredient: tofacitinib citrate) |
| 2013-700054 (○) | JP3982542 | 1- [3-chloro-1-methyl-4-[(5RS) -5,6-dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- {4,6-Dimethoxypyrimidin-2-yl] urea |
| 2013-700054 (■) | JP3982542 | Types of pesticides: Daimlon / Metazosulfuron granules Name of pesticides: Twin Star 1 kg granules Active ingredient Chemical name: 1- [3-chloro-1-methyl-4-[(5RS) -5, 6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- {4,6-dimethoxypyrimidin-2-yl] urea |
| 2013-700053 (○) | JP3864298 | Pesticide Name: Gatten Emulsion Active Ingredient :: (Z) -2- [2-Fluoro-5- (trifluoromethyl) phenylthio] -2- [3- (2-methoxyphenyl) -1,3- Thiazolidine-2-ylidene] acetonitrile |
| 2013-700053 (■) | JP3864298 | Pesticide type: Flutianil emulsion Pesticide name: Gatten emulsion Active ingredient: (Z) -2- [2-fluoro-5- (trifluoromethyl) phenylthio] -2- [3- (2- Methoxyphenyl) -1,3-thiazolidin-2-ylidene] acetonitrile |
| 2013-700052 (○) | JP3984785 | Name of Sale: New Pro Patch 13.5mg Active Ingredient: Rotigotine |
| 2013-700052 (■) | JP3984785 | Name of Sale: New Pro Patch 13.5mg Active Ingredient: Rotigotine |
| 2013-700051 (○) | JP3984785 | Name of Sale: New Pro Patch 9 mg Active Ingredient: Rotigotine |
| 2013-700051 (■) | JP3984785 | Name of Sale: New Pro Patch 9 mg Active Ingredient: Rotigotine |
| 2013-700050 (○) | JP3984785 | Name of Sale: New Pro Patch 4.5mg Active Ingredient: Rotigotine |
| 2013-700050 (■) | JP3984785 | Name of Sale: New Pro Patch 4.5mg Active Ingredient: Rotigotine |
| 2013-700049 (○) | JP3984785 | Name of Sale: New Pro Patch 2.25mg Active Ingredient: Rotigotine |
| 2013-700049 (■) | JP3984785 | Name of Sale: New Pro Patch 2.25mg Active Ingredient: Rotigotine |
| 2013-700048 (○) | JP4837916 | Name of Sale: New Pro Patch 13.5mg Active Ingredient: Rotigotine |
| 2013-700048 (■) | JP4837916 | Name of Sale: New Pro Patch 13.5mg Active Ingredient: Rotigotine |
| 2013-700047 (○) | JP4837916 | Name of Sale: New Pro Patch 9 mg Active Ingredient: Rotigotine |
| 2013-700047 (■) | JP4837916 | Name of Sale: New Pro Patch 9 mg Active Ingredient: Rotigotine |
| 2013-700046 (○) | JP4837916 | Name of Sale: New Pro Patch 4.5mg Active Ingredient: Rotigotine |
| 2013-700046 (■) | JP4837916 | Name of Sale: New Pro Patch 4.5mg Active Ingredient: Rotigotine |
| 2013-700045 (○) | JP4837916 | Name of Sale: New Pro Patch 2.25mg Active Ingredient: Rotigotine |
| 2013-700045 (■) | JP4837916 | Name of Sale: New Pro Patch 2.25mg Active Ingredient: Rotigotine |
| 2013-700044 (○) | JP4837915 | Name of Sale: New Pro Patch 13.5mg Active Ingredient: Rotigotine |
| 2013-700044 (■) | JP4837915 | Name of Sale: New Pro Patch 13.5mg Active Ingredient: Rotigotine |
| 2013-700043 (○) | JP4837915 | Name of Sale: New Pro Patch 9 mg Active Ingredient: Rotigotine |
| 2013-700043 (■) | JP4837915 | Name of Sale: New Pro Patch 9 mg Active Ingredient: Rotigotine |
| 2013-700042 (○) | JP4837915 | Name of Sale: New Pro Patch 4.5mg Active Ingredient: Rotigotine |
| 2013-700042 (■) | JP4837915 | Name of Sale: New Pro Patch 4.5mg Active Ingredient: Rotigotine |
| 2013-700041 (○) | JP4837915 | Name of Sale: New Pro Patch 2.25mg Active Ingredient: Rotigotine |
| 2013-700041 (■) | JP4837915 | Name of Sale: New Pro Patch 2.25mg Active Ingredient: Rotigotine |
| 2013-700040 (○) | JP5026656 | Name of Sale: New Pro Patch 13.5mg Active Ingredient: Rotigotine |
| 2013-700040 (■) | JP5026656 | Name of Sale: New Pro Patch 13.5mg Active Ingredient: Rotigotine |
| 2013-700039 (○) | JP5026656 | Name of Sale: New Pro Patch 9 mg Active Ingredient: Rotigotine |
| 2013-700039 (■) | JP5026656 | Name of Sale: New Pro Patch 9 mg Active Ingredient: Rotigotine |
| 2013-700038 (○) | JP5026656 | Name of Sale: New Pro Patch 4.5mg Active Ingredient: Rotigotine |
| 2013-700038 (■) | JP5026656 | Name of Sale: New Pro Patch 4.5mg Active Ingredient: Rotigotine |
| 2013-700037 (○) | JP5026656 | Name of Sale: New Pro Patch 2.25mg Active Ingredient: Rotigotine |
| 2013-700036 (○) | JP3768231 | Name of sale: Maralon combination tablet General name of active ingredient: Atovacon and proguanyl hydrochloride |
| 2013-700035 (○) | JP4784770 | Mobiprep formulation for internal use |
| 2013-700035 (■) | JP4784770 | Mobiprep formulation for internal use |
| 2013-700034 (○) | JP4131266 | Mobiprep formulation for internal use |
| 2013-700034 (■) | JP4131266 | Mobiprep formulation for internal use |
| 2013-700033 (○) | JP5093937 | Bennett Tablet 75 mg |
| 2013-700032 (○) | JP5093937 | Actonel Tablet 75 mg |
| 2013-700031 (○) | JP3717934 | Name of sale: Velcade injection 3 mg General name: bortezomib |
| 2013-700031 (■) | JP3717934 | Name of sale: Velcade injection 3 mg General name: bortezomib |
| 2013-700030 (○) | JP4476989 | Symdia subcutaneous injection 200 mg syringe (active ingredient: "Certolizumab pegol" (genetically modified)) |
| 2013-700030 (■) | JP4476989 | Symdia subcutaneous injection 200 mg syringe (active ingredient: "Certolizumab pegol" (genetically modified)) |
| 2013-700029 (○) | JP4064812 | Symdia subcutaneous injection 200 mg syringe (active ingredient: "Certolizumab pegol" (genetically modified)) |
| 2013-700029 (■) | JP4064812 | Symdia subcutaneous injection 200 mg syringe (active ingredient: "Certolizumab pegol" (genetically modified)) |
| 2013-700028 (○) | JP4808785 | (I) Name of sale: Rhizodeg mix injection Penfill (ii) General name: insulin degludec insulin aspart |
| 2013-700028 (■) | JP4808785 | (I) Name of sale: Rhizodeg mixed injection Penfill (ii) General name Insulin Degl deg Insulin Aspart |
| 2013-700027 (○) | JP4808785 | (I) Name of sale: Rhizodeg mix injection Flex touch (ii) General name: insulin degludec insulin aspart |
| 2013-700027 (■) | JP4808785 | (I) Name of sale: Rhizodeg combination injection Flex touch (ii) General name insulin degleg insulin aspart |
| 2013-700026 (○) | JP5026567 | (I) Name of sale: Rhizodeg mixed injection Penfill (ii) General name: insulin degludec insulin aspart |
| 2013-700026 (■) | JP5026567 | (I) Name of sale Rizodog combination injection Penfill (ii) General name Insulin degluce Insulin Aspart |
| 2013-700025 (○) | JP5026567 | (I) Name of sale: Rhizodeg mix injection Flex touch (ii) General name: insulin degludec insulin aspart |
| 2013-700025 (■) | JP5026567 | (I) Sales name Rhizodeg combination injection Flex touch (ii) General name Insulin degluc insulin aspart |
| 2013-700024 (○) | JP4463814 | (I) Name of sale: Rhizodeg mixed injection Penfill (ii) General name: insulin degludec insulin aspart |
| 2013-700023 (○) | JP4463814 | (I) Name of sale: Rhizodeg mix injection Flex touch (ii) General name: insulin degludec insulin aspart |
| 2013-700022 (○) | JP4100955 | Sales name: Draxin (active ingredient: turasulomycin) |
| 2013-700022 (■) | JP4100955 | Sales name: Draxin (active ingredient: turasulomycin) |
| 2013-700021 (○) | JP3893059 | Sales name: Draxin (active ingredient: turasulomycin) |
| 2013-700021 (■) | JP3893059 | Sales name: Draxin (active ingredient: turasulomycin) |
| 2013-700020 (○) | JP3315704 | Sales name: Draxin (active ingredient: turasulomycin) |
| 2013-700020 (■) | JP3315704 | Sales name: Draxin (active ingredient: turasulomycin) |
| 2013-700019 (○) | JP4202423 | Movent Floorable |
| 2013-700019 (■) | JP4202423 | Movent Floorable |
| 2013-700018 (○) | JP4781489 | Tobiace 8 mg |
| 2013-700018 (■) | JP4781489 | Tobiace 8 mg |
| 2013-700017 (○) | JP4781489 | Tobiace lock 4 mg |
| 2013-700017 (■) | JP4781489 | Tobiace lock 4 mg |
| 2013-700016 (○) | JP4743321 | Tobiace 8 mg |
| 2013-700016 (■) | JP4743321 | Tobiace 8 mg |
| 2013-700015 (○) | JP4743321 | Tobiace lock 4 mg |
| 2013-700015 (■) | JP4743321 | Tobiace lock 4 mg |
| 2013-700014 (○) | JP4083431 | Tobiace 8 mg |
| 2013-700014 (■) | JP4083431 | Tobiace 8 mg |
| 2013-700013 (○) | JP4083431 | Tobiace lock 4 mg |
| 2013-700013 (■) | JP4083431 | Tobiace lock 4 mg |
| 2013-700012 (○) | JP3929702 | Tobiace 8 mg |
| 2013-700012 (■) | JP3929702 | Tobiace 8 mg |
| 2013-700011 (○) | JP3929702 | Tobiace lock 4 mg |
| 2013-700011 (■) | JP3929702 | Tobiace lock 4 mg |
| 2013-700010 (○) | JP3127386 | Types of pesticides: Bencha Abaric Isopropyl Manzeb water dispersible powder Name of pesticides: Campanella water dispersible powder Active Ingredients: (general name) Bench Avalakab Isopropyl Chemical Name: Isopropyl = [ (S) -1-{[(R) -1- (6-fluoro-1,3-benzothiazol-2-yl) ethyl] carbamoyl} -2-methyl propyl] active ingredient: (general name) manzeb Chemical Name: Zinc Ion Coordination Manganeses Ethylene Bisdithiocarbamate |
| 2013-700009 (○) | JP4187274 | Fesoterodine fumarate |
| 2013-700009 (■) | JP4187274 | Fesoterodine fumarate |
| 2013-700008 (○) | JP4187274 | Fesoterodine fumarate |
| 2013-700008 (■) | JP4187274 | Fesoterodine fumarate |
| 2013-700007 (○) | JP4249621 | Name of sale: Erichus Tablets 5 mg Active ingredient: General name: apixaban |
| 2013-700007 (■) | JP4249621 | Name of Sale: Erikisu Tablet 5mg Active Ingredient Common Name: Apixaban |
| 2013-700006 (○) | JP4249621 | Name of sale: Erikisu Tablet 2.5mg Active Ingredient: General name: apixaban |
| 2013-700006 (■) | JP4249621 | Name of sale: ERICIUS Tablet 2.5mg Active ingredient General name: Apixaban |
| 2013-700005 (○) | JP3117462 | Name: Afinitor Tablet 5mg Common Name: Everolimus |
| 2013-700005 (■) | JP3117462 | Name: Afinitor Tablet 5mg Common Name: Everolimus |
| 2013-700004 (○) | JP3117462 | Name: Afinitor Tablet 2.5 mg Common Name: Everolimus |
| 2013-700004 (■) | JP3117462 | Name: Afinitor Tablet 2.5 mg Common Name: Everolimus |
| 2013-700003 (○) | JP3117462 | Name: Afinitor Tablet 5mg Common Name: Everolimus |
| 2013-700003 (■) | JP3117462 | Name: Afinitor Tablet 5mg Common Name: Everolimus |
| 2013-700002 (○) | JP3117462 | Name: Afinitor Tablet 2.5 mg Common Name: Everolimus |
| 2013-700002 (■) | JP3117462 | Name: Afinitor Tablet 2.5 mg Common Name: Everolimus |
| 2013-700001 (○) | JP5047285 | Name of sale: Rotrigger granular capsule 2g Active ingredient: (general name) omega-3 fatty acid ethyl |
| 2013-700001 (■) | JP5047285 | Name of sale: Rotrigger granular capsule 2g Active ingredient: (general name) omega-3 fatty acid ethyl |
| 2012-700206 (○) | JP3474195 | Name: Tobii Inhalant 300 mg General name: tobramycin |
| 2012-700206 (■) | JP3474195 | Name: Tobii Inhalant 300 mg General name: tobramycin |
| 2012-700205 (○) | JP4723140 | Airia Intravitreal Injection 40 mg / mL Aflibercept (genetically modified) |
| 2012-700205 (■) | JP4723140 | Airier Intravitreal Injection Kit 40 mg / mL Aflibercept (genetically modified) |
| 2012-700204 (○) | JP4723140 | Airia Intravitreal Injection 40 mg / mL Aflibercept (genetically modified) |
| 2012-700204 (■) | JP4723140 | Eyria intravitreal injection 40 mg / mL aflibercept (genetically modified) |
| 2012-700203 (○) | JP5042426 | (Name) Seabri Inhalation Capsule 50μg (Active Ingredient) Glycopyronium Bromide |
| 2012-700202 (○) | JP5000483 | Capsule 50μg for inhalation of sea bream |
| 2012-700202 (■) | JP5000483 | Capsule 50μg for inhalation of sea bream |
| 2012-700201 (○) | JP4643760 | General name: anagliptin (sale name: swiney tablet 100 mg) |
| 2012-700200 (○) | JP4184378 | General name: anagliptin (sale name: swiney tablet 100 mg) |
| 2012-700200 (■) | JP4184378 | General name: anagliptin (sale name: swiney tablet 100 mg) |
| 2012-700199 (○) | JP4802096 | Name of sale: Zometa Drip IV 4 mg / 100 mL Common name: zoledronic acid hydrate |
| 2012-700199 (■) | JP4802096 | Name of sale: Zometa Drip IV 4 mg / 100 mL Common name: zoledronic acid hydrate |
| 2012-700198 (○) | JP3632947 | Oxadiclomefon, pyrimisulfan, benzobicyclone granules Pesticide name: Naginata 1 kg granules Active ingredient: Oxadiclomefon, pyrimisulfan, benzobicyclone Chemical name: 3- [ 1- (3,5-dichlorophenyl) -1-methylethyl] -3,4-dihydro-6-methyl-5-phenyl-2H-1,3-oxazin-4-one, (RS) -2 '-[ (4,6-Dimethoxypyrimidin-2-yl) (hydroxy) methyl] -1,1-difluoro-6 '-(methoxymethyl) methanesulfonanilide, 3- (2-chloro-4-mesylbenzoyl) -2- Phenylthiobicyclo [3.2.1] octa-2-en-4-one |
| 2012-700197 (○) | JP3632947 | Pyrimisulfan granules Pesticide name: Atotri 1 kg granules Active ingredient: General name: Pyrimisulfan Chemical name: (RS) -2 '-[(4, 6-Dimethoxypyrimidin-2-yl) (hydroxy) methyl] -1,1-difluoro-6 '-(methoxymethyl) methanesulfonanilide |
| 2012-700196 (○) | JP3472245 | Pyribencarb Hydrate Pesticide Name: RIKEN Funtafu Granule Hydrate Active Ingredient: General Name: Pyribencarb Chemical Name: Methyl = {2-Chloro-5-[(E) -1- (6-Methyl-2-pyridylmethoxyimino) ethyl] benzyl} carbamate |
| 2012-700196 (■) | JP3472245 | Pyribencarb Hydrate Pesticide Name: RIKEN Funtafu Granule Hydrate Active Ingredient General Name: Pyribencarb |
| 2012-700195 (○) | JP4253188 | Name of sale: Vorient Tablet 200 mg General name of active ingredient: Pazopanib hydrochloride |
| 2012-700195 (■) | JP4253188 | Name of sale: Vorient Tablet 200 mg General name of active ingredient: Pazopanib hydrochloride |
| 2012-700194 (○) | JP3306473 | Tazobactam / piperacillin hydrate |
| 2012-700194 (■) | JP3306473 | Tazobactam / piperacillin hydrate |
| 2012-700193 (○) | JP5026567 | Insulin deguldek |
| 2012-700193 (■) | JP5026567 | (I) Name of sale: Receiver injection Penfill (ii) Active ingredient: Insulin Degladek (genetically modified) |
| 2012-700192 (○) | JP5026567 | Insulin deguldek |
| 2012-700192 (■) | JP5026567 | (I) Name of sale: Receiver injection Flex touch (ii) Active ingredient: Insulin degludec (genetically modified) |
| 2012-700191 (○) | JP4463814 | Insulin deguldek |
| 2012-700191 (■) | JP4463814 | (I) Name of sale: Receiver injection Penfill (ii) Active ingredient: Insulin Degladek (genetically modified) |
| 2012-700190 (○) | JP4463814 | Insulin deguldek |
| 2012-700190 (■) | JP4463814 | (I) Name of sale: Receiver injection Flex touch (ii) Active ingredient: Insulin degludec (genetically modified) |
| 2012-700189 (○) | JP2994182 | Flonicamid |
| 2012-700189 (■) | JP2994182 | (Kind of active ingredient) flonicamide (kind of agrochemical) flonicamide wettable powder (name of agrochemical) Urala DF |
| 2012-700188 (○) | JP3980639 | Nativo Floorable |
| 2012-700188 (■) | JP3980639 | Nativo Floorable |
| 2012-700187 (○) | JP4972081 | Tigecycline (brand name: 50 mg for intravenous injection of taigasil) |
| 2012-700187 (■) | JP4972081 | Tigecycline (brand name: 50 mg for intravenous injection of taigasil) |
| 2012-700186 (○) | JP2994182 | Flonicamid |
| 2012-700186 (■) | JP2994182 | (Kind of active ingredient) flonicamide (kind of agrochemical) flonicamide wettable powder (name of agrochemical) Urala 50DF |
| 2012-700185 (○) | JP3896002 | Clopidogrel sulfate |
| 2012-700184 (○) | JP3827946 | Clopidogrel sulfate |
| 2012-700183 (○) | JP3641584 | Clopidogrel sulfate |
| 2012-700183 (■) | JP3641584 | Name of sale: PLAVIX Tablet 25 mg Active ingredient: Clopidogrel sulfate |
| 2012-700182 (○) | JP3397385 | Clopidogrel sulfate |
| 2012-700182 (■) | JP3397385 | Name of sale: PLAVIX Tablet 25 mg Active ingredient: Clopidogrel sulfate |
| 2012-700181 (○) | JP3896002 | Clopidogrel sulfate |
| 2012-700180 (○) | JP3827946 | Clopidogrel sulfate |
| 2012-700179 (○) | JP3641584 | Clopidogrel sulfate |
| 2012-700179 (■) | JP3641584 | Name of sale: PLAVIX Tablet 25 mg Active ingredient: Clopidogrel sulfate |
| 2012-700178 (○) | JP3397385 | Clopidogrel sulfate |
| 2012-700178 (■) | JP3397385 | Name of sale: PLAVIX Tablet 25 mg Active ingredient: Clopidogrel sulfate |
| 2012-700177 (○) | JP3896002 | Clopidogrel sulfate |
| 2012-700176 (○) | JP3827946 | Clopidogrel sulfate |
| 2012-700175 (○) | JP3641584 | Clopidogrel sulfate |
| 2012-700175 (■) | JP3641584 | Name of sale: PLAVIX Tablet 75 mg Active ingredient: Clopidogrel sulfate |
| 2012-700174 (○) | JP3397385 | Clopidogrel sulfate |
| 2012-700174 (■) | JP3397385 | Name of sale: PLAVIX Tablet 75 mg Active ingredient: Clopidogrel sulfate |
| 2012-700173 (○) | JP3896002 | Clopidogrel sulfate |
| 2012-700172 (○) | JP3827946 | Clopidogrel sulfate |
| 2012-700171 (○) | JP3641584 | Clopidogrel sulfate |
| 2012-700171 (■) | JP3641584 | Name of sale: PLAVIX Tablet 75 mg Active ingredient: Clopidogrel sulfate |
| 2012-700170 (○) | JP3397385 | Clopidogrel sulfate |
| 2012-700170 (■) | JP3397385 | Name of sale: PLAVIX Tablet 75 mg Active ingredient: Clopidogrel sulfate |
| 2012-700169 (○) | JP3472245 | Pyribencarb hydrate |
| 2012-700169 (■) | JP3472245 | Pyribencarb hydrate |
| 2012-700168 (○) | JP3472245 | Iminoctadine albesylate / pyribencarb hydrate |
| 2012-700168 (■) | JP3472245 | Iminoctadine albesylate / pyribencarb hydrate |
| 2012-700167 (○) | JP4309481 | Name of sale: Bonalon Oral Jelly 35 mg Name of active ingredient sodium alendronate hydrate |
| 2012-700167 (■) | JP4309481 | Name of sale: Bonalon Oral Jelly 35 mg Name of active ingredient sodium alendronate hydrate |
| 2012-700166 (○) | JP3665498 | Name of sale: Bonalon Oral Jelly 35 mg Name of active ingredient sodium alendronate hydrate |
| 2012-700166 (■) | JP3665498 | Name of sale: Bonalon Oral Jelly 35 mg Name of active ingredient sodium alendronate hydrate |
| 2012-700165 (○) | JP4841710 | Name (sold name) Sonazoid for injection 16μL Active ingredient name: Perflubutane micro bubble |
| 2012-700164 (○) | JP4808842 | Name (sold name) Sonazoid for injection 16μL Active ingredient name: Perflubutane micro bubble |
| 2012-700163 (○) | JP4418033 | Name (sold name) Sonazoid for injection 16μL Active ingredient name: Perflubutane micro bubble |
| 2012-700163 (■) | JP4418033 | Name (sold name) Sonazoid for injection 16μL Active ingredient name: Perflubutane micro bubble |
| 2012-700162 (○) | JP4250747 | Name (sold name) Sonazoid for injection 16μL Active ingredient name: Perflubutane micro bubble |
| 2012-700162 (■) | JP4250747 | Name (brand name) Sonazoid for injection 16μL Active ingredient name: Perflubutane micro bubble |
| 2012-700161 (○) | JP4404181 | (Active ingredient) adalimumab (genetically modified) |
| 2012-700161 (■) | JP4404181 | Active ingredient: Adalimumab (genetically modified) Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL |
| 2012-700160 (○) | JP3861118 | (Active ingredient) adalimumab (genetically modified) |
| 2012-700160 (■) | JP3861118 | Active ingredient: Adalimumab (genetically modified) Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL |
| 2012-700159 (○) | JP3663382 | A Name of sale: Sutent Capsules 12.5 mg Active Ingredients: Sunitinib malate |
| 2012-700159 (■) | JP3663382 | A Name of sale: Sutent Capsules 12.5 mg Active Ingredients: Sunitinib malate |
| 2012-700158 (○) | JP4159988 | A Name of sale: Sutent Capsules 12.5 mg Active Ingredients: Sunitinib malate |
| 2012-700158 (■) | JP4159988 | A Name of sale: Sutent Capsules 12.5 mg Active Ingredients: Sunitinib malate |
| 2012-700157 (○) | JP3186863 | Tigecycline (brand name: 50 mg for intravenous injection of taigasil) |
| 2012-700157 (■) | JP3186863 | Tigecycline (brand name: 50 mg for intravenous injection of taigasil) |
| 2012-700156 (○) | JP4208938 | Tenelia Tablets 20 mg tenelligliptin hydrobromide hydrate |
| 2012-700156 (■) | JP4208938 | Tenelia Tablets 20 mg Tenelligliptin hydrobromide hydrate |
| 2012-700155 (○) | JP4101053 | Tenelia Tablets 20 mg tenelligliptin hydrobromide hydrate |
| 2012-700155 (■) | JP4101053 | Tenelia Tablets 20 mg Tenelligliptin hydrobromide hydrate |
| 2012-700154 (○) | JP4489186 | Name of sale: somatulin subcutaneous injection 120 mg Active ingredient: lanreotide acetate |
| 2012-700153 (○) | JP4489186 | Name of sale: Somatulin subcutaneous injection 90 mg Active ingredient: Lanreotide acetate |
| 2012-700152 (○) | JP4489186 | Name of sale: Somatulin subcutaneous injection 60 mg Active ingredient: Lanreotide acetate |
| 2012-700151 (○) | JP4162381 | Name of sale: somatulin subcutaneous injection 120 mg Active ingredient: lanreotide acetate |
| 2012-700151 (■) | JP4162381 | Name of sale: somatulin subcutaneous injection 120 mg Active ingredient: lanreotide acetate |
| 2012-700150 (○) | JP4162381 | Name of sale: Somatulin subcutaneous injection 90 mg Active ingredient: Lanreotide acetate |
| 2012-700150 (■) | JP4162381 | Name of sale: Somatulin subcutaneous injection 90 mg Active ingredient: Lanreotide acetate |
| 2012-700149 (○) | JP4162381 | Name of sale: Somatulin subcutaneous injection 60 mg Active ingredient: Lanreotide acetate |
| 2012-700149 (■) | JP4162381 | Name of sale: Somatulin subcutaneous injection 60 mg Active ingredient: Lanreotide acetate |
| 2012-700148 (○) | JP4648340 | Name of Sale: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700148 (■) | JP4648340 | Name: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700147 (○) | JP4851467 | Name of Sale: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700146 (○) | JP4783794 | Name of Sale: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700146 (■) | JP4783794 | Name: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700145 (○) | JP4889219 | Name of Sale: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700145 (■) | JP4889219 | Name: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700144 (○) | JP4786866 | Name of Sale: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700144 (■) | JP4786866 | Name: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700143 (○) | JP4852229 | Name of Sale: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700143 (■) | JP4852229 | Name: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700142 (○) | JP4332353 | Name of Sale: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700142 (■) | JP4332353 | Name: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700141 (○) | JP4684334 | Name of Sale: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700141 (■) | JP4684334 | Name: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700140 (○) | JP4332316 | Name of Sale: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700140 (■) | JP4332316 | Name: Amitiza Capsule 24μg Active Ingredient: Lubiprostone |
| 2012-700139 (○) | JP4845166 | Name of sale: Gonax subcutaneous injection 120 mg Active ingredient name: Degarelix acetate Active ingredient chemical name: N-Acetyl-3- (naphthalen-2-yl) -D-alanyl-4-chloro -D-phenylalanyl-3- (pyridin-3-yl) -D-alanyl-L-seryl-4-({[(4S) -2,6-dioxohexahydropyrimidin-4-yl] carbonyl} Amino) -L-phenylalanyl-4- (carbamoylamino) -D-phenylalanyl-L-leucyl-N-type 6- (1-methylethyl) -L-lysyl-L-prolyl-D-alanine amide acetic acid salt |
| 2012-700138 (○) | JP3645255 | Name of sale: Gonax subcutaneous injection 120 mg Active ingredient name: Degarelix acetate Active ingredient chemical name: N-Acetyl-3- (naphthalen-2-yl) -D-alanyl-4-chloro -D-phenylalanyl-3- (pyridin-3-yl) -D-alanyl-L-seryl-4-({[(4S) -2,6-dioxohexahydropyrimidin-4-yl] carbonyl} Amino) -L-phenylalanyl-4- (carbamoylamino) -D-phenylalanyl-L-leucyl-N6- (1-methylethyl) -L-lysyl-L-prolyl-D-alanine amide acetate |
| 2012-700138 (■) | JP3645255 | Name of sale: Gonax subcutaneous injection 120 mg Active ingredient name: Degarelix acetate Active ingredient chemical name: N-Acetyl-3- (naphthalen-2-yl) -D-alanyl-4-cu Rolo-D-phenylalanyl-3- (pyridin-3-yl) -D-alanyl-L-seryl-4-({[(4S) -2,6-dioxohexahydropyrimidin-4-yl] Carbonyl} amino) -L-phenylalanyl-4- (carbamoylamino) -D-phenylalanyl-L-leucyl-N 6- (1-methylethyl) -L-lysyl-L-prolyl-D-alanine Amidoacetate |
| 2012-700137 (○) | JP3645255 | Name of sale: Gonax for subcutaneous injection 80 mg active ingredient name: degarelix acetate active ingredient chemical name: N-acetyl-3- (naphthalen-2-yl) -D-alanyl-4-chloro -D-phenylalanyl-3- (pyridin-3-yl) -D-alanyl-L-seryl-4-({[(4S) -2,6-dioxohexahydropyrimidin-4-yl] carbonyl} Amino) -L-phenylalanyl-4- (carbamoylamino) -D-phenylalanyl-L-leucyl-N6- (1-methylethyl) -L-lysyl-L-prolyl-D-alanine amide acetate |
| 2012-700137 (■) | JP3645255 | Name of sale: Gonax for subcutaneous injection 80 mg active ingredient name: degarelix acetate active ingredient chemical name: N-acetyl-3- (naphthalen-2-yl) -D-alanyl-4-cu Rolo-D-phenylalanyl-3- (pyridin-3-yl) -D-alanyl-L-seryl-4-({[(4S) -2,6-dioxohexahydropyrimidin-4-yl] Carbonyl} amino) -L-phenylalanyl-4- (carbamoylamino) -D-phenylalanyl-L-leucyl-N 6- (1-methylethyl) -L-lysyl-L-prolyl-D-alanine Amidoacetate |
| 2012-700136 (○) | JP4532114 | (Active ingredient) aprepitant (brand name: Imendo capsule 125 mg) |
| 2012-700135 (○) | JP4532114 | (Active ingredient) aprepitant (brand name: Imendo capsule 80 mg) |
| 2012-700134 (○) | JP4532114 | (Active ingredient) Aprepitant (sale name: Imend capsule set) |
| 2012-700133 (○) | JP3245424 | (Active ingredient) aprepitant (brand name: Imendo capsule 125 mg) |
| 2012-700132 (○) | JP3245424 | (Active ingredient) aprepitant (brand name: Imendo capsule 80 mg) |
| 2012-700131 (○) | JP3245424 | (Active ingredient) Aprepitant (sale name: Imend capsule set) |
| 2012-700130 (○) | JP2634372 | (Active ingredient) aprepitant (brand name: Imendo capsule 125 mg) |
| 2012-700129 (○) | JP2634372 | (Active ingredient) aprepitant (brand name: Imendo capsule 80 mg) |
| 2012-700128 (○) | JP2634372 | (Active ingredient) Aprepitant (sale name: Imend capsule set) |
| 2012-700127 (○) | JP3856816 | Pregabalin (general name) |
| 2012-700127 (■) | JP3856816 | Name of sale: Lyrica Capsule 150 mg Active Ingredient Name: Pregabalin |
| 2012-700126 (○) | JP3856816 | Pregabalin (general name) |
| 2012-700126 (■) | JP3856816 | Name of sale: Lirica Capsule 75 mg Active Ingredient Name: Pregabalin |
| 2012-700125 (○) | JP3856816 | Pregabalin (general name) |
| 2012-700125 (■) | JP3856816 | Name of sale: Lyrica Capsule 25 mg Active Ingredient Name: Pregabalin |
| 2012-700124 (○) | JP4512203 | Name of sale: Orchis 9 μg Tarb Heeler 60 Inhaled General name: Formoterol fumarate hydrate inhalant |
| 2012-700124 (■) | JP4512203 | Name of sale: Orchis 9 μg Turbulehler 60 inhalation General name: Formoterol fumarate hydrate inhalant |
| 2012-700123 (○) | JP4512203 | Name of sale: Auxis 9 μg Tarb Heeler 28 Inhaled General name: Formoterol fumarate hydrate inhalant |
| 2012-700123 (■) | JP4512203 | Name of sale: Orchis 9 μg Turbulehler 28 inhalation Common name: Formoterol fumarate hydrate inhalant |
| 2012-700122 (○) | JP4002303 | Name of Sale: Nexium Capsule 20 mg Active Ingredient (Common Name): Esomeprazole Magnesium Hydrate |
| 2012-700121 (○) | JP3795917 | Name of Sale: Nexium Capsule 20 mg Active Ingredient (Common Name): Esomeprazole Magnesium Hydrate |
| 2012-700121 (■) | JP3795917 | Name of Sale: Nexium Capsule 20 mg Active Ingredient (Common Name): Esomeprazole Magnesium Hydrate |
| 2012-700120 (○) | JP3665334 | Name of Sale: Nexium Capsule 20 mg Active Ingredient (Common Name): Esomeprazole Magnesium Hydrate |
| 2012-700119 (○) | JP3959056 | Name of Sale: Nexium Capsule 20 mg Active Ingredient (Common Name): Esomeprazole Magnesium Hydrate |
| 2012-700119 (■) | JP3959056 | Name of Sale: Nexium Capsule 20 mg Active Ingredient (Common Name): Esomeprazole Magnesium Hydrate |
| 2012-700118 (○) | JP3878826 | Name of Sale: Nexium Capsule 20 mg Active Ingredient (Common Name): Esomeprazole Magnesium Hydrate |
| 2012-700117 (○) | JP4002303 | Name of sale: Nexium capsule 10 mg Active ingredient (general name): Esomeprazole magnesium hydrate |
| 2012-700116 (○) | JP3795917 | Name of sale: Nexium capsule 10 mg Active ingredient (general name): Esomeprazole magnesium hydrate |
| 2012-700116 (■) | JP3795917 | Name of sale: Nexium capsule 10 mg Active ingredient (general name): Esomeprazole magnesium hydrate |
| 2012-700115 (○) | JP3665334 | Name of sale: Nexium capsule 10 mg Active ingredient (general name): Esomeprazole magnesium hydrate |
| 2012-700114 (○) | JP3959056 | Name of sale: Nexium capsule 10 mg Active ingredient (general name): Esomeprazole magnesium hydrate |
| 2012-700114 (■) | JP3959056 | Name of sale: Nexium capsule 10 mg Active ingredient (general name): Esomeprazole magnesium hydrate |
| 2012-700113 (○) | JP3878826 | Name of sale: Nexium capsule 10 mg Active ingredient (general name): Esomeprazole magnesium hydrate |
| 2012-700112 (○) | JP3521145 | Name of Sale: Corvette Tablet 25mg Active Ingredient: Igratimod |
| 2012-700112 (■) | JP3521145 | Name of Sale: Corvette Tablet 25mg Active Ingredient: Igratimod |
| 2012-700111 (○) | JP4608087 | Name of Sale: Corvette Tablet 25mg Active Ingredient: Igratimod |
| 2012-700111 (■) | JP4608087 | Name of Sale: Corvette Tablet 25mg Active Ingredient: Igratimod |
| 2012-700110 (○) | JP2994182 | Flonicamid |
| 2012-700110 (■) | JP2994182 | Flonicamid |
| 2012-700109 (○) | JP3693258 | Pregabalin (brand name: Lyrica Capsule 150 mg) |
| 2012-700109 (■) | JP3693258 | Pregabalin (brand name: Lyrica Capsule 150 mg) |
| 2012-700108 (○) | JP3693258 | Pregabalin (brand name: Lilyca Capsule 75 mg) |
| 2012-700108 (■) | JP3693258 | Pregabalin (brand name: Lilyca Capsule 75 mg) |
| 2012-700107 (○) | JP3693258 | Pregabalin (brand name: Lyrica Capsule 25 mg) |
| 2012-700107 (■) | JP3693258 | Pregabalin (brand name: Lyrica Capsule 25 mg) |
| 2012-700106 (○) | JP3375084 | 0.5g for Fininibacs intravenous drip infusion |
| 2012-700106 (■) | JP3375084 | Product Name: Finivacs Intravenous Drip Injection 0.5g Active Ingredient: Doripenem Hydrate |
| 2012-700105 (○) | JP2843444 | 0.5g for Fininibacs intravenous drip infusion |
| 2012-700105 (■) | JP2843444 | Product Name: Finivacs Intravenous Drip Injection 0.5g Active Ingredient: Doripenem Hydrate |
| 2012-700104 (○) | JP3375084 | Finibacs kit 0.25g for intravenous drip infusion |
| 2012-700104 (■) | JP3375084 | Name of sale: Finibacs kit for intravenous infusion 0.25g Active ingredient: Doripenem hydrate |
| 2012-700103 (○) | JP2843444 | Finibacs kit 0.25g for intravenous drip infusion |
| 2012-700103 (■) | JP2843444 | Name of sale: Finibacs kit for intravenous infusion 0.25g Active ingredient: Doripenem hydrate |
| 2012-700102 (○) | JP3375084 | 0.25g for Fininibacs intravenous drip infusion |
| 2012-700102 (■) | JP3375084 | Product Name: Finibacs Intravenous Drip Injection 0.25g Active Ingredient: Doripenem Hydrate |
| 2012-700101 (○) | JP2843444 | 0.25g for Fininibacs intravenous drip infusion |
| 2012-700101 (■) | JP2843444 | Product Name: Finibacs Intravenous Drip Injection 0.25g Active Ingredient: Doripenem Hydrate |
| 2012-700100 (○) | JP4274739 | 0.5g for Fininibacs intravenous drip infusion |
| 2012-700100 (■) | JP4274739 | Product Name: Finivacs Intravenous Drip Injection 0.5g Active Ingredient: Doripenem Hydrate |
| 2012-700099 (○) | JP4149506 | 0.5g for Fininibacs intravenous drip infusion |
| 2012-700099 (■) | JP4149506 | Product Name: Finivacs Intravenous Drip Injection 0.5g Active Ingredient: Doripenem Hydrate |
| 2012-700098 (○) | JP4274739 | Finibacs kit 0.25g for intravenous drip infusion |
| 2012-700098 (■) | JP4274739 | Name of sale: Finibacs kit for intravenous infusion 0.25g Active ingredient: Doripenem hydrate |
| 2012-700097 (○) | JP4149506 | Finibacs kit 0.25g for intravenous drip infusion |
| 2012-700097 (■) | JP4149506 | Name of sale: Finibacs kit for intravenous infusion 0.25g Active ingredient: Doripenem hydrate |
| 2012-700096 (○) | JP4274739 | 0.25g for Fininibacs intravenous drip infusion |
| 2012-700096 (■) | JP4274739 | Product Name: Finibacs Intravenous Drip Injection 0.25g Active Ingredient: Doripenem Hydrate |
| 2012-700095 (○) | JP4149506 | 0.25g for Fininibacs intravenous drip infusion |
| 2012-700095 (■) | JP4149506 | Product Name: Finibacs Intravenous Drip Injection 0.25g Active Ingredient: Doripenem Hydrate |
| 2012-700094 (○) | JP3878849 | A Sales name: Inlite 5 mg Active ingredient: Axitinib |
| 2012-700094 (■) | JP3878849 | A Sales name: Inlite 5 mg Active ingredient: Axitinib |
| 2012-700093 (○) | JP3878849 | A Sales name: Inlighter Tablet 1 mg Active ingredient: Axitinib |
| 2012-700093 (■) | JP3878849 | A Sales name: Inlighter Tablet 1 mg Active ingredient: Axitinib |
| 2012-700092 (○) | JP4912309 | Drugs subject to disposal (brand name) Edurant 25 mg active ingredients of drug subject to disposal (general name) rilpivirine hydrochloride |
| 2012-700092 (■) | JP4912309 | Drugs subject to disposal (brand name) Ejuland Tablet 25 mg active ingredients of drug subject to disposal (general name) rilpivirine hydrochloride |
| 2012-700091 (○) | JP4838396 | Drugs subject to disposal (brand name) Edurant 25 mg active ingredients of drug subject to disposal (general name) rilpivirine hydrochloride |
| 2012-700091 (■) | JP4838396 | Drugs subject to disposal (brand name) Ejuland Tablet 25 mg active ingredients of drug subject to disposal (general name) rilpivirine hydrochloride |
| 2012-700090 (○) | JP4219932 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2012-700090 (■) | JP4219932 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2012-700089 (○) | JP4052515 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2012-700089 (■) | JP4052515 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2012-700088 (○) | JP3926153 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2012-700088 (■) | JP3926153 | Potelligio IV infusion 20 mg mogamurizumab (genetically modified) |
| 2012-700087 (○) | JP4695588 | A Name of sale: Zakori Capsule 250 mg Active ingredient: Crizotinib |
| 2012-700087 (■) | JP4695588 | A Name of sale: Zakori Capsule 250 mg Active ingredient: Crizotinib |
| 2012-700086 (○) | JP4695588 | A Name of sale: Zakori Capsule 200 mg Active ingredient: Crizotinib |
| 2012-700086 (■) | JP4695588 | A Name of sale: Zakori Capsule 200 mg Active ingredient: Crizotinib |
| 2012-700085 (○) | JP4663619 | A Name of sale: Zakori Capsule 200 mg Active ingredient: Crizotinib |
| 2012-700085 (■) | JP4663619 | A Name of sale: Zakori Capsule 200 mg Active ingredient: Crizotinib |
| 2012-700084 (○) | JP4663619 | A Name of sale: Zakori Capsule 250 mg Active ingredient: Crizotinib |
| 2012-700084 (■) | JP4663619 | A Name of sale: Zakori Capsule 250 mg Active ingredient: Crizotinib |
| 2012-700083 (○) | JP4619346 | A Name of sale: Zakori Capsule 200 mg Active ingredient: Crizotinib |
| 2012-700083 (■) | JP4619346 | A Name of sale: Zakori Capsule 200 mg Active ingredient: Crizotinib |
| 2012-700082 (○) | JP4619346 | A Name of sale: Zakori Capsule 250 mg Active ingredient: Crizotinib |
| 2012-700082 (■) | JP4619346 | A Name of sale: Zakori Capsule 250 mg Active ingredient: Crizotinib |
| 2012-700081 (○) | JP4242911 | A Name of sale: Zakori Capsule 200 mg Active ingredient: Crizotinib |
| 2012-700081 (■) | JP4242911 | A Name of sale: Zakori Capsule 200 mg Active ingredient: Crizotinib |
| 2012-700080 (○) | JP4242911 | A Name of sale: Zakori Capsule 250 mg Active ingredient: Crizotinib |
| 2012-700080 (■) | JP4242911 | A Name of sale: Zakori Capsule 250 mg Active ingredient: Crizotinib |
| 2012-700079 (○) | JP3707831 | Product Name: Cyvarta Capsule 30 mg Common Name: Duloxetine Hydrochloride Chemical Name: (+)-(S) -N-Methyl-3- (1-naphthyloxy) -3- (2-thienyl) ) Propylamine monohydrochloride |
| 2012-700079 (■) | JP3707831 | Sales name: Cyvarta capsule 30 mg Common name: duloxetine hydrochloride Chemical name: (+)-(S) -N-Methyl-3- (1-naphthyloxy) -3-2-thienyl) Propylamine monohydrochloride |
| 2012-700078 (○) | JP3707831 | Product Name: Cyvarta Capsule 20 mg Common Name: Duloxetine Hydrochloride Chemical Name: (+)-(S) -N-Methyl-3- (1-naphthyloxy) -3- (2-thienyl) ) Propylamine monohydrochloride |
| 2012-700078 (■) | JP3707831 | Sales name: Cyvarta capsule 20 mg Common name: duloxetine hydrochloride Chemical name: (+)-(S) -N-Methyl-3- (1-naphthyloxy) -3-2-thienyl) Propylamine monohydrochloride |
| 2012-700077 (○) | JP2706682 | Name of Sales: Gleevec Tablet 100 mg Common Name: Imatinib Mesylate |
| 2012-700077 (■) | JP2706682 | Name of Sales: Gleevec Tablet 100 mg Common Name: Imatinib Mesylate |
| 2012-700076 (○) | JP3996944 | Name of Sale: Kick Lynn Capsule 250mg Common Name of Active Ingredient: Bixalomer |
| 2012-700076 (■) | JP3996944 | Name of Sale: Kick Lynn Capsule 250mg Common Name of Active Ingredient: Bixalomer |
| 2012-700075 (○) | JP3224544 | Lanthanum carbonate hydrate (brand name: hosurenol granule package 500 mg) |
| 2012-700075 (■) | JP3224544 | Lanthanum carbonate hydrate (brand name: hosurenol granule package 500 mg) |
| 2012-700074 (○) | JP3224544 | Lanthanum carbonate hydrate (brand name: Hosurenol Granule package 250 mg) |
| 2012-700074 (■) | JP3224544 | Lanthanum carbonate hydrate (brand name: Hosurenol Granule package 250 mg) |
| 2012-700073 (○) | JP4143297 | Name: Xazaret Tablets 10 mg General name: River Loxaban |
| 2012-700073 (■) | JP4143297 | Name: Xazaret Tablets 10 mg General name: River Loxaban |
| 2012-700072 (○) | JP4143297 | Name: Xazaret Tablets 15 mg General name: River Loxaban |
| 2012-700072 (■) | JP4143297 | Name: Xazaret Tablets 15 mg General name: River Loxaban |
| 2012-700071 (○) | JP4852423 | Name: Xazaret Tablets 10 mg General name: River Loxaban |
| 2012-700071 (■) | JP4852423 | Name: Xazaret Tablets 10 mg General name: River Loxaban |
| 2012-700070 (○) | JP4852423 | Name: Xazaret Tablets 15 mg General name: River Loxaban |
| 2012-700070 (■) | JP4852423 | Name: Xazaret Tablets 15 mg General name: River Loxaban |
| 2012-700069 (○) | JP4667744 | Name: Xazaret Tablets 10 mg General name: River Loxaban |
| 2012-700068 (○) | JP4667744 | Name: Xazaret Tablets 15 mg General name: River Loxaban |
| 2012-700067 (○) | JP3760264 | ABILIFY OD Tablet 24 mg (General name: aripiprazole) |
| 2012-700066 (○) | JP4614870 | ABILIFY Tablet 12 mg (Common name: aripiprazole) |
| 2012-700065 (○) | JP4902945 | ABILIFY OD Tablet 24 mg (General name: aripiprazole) |
| 2012-700065 (■) | JP4902945 | ABILIFY OD tablets 24 mg (General name: aripiprazole) |
| 2012-700064 (○) | JP4902945 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2012-700064 (■) | JP4902945 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2012-700063 (○) | JP4902945 | ABILIFY powder 1% (common name: aripiprazole) |
| 2012-700063 (■) | JP4902945 | ABILIFY powder 1% (common name: aripiprazole) |
| 2012-700062 (○) | JP4902945 | ABILIFY Tablet 12 mg (Common name: aripiprazole) |
| 2012-700062 (■) | JP4902945 | ABILIFY Tablet 12 mg (Common name: aripiprazole) |
| 2012-700061 (○) | JP4401077 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2012-700061 (■) | JP4401077 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2012-700060 (○) | JP4178032 | ABILIFY OD Tablet 24 mg (General name: aripiprazole) |
| 2012-700060 (■) | JP4178032 | ABILIFY OD Tablet 24 mg (General name: aripiprazole) |
| 2012-700059 (○) | JP4178032 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2012-700059 (■) | JP4178032 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2012-700058 (○) | JP4178032 | ABILIFY powder 1% (common name: aripiprazole) |
| 2012-700058 (■) | JP4178032 | ABILIFY powder 1% (common name: aripiprazole) |
| 2012-700057 (○) | JP4178032 | ABILIFY Tablet 12 mg (Common name: aripiprazole) |
| 2012-700057 (■) | JP4178032 | ABILIFY Tablet 12 mg (Common name: aripiprazole) |
| 2012-700056 (○) | JP3760264 | ABILIFY OD Tablet 24 mg (General name: aripiprazole) |
| 2012-700056 (■) | JP3760264 | ABILIFY OD Tablet 24 mg (General name: aripiprazole) |
| 2012-700055 (○) | JP3760264 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2012-700055 (■) | JP3760264 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2012-700054 (○) | JP3760264 | ABILIFY powder 1% (common name: aripiprazole) |
| 2012-700054 (■) | JP3760264 | ABILIFY powder 1% (common name: aripiprazole) |
| 2012-700053 (○) | JP3760264 | ABILIFY Tablet 12 mg (Common name: aripiprazole) |
| 2012-700053 (■) | JP3760264 | ABILIFY Tablet 12 mg (Common name: aripiprazole) |
| 2012-700052 (○) | JP3750023 | ABILIFY OD Tablet 24 mg (General name: aripiprazole) |
| 2012-700051 (○) | JP3750023 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2012-700050 (○) | JP3750023 | ABILIFY powder 1% (common name: aripiprazole) |
| 2012-700049 (○) | JP3750023 | ABILIFY Tablet 12 mg (Common name: aripiprazole) |
| 2012-700048 (○) | JP3922392 | Controlled-release preparation of paroxetine hydrochloride hydrate (CR tablet) |
| 2012-700048 (■) | JP3922392 | Name of Sales: Paxil CR Tablets 12.5 mg Common Name of Active Ingredient: Paroxetine Hydrochloride Hydrate |
| 2012-700047 (○) | JP3784084 | Aziruba Tablet 40 mg |
| 2012-700046 (○) | JP3784084 | Aziruba Tablet 20 mg |
| 2012-700046 (■) | JP3784084 | AZILBA Tablet 20 mg Azilsartan as active ingredient |
| 2012-700045 (○) | JP2645962 | Aziruba Tablet 40 mg |
| 2012-700045 (■) | JP2645962 | AZILBA Tablet 40 mg Azilsartan as active ingredient |
| 2012-700044 (○) | JP2645962 | Aziruba Tablet 20 mg |
| 2012-700044 (■) | JP2645962 | AZILBA Tablet 20 mg Azilsartan as active ingredient |
| 2012-700043 (○) | JP3258672 | Common Name: Caspofungin Acetate for Injection Name: Cancidas Intravenous Drip Injection 70 mg Active Ingredient: Caspofungin Acetate |
| 2012-700043 (■) | JP3258672 | Common Name: Caspofungin Acetate for Injection Name: Cancidas Intravenous Drip Injection 70 mg Active Ingredient: Caspofungin Acetate |
| 2012-700042 (○) | JP3258672 | General name: caspofungin acetate for injection Name of sale: Cansidas intravenous drip 50 mg Active ingredient: caspofungin acetate |
| 2012-700042 (■) | JP3258672 | General name: caspofungin acetate for injection Name of sale: Cansidas intravenous drip 50 mg Active ingredient: caspofungin acetate |
| 2012-700041 (○) | JP2568474 | Common Name: Caspofungin Acetate for Injection Name: Cancidas Intravenous Drip Injection 70 mg Active Ingredient: Caspofungin Acetate |
| 2012-700041 (■) | JP2568474 | Common Name: Caspofungin Acetate for Injection Name: Cancidas Intravenous Drip Injection 70 mg Active Ingredient: Caspofungin Acetate |
| 2012-700040 (○) | JP2568474 | General name: caspofungin acetate for injection Name of sale: Cansidas intravenous drip 50 mg Active ingredient: caspofungin acetate |
| 2012-700040 (■) | JP2568474 | General name: caspofungin acetate for injection Name of sale: Cansidas intravenous drip 50 mg Active ingredient: caspofungin acetate |
| 2012-700039 (○) | JP2852128 | Common Name: Caspofungin Acetate for Injection Name: Cancidas Intravenous Drip Injection 70 mg Active Ingredient: Caspofungin Acetate |
| 2012-700039 (■) | JP2852128 | Common Name: Caspofungin Acetate for Injection Name: Cancidas Intravenous Drip Injection 70 mg Active Ingredient: Caspofungin Acetate |
| 2012-700038 (○) | JP2852128 | General name: caspofungin acetate for injection Name of sale: Cansidas intravenous drip 50 mg Active ingredient: caspofungin acetate |
| 2012-700038 (■) | JP2852128 | General name: caspofungin acetate for injection Name of sale: Cansidas intravenous drip 50 mg Active ingredient: caspofungin acetate |
| 2012-700037 (○) | JP4653262 | General name: Pentavalent oral attenuated live rotavirus vaccine Sales name: Rotatech internal solution Active ingredient: G1 rotavirus, G2 rotavirus, G3 rotavirus, G4 rotavirus and P1A [8 ] Type rotavirus |
| 2012-700037 (■) | JP4653262 | General name: Pentavalent oral attenuated live rotavirus vaccine Sales name: Rotatech internal solution Active ingredient: G1 rotavirus, G2 rotavirus, G3 rotavirus G4 rotavirus and P1A [8] Rotavirus |
| 2012-700036 (○) | JP4138314 | General name: Pentavalent oral attenuated live rotavirus vaccine Sales name: Rotatech internal solution Active ingredient: G1 rotavirus, G2 rotavirus, G3 rotavirus, G4 rotavirus and P1A [8 ] Type rotavirus |
| 2012-700036 (■) | JP4138314 | General name: Pentavalent oral attenuated live rotavirus vaccine Sales name: Rotatech internal solution Active ingredient: G1 rotavirus, G2 rotavirus, G3 rotavirus, G4 rotavirus and P1A [8 ] Type rotavirus |
| 2012-700035 (○) | JP4308263 | Legnight Tablet 300 mg |
| 2012-700035 (■) | JP4308263 | Legnight Tablet 300 mg |
| 2012-700034 (○) | JP4216713 | Legnight Tablet 300 mg |
| 2012-700034 (■) | JP4216713 | Legnight Tablet 300 mg |
| 2012-700033 (○) | JP3117462 | Name: Certican Tablet 0.75 mg Common Name: Everolimus |
| 2012-700033 (■) | JP3117462 | Name: Certican Tablet 0.75 mg Common Name: Everolimus |
| 2012-700032 (○) | JP3117462 | Name: Certican Tablets 0.5 mg Common Name: Everolimus |
| 2012-700032 (■) | JP3117462 | Name: Certican Tablets 0.5 mg Common Name: Everolimus |
| 2012-700031 (○) | JP3117462 | Name: Certican Tablet 0.25 mg Common Name: Everolimus |
| 2012-700031 (■) | JP3117462 | Name: Certican Tablet 0.25 mg Common Name: Everolimus |
| 2012-700030 (○) | JP4149905 | Name: Certican Tablet 0.75 mg Common Name: Everolimus |
| 2012-700029 (○) | JP4149905 | Name: Certican Tablets 0.5 mg Common Name: Everolimus |
| 2012-700028 (○) | JP4149905 | Name: Certican Tablet 0.25 mg Common Name: Everolimus |
| 2012-700027 (○) | JP3942641 | Name: Certican Tablet 0.75 mg Common Name: Everolimus |
| 2012-700026 (○) | JP3942641 | Name: Certican Tablets 0.5 mg Common Name: Everolimus |
| 2012-700025 (○) | JP3942641 | Name: Certican Tablet 0.25 mg Common Name: Everolimus |
| 2012-700024 (○) | JP4401613 | Common Name: Denosumab (genetically modified) |
| 2012-700024 (■) | JP4401613 | Common Name: Denosumab (genetically modified) |
| 2012-700023 (○) | JP3747070 | Common name: peginterferon alpha-2b (genetically modified) |
| 2012-700023 (■) | JP3747070 | Name (sales name etc.): Pegintron for subcutaneous injection 150 μg / 0.5 mL Active ingredient (general name): peginterferon alpha-2b (genetically modified) |
| 2012-700022 (○) | JP3747070 | Common name: peginterferon alpha-2b (genetically modified) |
| 2012-700022 (■) | JP3747070 | Name (brand name, etc.): Active ingredient for 100 μg / 0.5 mL of pegintron subcutaneous injection (general name): peginterferon alpha-2b (genetically modified) |
| 2012-700021 (○) | JP3747070 | Common name: peginterferon alpha-2b (genetically modified) |
| 2012-700021 (■) | JP3747070 | Name (brand name, etc.): active ingredient for 50 μg / 0.5 mL of pegintron for subcutaneous injection (general name): peginterferon alpha-2b (genetically modified) |
| 2012-700020 (○) | JP3643034 | Common name: peginterferon alpha-2b (genetically modified) |
| 2012-700020 (■) | JP3643034 | Name (marketing name, etc.): 150 μg / 0.5 mL for pegintron subcutaneous injection Active ingredient (general name): peginterferon alpha-2b (genetically modified) |
| 2012-700019 (○) | JP3643034 | Common name: peginterferon alpha-2b (genetically modified) |
| 2012-700019 (■) | JP3643034 | Name (brand name, etc.): 100 ng / 0.5 mL for pegintron subcutaneous injection Active ingredient (general name): peginterferon alpha-2b (genetically modified) |
| 2012-700018 (○) | JP3643034 | Common name: peginterferon alpha-2b (genetically modified) |
| 2012-700018 (■) | JP3643034 | Name (sales name etc.): 50 μg / 0.5 mL for pegintron subcutaneous injection Active ingredient (general name): peginterferon alpha-2b (genetically modified) |
| 2012-700017 (○) | JP3117462 | Name: Afinitor Tablet 5mg Common Name: Everolimus |
| 2012-700017 (■) | JP3117462 | Name: Afinitor Tablet 5mg Common Name: Everolimus |
| 2012-700016 (○) | JP4358282 | Common Name: Denosumab (genetically modified) |
| 2012-700016 (■) | JP4358282 | Common Name: Denosumab (genetically engineered) Name of sale: Lanmark SC injection 120 mg |
| 2012-700015 (○) | JP4212470 | Common Name: Denosumab (genetically modified) |
| 2012-700015 (■) | JP4212470 | Common Name: Denosumab (genetically modified) |
| 2012-700014 (○) | JP3563036 | Celecoxib (brand name: Celecox Tablet 200 mg) |
| 2012-700014 (■) | JP3563036 | Celecoxib (brand name: Celecox Tablet 200 mg) |
| 2012-700013 (○) | JP3563036 | Celecoxib (brand name: Celecox Tablet 100 mg) |
| 2012-700013 (■) | JP3563036 | Celecoxib (brand name: Celecox Tablet 100 mg) |
| 2012-700012 (○) | JP3025017 | Celecoxib (brand name: Celecox Tablet 200 mg) |
| 2012-700012 (■) | JP3025017 | Celecoxib (brand name: Celecox Tablet 200 mg) |
| 2012-700011 (○) | JP3025017 | Celecoxib (brand name: Celecox Tablet 100 mg) |
| 2012-700011 (■) | JP3025017 | Celecoxib (brand name: Celecox Tablet 100 mg) |
| 2012-700010 (○) | JP3935861 | Denosumab (genetically modified) |
| 2012-700010 (■) | JP3935861 | Denosumab (genetically modified) |
| 2012-700009 (○) | JP3523650 | Denosumab (genetically modified) |
| 2012-700009 (■) | JP3523650 | Denosumab (genetically modified) |
| 2012-700008 (○) | JP4124480 | (I) Name of sale 150 for Herceptin injection (ii) Active ingredient Trastuzumab |
| 2012-700008 (■) | JP4124480 | (I) Name of sale 150 for Herceptin injection (ii) Active ingredient Trastuzumab |
| 2012-700007 (○) | JP4124480 | (I) Name of sale 60 for Herceptin injection (ii) Active ingredient Trastuzumab |
| 2012-700007 (■) | JP4124480 | (I) Name of sale 60 for Herceptin injection (ii) Active ingredient Trastuzumab |
| 2012-700006 (○) | JP4443119 | Drugs subject to disposal (brand name) Modiodal Tablet 100 mg active ingredients of drug subject to disposal (general name) modafinil |
| 2012-700006 (■) | JP4443119 | Drugs subject to disposal (brand name) Modiodal Tablets 100 mg Active ingredient (general name) modafinil for medications subject to disposal |
| 2012-700005 (○) | JP4351627 | Drugs subject to disposal (brand name) Modiodal Tablet 100 mg active ingredients of drug subject to disposal (general name) modafinil |
| 2012-700004 (○) | JP2915146 | Drugs subject to disposal (brand name) Modiodal Tablet 100 mg active ingredients of drug subject to disposal (general name) modafinil |
| 2012-700004 (■) | JP2915146 | Drugs subject to disposal (brand name) Modiodal Tablet 100 mg Active ingredients of drug subject to disposal (general name) Modafinil |
| 2012-700003 (○) | JP3040486 | Gefitinib |
| 2012-700002 (○) | JP2994165 | Gefitinib |
| 2012-700001 (○) | JP4242913 | Lanmark subcutaneous injection 120 mg |
| 2012-700001 (■) | JP4242913 | Lanmark subcutaneous injection 120 mg (active ingredient: "denosumab") |
| 2011-700298 (○) | JP3957765 | Bevacizumab (genetically modified) |
| 2011-700298 (■) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 400 mg / 16 mL Common name: bevacizumab (genetically modified) |
| 2011-700297 (○) | JP3398382 | Bevacizumab (genetically modified) |
| 2011-700297 (■) | JP3398382 | Name of sale: Avastin for intravenous drip infusion 400 mg / 16 mL Common name: bevacizumab (genetically modified) |
| 2011-700296 (○) | JP3957765 | Bevacizumab (genetically modified) |
| 2011-700296 (■) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 100 mg / 4 mL Common name: bevacizumab (genetically modified) |
| 2011-700295 (○) | JP3398382 | Bevacizumab (genetically modified) |
| 2011-700295 (■) | JP3398382 | Name of sale: Avastin for intravenous drip infusion 100 mg / 4 mL Common name: bevacizumab (genetically modified) |
| 2011-700294 (○) | JP4689938 | Terrapreville |
| 2011-700294 (■) | JP4689938 | Terrapreville |
| 2011-700293 (○) | JP3073770 | Hosa prep tant megulmin (sale name: 150 mg for Promened IV) |
| 2011-700293 (■) | JP3073770 | (Active ingredient) Hosa prepitant megulmin (sale name: 150 mg for proimed drip infusion) |
| 2011-700292 (○) | JP4363846 | Fulvestland |
| 2011-700292 (■) | JP4363846 | Name of sale: Festrodex muscle injection 250mg Active ingredient: Fulvestrant |
| 2011-700291 (○) | JP3713237 | Fulvestland |
| 2011-700291 (■) | JP3713237 | Name of sale: Festrodex muscle injection 250mg Active ingredient: Fulvestrant |
| 2011-700290 (○) | JP4503184 | Fingolimod hydrochloride |
| 2011-700289 (○) | JP4079505 | Fingolimod hydrochloride |
| 2011-700288 (○) | JP3632979 | Fingolimod hydrochloride |
| 2011-700287 (○) | JP2579602 | Fingolimod hydrochloride |
| 2011-700287 (■) | JP2579602 | Imcella Capsule 0.5mg Fingolimod Hydrochloride |
| 2011-700286 (○) | JP4493342 | Pyrimisulfan-benzobicyclo granules |
| 2011-700286 (■) | JP4493342 | Pyrimisulfan-benzobicyclo granules |
| 2011-700285 (○) | JP2980569 | Peginterferon alpha-2a (genetically modified) (brand name: Pegasys subcutaneous injection 180 μg) |
| 2011-700285 (■) | JP2980569 | Peginterferon alpha-2a (genetically modified) (brand name: Pegasys subcutaneous injection 180 μg) |
| 2011-700284 (○) | JP2980569 | Peginterferon alpha-2a (genetically modified) (brand name: Pegasys subcutaneous injection 90 μg) |
| 2011-700284 (■) | JP2980569 | Peginterferon alpha-2a (genetically modified) (brand name: Pegasys subcutaneous injection 90 μg) |
| 2011-700283 (○) | JP3199741 | i) Common Name: Mycophenolate Mofetil ii) Name of Sales: Cellcept Capsule 250 |
| 2011-700282 (○) | JP3717934 | Bortezomib |
| 2011-700282 (■) | JP3717934 | Name of sale: Velcade injection 3 mg Active ingredient: Bortezomib |
| 2011-700281 (○) | JP4271936 | Name of sale: Ilaris for subcutaneous injection 150 mg Common name: canakinumab (genetically modified) |
| 2011-700281 (■) | JP4271936 | Name of sale: Ilaris for subcutaneous injection 150 mg Common name: canakinumab (genetically modified) |
| 2011-700280 (○) | JP3762407 | Common Name: Sitagliptin Phosphate Hydrate |
| 2011-700280 (■) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 100 mg |
| 2011-700279 (○) | JP3762407 | Common Name: Sitagliptin Phosphate Hydrate |
| 2011-700279 (■) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia tablet 50 mg |
| 2011-700278 (○) | JP3762407 | Common Name: Sitagliptin Phosphate Hydrate |
| 2011-700278 (■) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 25 mg |
| 2011-700277 (○) | JP4463768 | Common Name: Sitagliptin Phosphate Hydrate |
| 2011-700277 (■) | JP4463768 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 100 mg |
| 2011-700276 (○) | JP4463768 | Common Name: Sitagliptin Phosphate Hydrate |
| 2011-700276 (■) | JP4463768 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia tablet 50 mg |
| 2011-700275 (○) | JP4463768 | Common Name: Sitagliptin Phosphate Hydrate |
| 2011-700275 (■) | JP4463768 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 25 mg |
| 2011-700274 (○) | JP3113078 | 3-mesityl-2-oxo-1-oxaspiro [4.4] non-3-en-4-yl = 3,3-dimethyl butyrate |
| 2011-700273 (○) | JP3093661 | Name of sale: Mucosta ophthalmic solution UD 2% active ingredient General name: rebamipido |
| 2011-700273 (■) | JP3093661 | Name of sale: Mucosta ophthalmic solution UD 2% active ingredient General name: rebamipido |
| 2011-700272 (○) | JP2662842 | Common Name: Teriparatide Acetate |
| 2011-700272 (■) | JP2662842 | Name of sale: 56.5 μg for subcutaneous injection of Teribon common name of active ingredient: teriparatide acetate |
| 2011-700271 (○) | JP3714970 | Grascepter capsule 5 mg |
| 2011-700270 (○) | JP3714970 | Grasceptor capsule 1 mg |
| 2011-700269 (○) | JP3714970 | Grascepter capsule 0.5 mg |
| 2011-700268 (○) | JP3797387 | Name of Sale: Nauseline OD Tablet 5 Nauseline OD Tablet 5 is an orally disintegrating tablet containing 5 mg of domperidone in one tablet. |
| 2011-700268 (■) | JP3797387 | Active ingredient: Domperidone Sales name: Nauzerin OD Tablet 5 |
| 2011-700267 (○) | JP3797387 | Name of Sale: Nauseline OD Tablet 10 Nauseline OD Tablet 10 is an orally disintegrating tablet containing 10 mg of domperidone in one tablet. |
| 2011-700267 (■) | JP3797387 | Active ingredient: Domperidone Sales name: Nauzerin OD Tablet 10 |
| 2011-700266 (○) | JP3375084 | 0.5g for Fininibacs intravenous drip infusion |
| 2011-700265 (○) | JP2843444 | 0.5g for Fininibacs intravenous drip infusion |
| 2011-700264 (○) | JP2542773 | 0.5g for Fininibacs intravenous drip infusion |
| 2011-700263 (○) | JP3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2011-700263 (■) | JP3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile Type of pesticide: ethiprole wettable powder Name of pesticide: clean flowable |
| 2011-700262 (○) | JP3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2011-700262 (■) | JP3986085 | General name: ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile Types of Pesticides: Echiprol Powder Name of Pesticides: Killop Powder DL |
| 2011-700261 (○) | JP4440471 | Human papilloma virus type 6 L1 protein virus-like particle Human papilloma virus type 11 L1 protein virus-like particle Human papilloma virus type 16 L1 protein virus-like particle Human papilloma virus type 18 L1 protein virus-like particle (brand name: Gardasil aqueous suspension Turbid muscle injection) |
| 2011-700261 (■) | JP4440471 | Human papilloma virus type 6 L1 protein virus-like particle Human papilloma virus type 11 L1 protein virus-like particle Human papilloma virus type 16 L1 protein virus-like particle Human papilloma virus type 18 L1 protein virus-like particle (brand name: Gardasil aqueous suspension Turbid muscle injection) |
| 2011-700260 (○) | JP4440471 | Human papilloma virus type 6 L1 protein virus-like particle Human papilloma virus type 11 L1 protein virus-like particle Human papilloma virus type 16 L1 protein virus-like particle Human papilloma virus type 18 L1 protein virus-like particle (brand name: Gardasil aqueous suspension Turbid muscle injection syringe) |
| 2011-700260 (■) | JP4440471 | Human papilloma virus type 6 L1 protein virus-like particle Human papilloma virus type 11 L1 protein virus-like particle Human papilloma virus type 16 L1 protein virus-like particle Human papilloma virus type 18 L1 protein virus-like particle (brand name: Gardasil aqueous suspension Turbid muscle injection syringe) |
| 2011-700259 (○) | JP4594534 | Human papilloma virus type 6 L1 protein virus-like particle Human papilloma virus type 11 L1 protein virus-like particle Human papilloma virus type 16 L1 protein virus-like particle Human papilloma virus type 18 L1 protein virus-like particle (brand name: Gardasil aqueous suspension Turbid muscle injection) |
| 2011-700259 (■) | JP4594534 | Human papilloma virus type 6 L1 protein virus-like particle Human papilloma virus type 11 L1 protein virus-like particle Human papilloma virus type 16 L1 protein virus-like particle Human papilloma virus type 18 L1 protein virus-like particle (brand name: Gardasil aqueous suspension Turbid muscle injection) |
| 2011-700258 (○) | JP4594534 | Human papilloma virus type 6 L1 protein virus-like particle Human papilloma virus type 11 L1 protein virus-like particle Human papilloma virus type 16 L1 protein virus-like particle Human papilloma virus type 18 L1 protein virus-like particle (brand name: Gardasil aqueous suspension Turbid muscle injection syringe) |
| 2011-700258 (■) | JP4594534 | Human papilloma virus type 6 L1 protein virus-like particle Human papilloma virus type 11 L1 protein virus-like particle Human papilloma virus type 16 L1 protein virus-like particle Human papilloma virus type 18 L1 protein virus-like particle (brand name: Gardasil aqueous suspension Turbid muscle injection syringe) |
| 2011-700257 (○) | JP3918877 | Human papilloma virus type 6 L1 protein virus-like particle Human papilloma virus type 11 L1 protein virus-like particle Human papilloma virus type 16 L1 protein virus-like particle Human papilloma virus type 18 L1 protein virus-like particle (brand name: Gardasil aqueous suspension Turbid muscle injection |
| 2011-700257 (■) | JP3918877 | Human papilloma virus type 6 L1 protein virus-like particle Human papilloma virus type 11 L1 protein virus-like particle Human papilloma virus type 16 L1 protein virus-like particle Human papilloma virus type 18 L1 protein virus-like particle (brand name: Gardasil aqueous suspension Turbid muscle injection) |
| 2011-700256 (○) | JP3918877 | Human papilloma virus type 6 L1 protein virus-like particles Human papilloma virus type 11 L1 protein virus-like particles Human papilloma virus type 16 L1 protein virus-like particles Human papilloma virus type 18 L1 protein virus-like particles (sale name: Gardasil aqueous solution Suspension muscle injection syringe) |
| 2011-700256 (■) | JP3918877 | Human papilloma virus type 6 L1 protein virus-like particle Human papilloma virus type 11 L1 protein virus-like particle Human papilloma virus type 16 L1 protein virus-like particle Human papilloma virus type 18 L1 protein virus-like particle (brand name: Gardasil aqueous suspension Turbid muscle injection syringe) |
| 2011-700255 (○) | JP4732693 | Vorinostat |
| 2011-700255 (■) | JP4732693 | Vorinostat |
| 2011-700254 (○) | JP3432823 | Vorinostat |
| 2011-700254 (■) | JP3432823 | Vorinostat |
| 2011-700253 (○) | JP4689916 | Erlotinib hydrochloride (common name) |
| 2011-700253 (■) | JP4689916 | Erlotinib hydrochloride (common name) |
| 2011-700252 (○) | JP4689916 | Erlotinib hydrochloride (common name) |
| 2011-700252 (■) | JP4689916 | Erlotinib hydrochloride (common name) |
| 2011-700251 (○) | JP3420549 | Erlotinib hydrochloride (common name) |
| 2011-700250 (○) | JP3420549 | Erlotinib hydrochloride (common name) |
| 2011-700249 (○) | JP3088018 | Erlotinib hydrochloride (common name) |
| 2011-700249 (■) | JP3088018 | Name of sale: Tarceva Tablet 100 mg Active ingredient: Erlotinib hydrochloride |
| 2011-700248 (○) | JP3088018 | Erlotinib hydrochloride (common name) |
| 2011-700248 (■) | JP3088018 | Name of sale: Tarceva Tablet 25 mg Active ingredient: Erlotinib hydrochloride |
| 2011-700247 (○) | JP3861118 | Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2011-700247 (■) | JP3861118 | Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2011-700246 (○) | JP3861118 | Adalimumab (genetically modified) |
| 2011-700246 (■) | JP3861118 | Adalimumab (genetically modified) |
| 2011-700245 (○) | JP4404181 | Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2011-700245 (■) | JP4404181 | Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2011-700244 (○) | JP4404181 | Adalimumab (genetically modified) |
| 2011-700244 (■) | JP4404181 | Adalimumab (genetically modified) |
| 2011-700243 (○) | JP4233115 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700242 (○) | JP4233115 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700241 (○) | JP4195507 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700240 (○) | JP4195507 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700239 (○) | JP4039999 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700238 (○) | JP4039999 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700237 (○) | JP4002303 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700236 (○) | JP4002303 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700235 (○) | JP3959056 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700235 (■) | JP3959056 | Name of Sale: Nexium Capsule 20 mg Active Ingredient (Common Name): Esomeprazole Magnesium Hydrate |
| 2011-700234 (○) | JP3959056 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700234 (■) | JP3959056 | Name of sale: Nexium capsule 10 mg Active ingredient (general name): Esomeprazole magnesium hydrate |
| 2011-700233 (○) | JP3878826 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700232 (○) | JP3878826 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700231 (○) | JP3795917 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700231 (■) | JP3795917 | Name of Sale: Nexium Capsule 20 mg Active Ingredient (Common Name): Esomeprazole Magnesium Hydrate |
| 2011-700230 (○) | JP3795917 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700230 (■) | JP3795917 | Name of sale: Nexium capsule 10 mg Active ingredient (general name): Esomeprazole magnesium hydrate |
| 2011-700229 (○) | JP3665334 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700228 (○) | JP3665334 | Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2011-700227 (○) | JP4233524 | Trazenta Tablets 5 mg |
| 2011-700227 (■) | JP4233524 | Trazenta Tablets 5 mg |
| 2011-700226 (○) | JP4395304 | Trazenta Tablets 5 mg |
| 2011-700226 (■) | JP4395304 | Trazenta Tablets 5 mg |
| 2011-700225 (○) | JP3828570 | Gardasil aqueous suspension (active ingredient: virus like particles of human papilloma virus HPV-6 and HPV-11) |
| 2011-700225 (■) | JP3828570 | Gardasil aqueous suspension intramuscular injection (active ingredients: human papilloma virus type 6 L1 protein virus-like particles, human papilloma virus type 11 L1 protein virus like particles, human papilloma virus type 11 L1 protein virus like particles, human papilloma virus type 16 L1 protein Virus like particle, human papilloma virus type 18 L1 protein virus like particle) |
| 2011-700224 (○) | JP3828570 | Gardasil aqueous suspension muscle injection syringe (active ingredient: virus like particles of human papilloma virus HPV-6 and HPV-11) |
| 2011-700224 (■) | JP3828570 | Gardasil aqueous suspension muscle injection syringe (active ingredient: human papilloma virus type 6 L1 protein virus like particles, human papilloma virus type 11 L1 protein virus like particles, human papilloma virus type 11 L1 protein virus like particles, human papilloma virus type 16 L1 protein White matter virus like particle, human papilloma virus type 18 L1 protein virus like particle) |
| 2011-700223 (○) | JP3839667 | Ribavirin (brand name: Copegas Tablets 200 mg) |
| 2011-700223 (■) | JP3839667 | Ribavirin (brand name: Copegas Tablets 200 mg) |
| 2011-700222 (○) | JP3839667 | Peginterferon alpha-2a (genetically modified) (marketed name: Pegasys subcutaneously 90 μg) |
| 2011-700222 (■) | JP3839667 | Peginterferon alpha-2a (genetically modified) (brand name: Pegasys subcutaneous injection 90 μg) |
| 2011-700221 (○) | JP2980569 | Peginterferon alpha-2a (genetically modified) (marketed name: Pegasys subcutaneously 90 μg) |
| 2011-700221 (■) | JP2980569 | Peginterferon alpha-2a (genetically modified) (brand name: Pegasys subcutaneous injection 90 μg) |
| 2011-700220 (○) | JP4748920 | General name: golimumab FB (as golimumab (genetically modified)) Sales name: Sinpony subcutaneous injection 50 mg syringe amino acid sequence (approval number 22300 AMX00596000 drug manufacturing and marketing approval application (June 29, 2010) See page 10 of the attached sheet) |
| 2011-700220 (■) | JP4748920 | General name: golimumab FB (as golimumab (genetically modified)) Sales name: Sinpony subcutaneous injection 50 mg syringe amino acid sequence (approval number 22300 AMX00596000 drug manufacturing and marketing approval application (June 29, 2010) See page 10 of the attached sheet) |
| 2011-700219 (○) | JP3785365 | Name: Capsule for Ombrese Inhalation 150μg Common Name: Indacaterol Maleate |
| 2011-700219 (■) | JP3785365 | Name: Capsule for Ombrese Inhalation 150μg Common Name: Indacaterol Maleate |
| 2011-700218 (○) | JP4726778 | Name: Capsule for Ombrese Inhalation 150μg Common Name: Indacaterol Maleate |
| 2011-700217 (○) | JP3895349 | Alogliptin benzoate, pioglitazone hydrochloride (brand name: Riobell combination tablet HD) |
| 2011-700216 (○) | JP3895349 | Alogliptin benzoate, pioglitazone hydrochloride (brand name: Rio Bell combination tablet LD) |
| 2011-700215 (○) | JP4688089 | Betanis R Tablet 50 mg (mirabegron as active ingredient) |
| 2011-700215 (■) | JP4688089 | Betanis R Tablet 50 mg (mirabegron as active ingredient) |
| 2011-700214 (○) | JP4688089 | Betanis R Tablets 25 mg (mirabegron as active ingredient) |
| 2011-700214 (■) | JP4688089 | Betanis R Tablets 25 mg (mirabegron as active ingredient) |
| 2011-700213 (○) | JP3462490 | Betanis R Tablet 50 mg (mirabegron as active ingredient) |
| 2011-700213 (■) | JP3462490 | Betanis R Tablet 50 mg (mirabegron as active ingredient) |
| 2011-700212 (○) | JP3462490 | Betanis R Tablets 25 mg (mirabegron as active ingredient) |
| 2011-700212 (■) | JP3462490 | Betanis R Tablets 25 mg (mirabegron as active ingredient) |
| 2011-700211 (○) | JP3140465 | Betanis R Tablet 50 mg (mirabegron as active ingredient) |
| 2011-700211 (■) | JP3140465 | Betanis R Tablet 50 mg (mirabegron as active ingredient) |
| 2011-700210 (○) | JP3140465 | Betanis R Tablets 25 mg (mirabegron as active ingredient) |
| 2011-700210 (■) | JP3140465 | Betanis R Tablets 25 mg (mirabegron as active ingredient) |
| 2011-700209 (○) | JP3815496 | Betanis R Tablet 50 mg (mirabegron as active ingredient) |
| 2011-700209 (■) | JP3815496 | Betanis R Tablet 50 mg (mirabegron as active ingredient) |
| 2011-700208 (○) | JP3815496 | Betanis R Tablets 25 mg (mirabegron as active ingredient) |
| 2011-700208 (■) | JP3815496 | Betanis R Tablets 25 mg (mirabegron as active ingredient) |
| 2011-700207 (○) | JP3800220 | Betanis R Tablet 50 mg (mirabegron as active ingredient) |
| 2011-700207 (■) | JP3800220 | Betanis R Tablet 50 mg (mirabegron as active ingredient) |
| 2011-700206 (○) | JP3800220 | Betanis R Tablets 25 mg (mirabegron as active ingredient) |
| 2011-700206 (■) | JP3800220 | Betanis R Tablets 25 mg (mirabegron as active ingredient) |
| 2011-700205 (○) | JP3193706 | Betanis R Tablet 50 mg (mirabegron as active ingredient) |
| 2011-700205 (■) | JP3193706 | Betanis R Tablet 50 mg (mirabegron as active ingredient) |
| 2011-700204 (○) | JP3193706 | Betanis R Tablets 25 mg (mirabegron as active ingredient) |
| 2011-700204 (■) | JP3193706 | Betanis R Tablets 25 mg (mirabegron as active ingredient) |
| 2011-700203 (○) | JP4184607 | Common Name: Daptomycin |
| 2011-700203 (■) | JP4184607 | Name of sale: 350mg for intravenous administration of cubicin Active ingredient: Daptomycin |
| 2011-700202 (○) | JP3385208 | Minodronic acid hydrate |
| 2011-700201 (○) | JP3302647 | Landiolol hydrochloride |
| 2011-700201 (■) | JP3302647 | General name: Landiolol hydrochloride, Name of sale: 12.5 mg for core beta intravenous injection |
| 2011-700200 (○) | JP3989175 | Common Name: Dasatinib Hydrate Sales Name: Sprycel Tablets 50 mg |
| 2011-700200 (■) | JP3989175 | Common Name: Dasatinib Hydrate Sales Name: Sprycel Tablets 50 mg |
| 2011-700199 (○) | JP3989175 | Common Name: Dasatinib Hydrate Name: Sprisel Tablets 20 mg |
| 2011-700199 (■) | JP3989175 | Common Name: Dasatinib Hydrate Name: Sprisel Tablets 20 mg |
| 2011-700198 (○) | JP3945885 | Nobilis MGMS |
| 2011-700198 (■) | JP3945885 | Active Ingredients: Attenuated Mycoplasma gallisepticum 6/85 and Attenuated Mycoplasma cynobi MS1 Sales name: Nobilis MGMS |
| 2011-700197 (○) | JP4707934 | Types of pesticides: tefuryltrione / fentrazamide granules name of pesticides: bodyguard jumbo common name, chemical name and content of active ingredients: (General name): tefuryl trione Chemical name: 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (general name): fentrazamide (chemical name): 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole-1 -Carboxamide (content): 7.5% |
| 2011-700196 (○) | JP4707934 | Types of pesticides: tefuryltrione / fentrazamide granules pesticide names: bodyguard 1 kg granules active ingredient General name, chemical name and content: (General name): tefuryl trione (General name): phentrazamide (chemical name): 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole -1-carboxamide (content): 3.0% |
| 2011-700196 (■) | JP4707934 | Types of pesticides: tefuryltrione / fentrazamide granules pesticide names: bodyguard 1 kg granules active ingredient General name, chemical name and content: (General name): tefuryl trione (chemical name): 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (content): 3 .0%, and (General name): phentrazamide (chemical name): 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole -1-carboxamide (content): 3.0% |
| 2011-700195 (○) | JP4227418 | Types of pesticides: tefuryl trione, mefenaset granules pesticide names: possible jumbo common name, chemical name and content of active ingredients: (General name): tefuryl trione ( Chemical name): 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (General name): mefenaset (chemical name): 2-benzothiazol-2-yloxy-N-methylacetanilide (content): 20.0% |
| 2011-700195 (■) | JP4227418 | Types of pesticides: tefuryl trione, mefenaset granules pesticide names: possible jumbo common name, chemical name and content of active ingredients: (General name): tefuryl trione ( Chemical name): 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (General name): mefenaset (chemical name): 2-benzothiazol-2-yloxy-N-methylacetanilide (content): 20.0% |
| 2011-700194 (○) | JP4227418 | Types of pesticides: tefuryl trione, mefenaset granules Name of pesticides: 1 kg granules possible active ingredient name, chemical name and content: (General name): tefuryl trione < br> (chemical name): 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (content): 3.0 %, And (common name): mefenacet (chemical name): 2-benzothiazol-2-yloxy-N-methylacetanilide (content) 12.0% |
| 2011-700194 (■) | JP4227418 | Types of pesticides: tefuryl trione, mefenaset granules Name of pesticides: 1 kg granules possible active ingredient name, chemical name and content: (General name): tefuryl trione < br> (chemical name): 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (content): 3.0 %, And (common name): mefenacet (chemical name): 2-benzothiazol-2-yloxy-N-methylacetoanilide |
| 2011-700193 (○) | JP4463768 | Common Name: Sitagliptin Phosphate Hydrate |
| 2011-700193 (■) | JP4463768 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 100 mg |
| 2011-700192 (○) | JP4463768 | Common Name: Sitagliptin Phosphate Hydrate |
| 2011-700192 (■) | JP4463768 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 50 mg |
| 2011-700191 (○) | JP4463768 | Common Name: Sitagliptin Phosphate Hydrate |
| 2011-700191 (■) | JP4463768 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 25 mg |
| 2011-700190 (○) | JP3762407 | Common Name: Sitagliptin Phosphate Hydrate |
| 2011-700190 (■) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 100 mg |
| 2011-700189 (○) | JP3762407 | Common Name: Sitagliptin Phosphate Hydrate |
| 2011-700189 (■) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 50 mg |
| 2011-700188 (○) | JP3762407 | Common Name: Sitagliptin Phosphate Hydrate |
| 2011-700188 (■) | JP3762407 | Active ingredient: Sitagliptin phosphate hydrate Name of sale: Janubia Tablet 25 mg |
| 2011-700187 (○) | JP3820103 | Name of sale: Xelon Patch 18 mg General name: Rivastigmine |
| 2011-700187 (■) | JP3820103 | Name of sale: Xelon Patch 18 mg General name: Rivastigmine |
| 2011-700186 (○) | JP3820103 | Name: Xcelon Patch 13.5mg General name: Rivastigmine |
| 2011-700186 (■) | JP3820103 | Name: Xcelon Patch 13.5mg General name: Rivastigmine |
| 2011-700185 (○) | JP3820103 | Name of sale: Xcelon patch 9 mg Common name: Rivastigmine |
| 2011-700185 (■) | JP3820103 | Name of sale: Xcelon patch 9 mg Common name: Rivastigmine |
| 2011-700184 (○) | JP3820103 | Name: Xelon Patch 4.5 mg General name: Rivastigmine |
| 2011-700184 (■) | JP3820103 | Name: Xelon Patch 4.5 mg General name: Rivastigmine |
| 2011-700183 (○) | JP3704470 | Common Name: Robenacoxib Chemical Name: {5-ethyl-2-((2,3,5,6-tetrafluorophenyl) amino) phenyl} acetic acid |
| 2011-700183 (■) | JP3704470 | Oncyl 2% injection solution Main agent: robenacoxib (General name: {5-ethyl-2-((2,3,5,6-tetrafluorophenyl) amino) phenyl} acetic acid) |
| 2011-700182 (○) | JP3375084 | 0.25g for finivac kit drip |
| 2011-700181 (○) | JP3375084 | 0.25g for finivacs infusion |
| 2011-700180 (○) | JP2843444 | 0.25g for finivac kit drip |
| 2011-700179 (○) | JP2843444 | 0.25g for finivacs infusion |
| 2011-700178 (○) | JP2542773 | 0.25g for finivac kit drip |
| 2011-700177 (○) | JP2542773 | 0.25g for finivacs infusion |
| 2011-700176 (○) | JP3967594 | Epoetin beta pegol (genetically engineered) (brand name: Mircera injection syringe 250 μg) |
| 2011-700176 (■) | JP3967594 | Epoetin beta pegol (genetically engineered) (brand name: Mircera injection syringe 250 μg) |
| 2011-700175 (○) | JP3967594 | Epoetin beta pegol (genetically modified) (brand name: Mircera injection syringe 200 μg) |
| 2011-700175 (■) | JP3967594 | Epoetin beta pegol (genetically modified) (brand name: Mircera injection syringe 200 μg) |
| 2011-700174 (○) | JP3967594 | Epoetin beta pegol (genetically modified) (brand name: Milsera injection syringe 150 μg) |
| 2011-700174 (■) | JP3967594 | Epoetin beta pegol (genetically modified) (brand name: Milsera injection syringe 150 μg) |
| 2011-700173 (○) | JP3967594 | Epoetin beta pegol (genetically modified) (brand name: Mircera injection syringe 100 μg) |
| 2011-700173 (■) | JP3967594 | Epoetin beta pegol (genetically modified) (brand name: Mircera injection syringe 100 μg) |
| 2011-700172 (○) | JP3967594 | Epoetin beta pegol (genetically modified) (brand name: Mircera injection syringe 75 μg) |
| 2011-700172 (■) | JP3967594 | Epoetin beta pegol (genetically modified) (brand name: Mircera injection syringe 75 μg) |
| 2011-700171 (○) | JP3967594 | Epoetin beta pegol (genetically engineered) (brand name: Mircera injection syringe 50 μg) |
| 2011-700171 (■) | JP3967594 | Epoetin beta pegol (genetically engineered) (brand name: Mircera injection syringe 50 μg) |
| 2011-700170 (○) | JP3967594 | Epoetin beta pegol (genetically modified) (brand name: Mircera injection syringe 25 μg) |
| 2011-700170 (■) | JP3967594 | Epoetin beta pegol (genetically modified) (brand name: Mircera injection syringe 25 μg) |
| 2011-700169 (○) | JP4463875 | Edoxaban tosylate hydrate |
| 2011-700169 (■) | JP4463875 | Rixiana Tablets 30mg Edoxaban tosylate Hydrate Hydrate |
| 2011-700168 (○) | JP4463875 | Edoxaban tosylate hydrate |
| 2011-700168 (■) | JP4463875 | Rixiana Tablets 15mg Edoxaban tosylate Hydrate Hydrate |
| 2011-700167 (○) | JP4510088 | Edoxaban tosylate hydrate |
| 2011-700167 (■) | JP4510088 | Rixiana Tablets 30mg Edoxaban tosylate Hydrate Hydrate |
| 2011-700166 (○) | JP4510088 | Edoxaban tosylate hydrate |
| 2011-700166 (■) | JP4510088 | Rixiana Tablets 15mg Edoxaban tosylate Hydrate Hydrate |
| 2011-700165 (○) | JP4109288 | Edoxaban tosylate hydrate |
| 2011-700165 (■) | JP4109288 | Rixiana Tablets 30mg Edoxaban tosylate Hydrate Hydrate |
| 2011-700164 (○) | JP4109288 | Edoxaban tosylate hydrate |
| 2011-700164 (■) | JP4109288 | Rixiana Tablets 15mg Edoxaban tosylate Hydrate Hydrate |
| 2011-700163 (○) | JP4128138 | Edoxaban tosylate hydrate |
| 2011-700163 (■) | JP4128138 | Rixiana Tablets 30mg Edoxaban tosylate Hydrate Hydrate |
| 2011-700162 (○) | JP4128138 | Edoxaban tosylate hydrate |
| 2011-700162 (■) | JP4128138 | Rixiana Tablets 15mg Edoxaban tosylate Hydrate Hydrate |
| 2011-700161 (○) | JP3830816 | Malopitant citrate monohydrate |
| 2011-700161 (■) | JP3830816 | Malopitant citrate monohydrate (brand name: Serenia Tablet 160) |
| 2011-700160 (○) | JP3830816 | Malopitant citrate monohydrate |
| 2011-700160 (■) | JP3830816 | Malopitant citrate monohydrate (sale name: Serenia Tablet 60) |
| 2011-700159 (○) | JP3830816 | Malopitant citrate monohydrate |
| 2011-700159 (■) | JP3830816 | Malopitant citrate monohydrate (sale name: Serenia Tablet 24) |
| 2011-700158 (○) | JP2645225 | Malopitant citrate monohydrate |
| 2011-700158 (■) | JP2645225 | Malopitant citrate monohydrate (brand name: Serenia Tablet 160) |
| 2011-700157 (○) | JP2645225 | Malopitant citrate monohydrate |
| 2011-700157 (■) | JP2645225 | Malopitant citrate monohydrate (brand name: Serenia Tablet 60) |
| 2011-700156 (○) | JP2645225 | Malopitant citrate monohydrate |
| 2011-700156 (■) | JP2645225 | Malopitant citrate monohydrate (brand name: Serenia Tablet 24) |
| 2011-700155 (○) | JP3381190 | Drugs subject to disposal (brand name) Tramset combination tablets active ingredients of medications subject to disposal (general name) tramadol hydrochloride acetaminophen |
| 2011-700155 (■) | JP3381190 | Drugs subject to disposal (brand name) Tramset combination tablets active ingredients of medications subject to disposal (general name) tramadol hydrochloride acetaminophen |
| 2011-700154 (○) | JP3727009 | Epoetin beta pegol (genetically modified) |
| 2011-700154 (■) | JP3727009 | Epoetin beta pegol (genetically modified) Milcera injection syringe 250 μg |
| 2011-700153 (○) | JP3727009 | Epoetin beta pegol (genetically modified) |
| 2011-700153 (■) | JP3727009 | Epoetin beta pegol (genetically modified) Milcera injection syringe 200 μg |
| 2011-700152 (○) | JP3727009 | Epoetin beta pegol (genetically modified) |
| 2011-700152 (■) | JP3727009 | Epoetin beta pegol (genetically modified) Milcera injection syringe 150 μg |
| 2011-700151 (○) | JP3727009 | Epoetin beta pegol (genetically modified) |
| 2011-700151 (■) | JP3727009 | Epoetin beta pegol (genetically modified) Mircera injection syringe 100 μg |
| 2011-700150 (○) | JP3727009 | Epoetin beta pegol (genetically modified) |
| 2011-700150 (■) | JP3727009 | Epoetin beta pegol (genetically modified) Milcera injection syringe 75μg |
| 2011-700149 (○) | JP3727009 | Epoetin beta pegol (genetically modified) |
| 2011-700149 (■) | JP3727009 | Epoetin beta pegol (genetically modified) Mircera injection syringe 50 μg |
| 2011-700148 (○) | JP3727009 | Epoetin beta pegol (genetically modified) |
| 2011-700148 (■) | JP3727009 | Epoetin beta pegol (genetically modified) Mircera injection syringe 25 μg |
| 2011-700147 (○) | JP4153124 | Ibuprofen and butyl scopolamine bromide |
| 2011-700147 (■) | JP4153124 | Ibuprofen and butyl scopolamine bromide |
| 2011-700146 (○) | JP3986085 | Common name: Ethiprole Chemical name: 5-amino-1- (2,6-dichloro-α, α, α-trifluoro-p-tolyl) -4-ethylsulfinylpyrazole-3-carbonitrile |
| 2011-700146 (■) | JP3986085 | Common Name: Ethiprole Chemical Name: 5-Amino-1- (2,6-Dichloro-α, α, α-Trifluoro-p-Tolyl) -4-Ethylsulfinylpyrazole-3-carbonitrile Types of Pesticides: Ethiprole / Metominostrobin Granules Name of Pesticides: Imochie Ski Wrap Granules |
| 2011-700145 (○) | JP4230524 | Mitiglinide calcium hydrate / voglibose combination tablet |
| 2011-700145 (■) | JP4230524 | Mitiglinide calcium hydrate / voglibose combination tablet |
| 2011-700144 (○) | JP4454151 | Haraven IV 1 mg |
| 2011-700144 (■) | JP4454151 | Haraven IV 1 mg |
| 2011-700143 (○) | JP3665339 | 1- (4,6-dimethoxypyrimidin-2-yl) -3- [2- (dimethylcarbamoyl) -5-formamidophenylsulfonyl] urea |
| 2011-700143 (■) | JP3665339 | Active ingredient compound: 1- (4,6-dimethoxypyrimidin-2-yl) -3- [2-dimethylcarbamoyl) -5-formamidophenylsulfonyl] urea Pesticide type: phoramsulfuron wettable powder Pesticide Name: Tribute OD |
| 2011-700142 (○) | JP4088036 | Types and names of pesticides targeted for disposal Types of pesticides: imidacloprid, chlorantraniliprole, isotianil granules Name of pesticides: routine tress box granules targeted for disposal The active ingredient compound 3,4-dichloro-2'-cyano-1,2-thiazole-5-carboxanilide (general name: isothianyl) |
| 2011-700140 (○) | JP4599355 | Trastuzumab |
| 2011-700140 (■) | JP4599355 | Trastuzumab |
| 2011-700139 (○) | JP4599355 | Trastuzumab |
| 2011-700139 (■) | JP4599355 | Trastuzumab |
| 2011-700138 (○) | JP4469933 | Trastuzumab |
| 2011-700137 (○) | JP4469933 | Trastuzumab |
| 2011-700136 (○) | JP4031049 | Trastuzumab |
| 2011-700136 (■) | JP4031049 | Trastuzumab |
| 2011-700135 (○) | JP4031049 | Trastuzumab |
| 2011-700135 (■) | JP4031049 | Trastuzumab |
| 2011-700134 (○) | JP4124480 | Trastuzumab |
| 2011-700134 (■) | JP4124480 | Trastuzumab |
| 2011-700133 (○) | JP4124480 | Trastuzumab |
| 2011-700133 (■) | JP4124480 | Trastuzumab |
| 2011-700132 (○) | JP3830816 | Malopitant citrate monohydrate |
| 2011-700132 (■) | JP3830816 | Malopitant citrate monohydrate (sale name: Serenia injection) |
| 2011-700131 (○) | JP3830816 | Malopitant citrate monohydrate |
| 2011-700131 (■) | JP3830816 | Malopitant citrate monohydrate (brand name: Serenia Tablet 16) |
| 2011-700130 (○) | JP2645225 | Malopitant citrate monohydrate |
| 2011-700130 (■) | JP2645225 | Malopitant citrate monohydrate (brand name: Serenia tablets) |
| 2011-700129 (○) | JP2645225 | Malopitant citrate monohydrate |
| 2011-700129 (■) | JP2645225 | Malopitant citrate monohydrate (brand name: Serenia Tablet 16) |
| 2011-700128 (○) | JP3987130 | Cyazofamid |
| 2011-700127 (○) | JP2778632 | Nogitecan hydrochloride |
| 2011-700127 (■) | JP2778632 | Name of sale: Hycamtin for injection 1.1 mg Active ingredient: Nogitecan hydrochloride |
| 2011-700126 (○) | JP3895349 | Alogliptin benzoate (brand name: Nesina Tablets 25 mg) |
| 2011-700126 (■) | JP3895349 | Alogliptin benzoate (brand name: Nesina Tablets 25 mg) |
| 2011-700125 (○) | JP3895349 | Alogliptin benzoate (brand name: Nesina tablet 12.5 mg) |
| 2011-700125 (■) | JP3895349 | Alogliptin benzoate (brand name: Nesina Tablet 12.5 mg) |
| 2011-700124 (○) | JP3895349 | Alogliptin benzoate (brand name: Nesina Tablet 6.25 mg) |
| 2011-700124 (■) | JP3895349 | Alogliptin benzoate (brand name: Nesina 6.25 mg) |
| 2011-700123 (○) | JP2501297 | Capecitabine |
| 2011-700123 (■) | JP2501297 | Capecitabine |
| 2011-700122 (○) | JP3807509 | Ciclesonide |
| 2011-700121 (○) | JP3807509 | Ciclesonide |
| 2011-700120 (○) | JP3807509 | Ciclesonide |
| 2011-700119 (○) | JP3807509 | Ciclesonide |
| 2011-700118 (○) | JP3333210 | Ciclesonide |
| 2011-700117 (○) | JP3333210 | Ciclesonide |
| 2011-700116 (○) | JP3333210 | Ciclesonide |
| 2011-700115 (○) | JP3333210 | Ciclesonide |
| 2011-700114 (○) | JP3734090 | Ciclesonide |
| 2011-700113 (○) | JP3734090 | Ciclesonide |
| 2011-700112 (○) | JP3734090 | Ciclesonide |
| 2011-700111 (○) | JP3734090 | Ciclesonide |
| 2011-700110 (○) | JP4414020 | Erdecalcitol (general name) |
| 2011-700110 (■) | JP4414020 | Ediroll Capsule 0.75 μg (brand name) Eldecalcitol (active ingredient) |
| 2011-700109 (○) | JP4414020 | Erdecalcitol (general name) |
| 2011-700109 (■) | JP4414020 | Ediroll Capsule 0.5 μg (brand name) Eldecalcitol (active ingredient) |
| 2011-700108 (○) | JP3429432 | Erdecalcitol (general name) |
| 2011-700108 (■) | JP3429432 | Ediroll Capsule 0.75 μg (brand name) Eldecalcitol (active ingredient) |
| 2011-700107 (○) | JP3429432 | Erdecalcitol (general name) |
| 2011-700107 (■) | JP3429432 | Ediroll Capsule 0.5 μg (brand name) Eldecalcitol (active ingredient) |
| 2011-700106 (○) | JP4557426 | Common Name: Botulinum Toxin Type B Name: Narblock Myocardial injection 2500 units |
| 2011-700106 (■) | JP4557426 | General name: Botulinum toxin type B Sales name: Nervock my injection 2500 units |
| 2011-700105 (○) | JP4332163 | Lomiprostim (genetically modified) |
| 2011-700105 (■) | JP4332163 | Lomiprostim (genetically modified) |
| 2011-700104 (○) | JP3820105 | Lomiprostim (genetically modified) |
| 2011-700104 (■) | JP3820105 | Lomiprostim (genetically modified) |
| 2011-700103 (○) | JP3866715 | Plaza Xa Capsule 110 mg (active ingredient: dabigatran etexilate methanesulfonate) |
| 2011-700103 (■) | JP3866715 | Plaza Xa Capsule 110 mg (active ingredient: dabigatran etexilate methanesulfonate) |
| 2011-700102 (○) | JP3866715 | Plaza Xa Capsule 110 mg (active ingredient: dabigatran etexilate methanesulfonate) |
| 2011-700102 (■) | JP3866715 | Plazaxa Capsules 75mg (Active ingredient: dabigatran etexilate methanesulfonate) |
| 2011-700101 (○) | JP3343359 | Plaza Xa Capsule 110 mg (active ingredient: dabigatran etexilate methanesulfonate) |
| 2011-700101 (■) | JP3343359 | Plaza Xa Capsule 110 mg (active ingredient: dabigatran etexilate methanesulfonate) |
| 2011-700100 (○) | JP3343359 | Plazaxa Capsules 75mg (Active ingredient: dabigatran etexilate methanesulfonate) |
| 2011-700100 (■) | JP3343359 | Plazaxa Capsules 75mg (Active ingredient: dabigatran etexilate methanesulfonate) |
| 2011-700099 (○) | JP4084309 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700099 (■) | JP4084309 | Name of sale: Fabrik Tablets 20 mg Name of active ingredient Febuxostat |
| 2011-700098 (○) | JP3547707 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700098 (■) | JP3547707 | Name of sale: Fabrik Tablets 20 mg Name of active ingredient Febuxostat |
| 2011-700097 (○) | JP3202607 | Name of sale: Fabrik Tablet 40 mg Name of active ingredient Febuxostat |
| 2011-700097 (■) | JP3202607 | Name of sale: Fabrik Tablets 20 mg Name of active ingredient Febuxostat |
| 2011-700096 (○) | JP2706037 | Name of sale: Fabrik Tablet 40 mg Name of active ingredient Febuxostat |
| 2011-700095 (○) | JP2834971 | Name of sale: Fabrik Tablet 40 mg Name of active ingredient Febuxostat |
| 2011-700095 (■) | JP2834971 | Name of sale: Fabrik Tablets 20 mg Name of active ingredient Febuxostat |
| 2011-700094 (○) | JP2725886 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700094 (■) | JP2725886 | Name of sale: Fabrik Tablets 20 mg Name of active ingredient Febuxostat |
| 2011-700093 (○) | JP4084309 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700093 (■) | JP4084309 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700092 (○) | JP3547707 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700092 (■) | JP3547707 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700091 (○) | JP3202607 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700091 (■) | JP3202607 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700090 (○) | JP2706037 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700089 (○) | JP2834971 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700089 (■) | JP2834971 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700088 (○) | JP2725886 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700088 (■) | JP2725886 | Name of sale: Fabrik Tablets 40 mg Name of active ingredient Febuxostat |
| 2011-700087 (○) | JP4172820 | Drugs subject to disposal (brand name) Reminil tablet 12 mg active ingredient of medications subject to disposal (general name) galantamine hydrobromide |
| 2011-700087 (■) | JP4172820 | Drugs subject to disposal (brand name) Reminil tablet 12 mg active ingredient of medications subject to disposal (general name) galantamine hydrobromide |
| 2011-700086 (○) | JP4172820 | Drugs targeted for disposal (brand name) Reminil tablet 8 mg active ingredient for medications targeted for disposal (general name) Galantamine hydrobromide |
| 2011-700086 (■) | JP4172820 | Drugs targeted for disposal (brand name) Reminil tablet 8 mg active ingredient for medications targeted for disposal (general name) Galantamine hydrobromide |
| 2011-700085 (○) | JP4172820 | Drugs targeted for disposal (brand name) Reminil tablet 4 mg active ingredient for drugs targeted for disposal (general name) Galantamine hydrobromide |
| 2011-700085 (■) | JP4172820 | Drugs subject to disposal (brand name) Reminil tablet 4 mg active ingredient of medications subject to disposal (general name) galantamine hydrobromide |
| 2011-700084 (○) | JP2921982 | Sure Post Tablets 0.5 mg (Active ingredient: Repaglinide) |
| 2011-700084 (■) | JP2921982 | Sure Post Tablets 0.5 mg (Active ingredient: Repaglinide) |
| 2011-700083 (○) | JP2921982 | Sure Post Tablet 0.25 mg (active ingredient: repaglinide) |
| 2011-700083 (■) | JP2921982 | Sure Post Tablet 0.25 mg (active ingredient: repaglinide) |
| 2011-700082 (○) | JP3113078 | 3- (2,4-Dichlorophenyl) -2-oxo-1-oxaspiro [4.5] dec-3-en-4-yl = 2,2-dimethyl butyrate |
| 2011-700082 (■) | JP3113078 | Types of Pesticides Subjected to Disposal Spirodichlorphen Water Hydrate Pesticides Subjected to Disposal Daniemon Frouble Active Substance Compounds Subjected to Disposal > 3- (2,4-dichlorophenyl) -2-oxo-1-oxaspiro [4.5] dec-3-en-4-yl = 2,2-dimethyl butyrate |
| 2011-700081 (○) | JP4077055 | Name of sale: Kogenate FS Bioset injection 2000 Common name: Oktocog Alpha |
| 2011-700081 (■) | JP4077055 | Name of sale: Kogenate FS Bioset injection 2000 Common name: Oktocog Alpha |
| 2011-700080 (○) | JP4361461 | Pioglitazone hydrochloride glimepiride (Sonias combination tablet HD) |
| 2011-700080 (■) | JP4361461 | Name of sale: Sonias combination tablet HD Active ingredient: pioglitazone hydrochloride and glimepiride |
| 2011-700079 (○) | JP4361461 | Pioglitazone hydrochloride glimepiride (Sonias combination tablet LD) |
| 2011-700079 (■) | JP4361461 | Name of sale: Sonias combination tablet LD Active ingredient: pioglitazone hydrochloride and glimepiride |
| 2011-700078 (○) | JP3256841 | Pioglitazone hydrochloride glimepiride (Sonias combination tablet HD) |
| 2011-700078 (■) | JP3256841 | Name of sale: Sonias combination tablet HD Active ingredient: pioglitazone hydrochloride and glimepiride |
| 2011-700077 (○) | JP3256841 | Pioglitazone hydrochloride glimepiride (Sonias combination tablet LD) |
| 2011-700077 (■) | JP3256841 | Name of sale: Sonias combination tablet LD Active ingredient: pioglitazone hydrochloride and glimepiride |
| 2011-700076 (○) | JP3973280 | Pioglitazone hydrochloride glimepiride (Sonias combination tablet HD) |
| 2011-700075 (○) | JP3973280 | Pioglitazone hydrochloride glimepiride (Sonias combination tablet LD) |
| 2011-700074 (○) | JP4084309 | Name of sale: Fabrik tablet 10mg, 20mg, 40mg Name of active ingredient: Febuxostat |
| 2011-700074 (■) | JP4084309 | Name of sale: Fabrik Tablet 10 mg Name of active ingredient Febuxostat |
| 2011-700073 (○) | JP3547707 | Name of sale: Fabrik Tablet 10 mg, 20 mg, 40 mg Name of active ingredient Febuxostat |
| 2011-700073 (■) | JP3547707 | Name of sale: Fabrik Tablet 10 mg Name of active ingredient Febuxostat |
| 2011-700072 (○) | JP3202607 | Name of sale: Fabrik tablet 10mg, 20mg, 40mg Name of active ingredient: Febuxostat |
| 2011-700072 (■) | JP3202607 | Name of sale: Fabrik Tablet 10 mg Name of active ingredient Febuxostat |
| 2011-700071 (○) | JP2706037 | Name of sale: Fabrik tablet 10mg, 20mg, 40mg Name of active ingredient: Febuxostat |
| 2011-700070 (○) | JP2834971 | Name of sale: Fabrik tablet 10mg, 20mg, 40mg Name of active ingredient: Febuxostat |
| 2011-700070 (■) | JP2834971 | Name of sale: Fabrik Tablet 10 mg Name of active ingredient Febuxostat |
| 2011-700069 (○) | JP2725886 | Name of sale: Fabrik Tablet 10 mg, 20 mg, 40 mg Name of active ingredient Febuxostat |
| 2011-700069 (■) | JP2725886 | Name of sale: Fabrik Tablet 10 mg Name of active ingredient Febuxostat |
| 2011-700068 (○) | JP2618596 | Drugs targeted for disposal (brand name): Wantaxotere intravenous drip 80 mg / 4 mL active ingredient for drugs targeted for disposal (General name): docetaxel hydrate |
| 2011-700068 (■) | JP2618596 | Drugs targeted for disposal (brand name): Wantaxotere intravenous drip 80 mg / 4 mL active ingredient for drugs targeted for disposal (General name): docetaxel hydrate |
| 2011-700067 (○) | JP2618596 | Drugs subject to disposal (brand name): Wantaxotere IV infusion 20 mg / 1 mL active ingredient of drug subject to disposition (General name): docetaxel hydrate |
| 2011-700067 (■) | JP2618596 | Drugs subject to disposal (brand name): Wantaxotere IV infusion 20 mg / 1 mL active ingredient of drug subject to disposition (General name): docetaxel hydrate |
| 2011-700066 (○) | JP4367829 | Drugs targeted for disposal (brand name): Wantaxotere intravenous drip 80 mg / 4 mL active ingredient for drugs targeted for disposal (General name): docetaxel hydrate |
| 2011-700065 (○) | JP4367829 | Drugs subject to disposal (marketed name): Wantaxotere IV infusion 20 mg / 1 mL Active ingredient of medications subject to disposal (General name): Docetaxel hydrate |
| 2011-700064 (○) | JP4054992 | (E) -2- (4-tert-Butylphenyl) -2-cyano-1- (1,3,4-trimethylpyrazol-5-yl) vinyl = 2,2-dimethyl propionate |
| 2011-700064 (■) | JP4054992 | Types of Pesticides: Sheenopyraphen Water Hydrating Agent Pesticide Name: Star Mite Flowable Active Ingredient Chemical Name: (E) -2- (4-tert-Butylphenyl) -2-cyano-1- (1,) 3,4-Trimethylpyrazol-5-yl) vinyl = 2,2-dimethyl propionate |
| 2011-700063 (○) | JP4246207 | Types of pesticides: Pyraclonyl Propysulfuron wettable powder Pesticide name: Megazeta flowable Active ingredient Compound: 1- (3-chloro-4,5,6,7-tetrahydropyrazolo [1,5 -A] pyridin-2-yl) -5- [methyl (prop-2-ynyl) amino] pyrazole-4-carbonitrile 1- (2-chloro-6-propylimidazo [1,2-b] pyridazine-3 -Ylsulfonyl) -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2011-700063 (■) | JP4246207 | Types of pesticides: Pyraclonyl Propylisulfuron water-dispersible powder Pesticide name: Megazeta flowable Active ingredient Compound: 1- (3-chloro-4,5,6,7-tetrahydropyrazolo [1,5 -A] pyridin-2-yl) -5- [methyl (prop-2-ynyl) amino] pyrazole-4-carbonitrile 1- (2-chloro-6-propylimidazo [1,2-b] pyridazine-3 -Ylsulfonyl) -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2011-700062 (○) | JP3682288 | Propylsulfuron granules Pesticide name: Zeta one Jumbo Active ingredient Compound: 1- (2-chloro-6-propylimidazo [1,2-b] pyridazin-3-yl sulfonyl) -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2011-700062 (■) | JP3682288 | Propylsulfuron granules Pesticide name: Zeta one Jumbo Active ingredient Compound: 1- (2-chloro-6-propylimidazo [1,2-b] pyridazin-3-ylsulfonyl) -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2011-700061 (○) | JP3682288 | Propysulfuron water-dispersible powder Name of pesticide: Zeta one flour Active ingredient Compound: 1- (2-chloro-6-propylimidazo [1,2-b] pyridazin-3-yl sulfonyl) -3 -(4,6-dimethoxypyrimidin-2-yl) urea |
| 2011-700061 (■) | JP3682288 | Propysulfuron water-dispersible powder Name of pesticide: Zeta one flour active ingredient compound: 1- (2-chloro-6-propylimidazo [1,2-b] pyridazine-3-ylsulfonyl) -3 -(4,6-dimethoxypyrimidin-2-yl) urea |
| 2011-700060 (○) | JP4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2011-700060 (■) | JP4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2011-700059 (○) | JP4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2011-700059 (■) | JP4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2011-700058 (○) | JP4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2011-700058 (■) | JP4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2011-700057 (○) | JP4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2011-700057 (■) | JP4088036 | 3,4-Dichloro-2'-cyano-1,2-thiazole-5-carboxanilide |
| 2011-700056 (○) | JP3504667 | 1-Methylcyclopropene fumigant |
| 2011-700056 (■) | JP3504667 | Name of Pesticide: Smart Fresh Fumigant Active Ingredient: 1-Methylcyclopropene |
| 2011-700055 (○) | JP4524502 | Active ingredient name: imidafenacin trade name: Uritos OD tablet 0.1 mg chemical name: 4- (2-methyl-1H-imidazol-1-yl) -2,2-diphenyl tanamide |
| 2011-700055 (■) | JP4524502 | Active ingredient name: imidafenacin trade name: Uritos OD tablet 0.1 mg chemical name: 4- (2-methyl-1H-imidazol-1-yl) -2,2-diphenylbutanamide |
| 2011-700054 (○) | JP3113078 | 3-mesityl-2-oxo-1-oxaspiro [4.4] non-3-en-4-yl = 3,3-dimethyl butyrate |
| 2011-700054 (■) | JP3113078 | 3-mesityl-2-oxo-1-oxaspiro [4.4] non-3-en-4-yl = 3,3-dimethyl butyrate |
| 2011-700053 (○) | JP3113078 | 3-mesityl-2-oxo-1-oxaspiro [4.4] non-3-en-4-yl = 3,3-dimethyl butyrate |
| 2011-700053 (■) | JP3113078 | Types of Pesticides Subject to Disposal Akrinathrin / Spiromeshifene Water Hydrate Pesticides Subject to Disposal Clearol Wetting Agent Pesticides Subject to Disposition Active ingredient compound 3-mesityl-2-oxo-1-oxaspiro [4.4] non-3-en-4-yl = 3,3-dimethyl butyrate |
| 2011-700052 (○) | JP2994182 | Flonicamid |
| 2011-700052 (■) | JP2994182 | Flonicamid |
| 2011-700051 (○) | JP3632947 | Pyrimisulfan |
| 2011-700051 (■) | JP3632947 | Pesticide name: Best partner jumbo active ingredient: (general name) pyrimisulfan chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) (hydroxy) Methyl] -1,1-Difluoro-6 '-(methoxymethyl) methanesulfonanilide |
| 2011-700050 (○) | JP3632947 | Pyrimisulfan |
| 2011-700050 (■) | JP3632947 | Pesticide name: Myway Zero 1 kg granules Active ingredient: (general name) pyrimisulfan Chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl ) (Hydroxy) methyl] -1,1-difluoro-6 '-(methoxymethyl) methanesulfonanilide |
| 2011-700049 (○) | JP3632947 | Pyrimisulfan |
| 2011-700049 (■) | JP3632947 | Pesticide name: Myway Jumbo Active ingredient: (general name) pyrimisulfan Chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) (hydroxy) Methyl] -1,1-Difluoro-6 '-(methoxymethyl) methanesulfonanilide |
| 2011-700048 (○) | JP3632947 | Pyrimisulfan |
| 2011-700048 (■) | JP3632947 | Pesticide name: Myway beans 250 Active ingredient: (general name) pyrimisulfan chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) ( Hydroxy) methyl] -1,1-difluoro-6 '-(methoxymethyl) methanesulfonanilide |
| 2011-700047 (○) | JP3632947 | Pyrimisulfan |
| 2011-700047 (■) | JP3632947 | Pesticide name: Yiba mash 250 Active ingredient :: (general name) pyrimisulfan Chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) ( Hydroxy) methyl] -1,1-difluoro-6 '-(methoxymethyl) methanesulfonanilide |
| 2011-700046 (○) | JP3632947 | Pyrimisulfan |
| 2011-700046 (■) | JP3632947 | Pesticide name: Yaiba jumbo active ingredient: (general name) pyrimisulfan chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) (hydroxy) methyl ] 1,1-Difluoro-6 '-(methoxymethyl) methanesulfonanilide |
| 2011-700045 (○) | JP3632947 | Pyrimisulfan |
| 2011-700045 (■) | JP3632947 | Pesticide name: Myway 1 kg granules active ingredient :: (general name) pyrimisulfan chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl] ) (Hydroxy) methyl] -1,1-difluoro-6 '-(methoxymethyl) methanesulfonanilide |
| 2011-700044 (○) | JP3632947 | Pyrimisulfan |
| 2011-700044 (■) | JP3632947 | Pesticide name: Best partner bean curd 250 Active ingredient: (general name) pyrimisulfan chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) ( Hydroxy) methyl] -1,1-difluoro-6 '-(methoxymethyl) methanesulfonanilide |
| 2011-700043 (○) | JP3632947 | Pyrimisulfan |
| 2011-700043 (■) | JP3632947 | Pesticide name: Yaiba 1 kg granules Active ingredient: (general name) pyrimisulfan chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) ( Hydroxy) methyl] -1,1-difluoro-6 '-(methoxymethyl) methanesulfonanilide |
| 2011-700042 (○) | JP3632947 | Pyrimisulfan |
| 2011-700042 (■) | JP3632947 | Pesticide name: Best partner 1 kg granules Active ingredient: (general name) pyrimisulfan Chemical name: (RS) -2 '-[(4,6-dimethoxypyrimidin-2-yl) (Hydroxy) methyl] -1,1-difluoro-6 '-(methoxymethyl) methanesulfonanilide |
| 2011-700041 (○) | JP2866744 | Name of sale: Nevanak suspension eye drop 0.1% |
| 2011-700041 (■) | JP2866744 | General name: Nepafenac (brand name: Nevanac suspension ophthalmic solution 0.1%) |
| 2011-700040 (○) | JP4612414 | Erthrombopag olamine |
| 2011-700040 (■) | JP4612414 | Erthrombopag olamine |
| 2011-700039 (○) | JP4612414 | Erthrombopag olamine |
| 2011-700039 (■) | JP4612414 | Erthrombopag olamine |
| 2011-700038 (○) | JP4426727 | Ingredient name: exenatide |
| 2011-700038 (■) | JP4426727 | Ingredient name: exenatide |
| 2011-700037 (○) | JP4426727 | Ingredient name: exenatide |
| 2011-700037 (■) | JP4426727 | Ingredient name: exenatide |
| 2011-700036 (○) | JP4404181 | Adalimumab (genetically modified) |
| 2011-700036 (■) | JP4404181 | Adalimumab (genetically modified) |
| 2011-700035 (○) | JP4404181 | Adalimumab (genetically modified) |
| 2011-700035 (■) | JP4404181 | Adalimumab (genetically modified) |
| 2011-700034 (○) | JP3861118 | Adalimumab (genetically modified) |
| 2011-700034 (■) | JP3861118 | Adalimumab (genetically modified) |
| 2011-700033 (○) | JP3861118 | Adalimumab (genetically modified) |
| 2011-700033 (■) | JP3861118 | Adalimumab (genetically modified) |
| 2011-700032 (○) | JP4500679 | Drugs subject to disposal (brand name) Invega Tablets 9 mg active ingredients of drug subject to disposal (general name) paliperidone |
| 2011-700032 (■) | JP4500679 | Drugs subject to disposal (brand name) Invega Tablets 9 mg active ingredients of drug subject to disposal (general name) paliperidone |
| 2011-700031 (○) | JP4500679 | Drugs subject to disposal (brand name) Invega 6 mg active ingredient of medications subject to disposal (general name) paliperidone |
| 2011-700031 (■) | JP4500679 | Drugs subject to disposal (brand name) Invega 6 mg active ingredient of medications subject to disposal (general name) paliperidone |
| 2011-700030 (○) | JP4500679 | Drugs subject to disposal (brand name) Invega Tablet 3 mg active ingredient of medications subject to disposal (general name) paliperidone |
| 2011-700030 (■) | JP4500679 | Drugs subject to disposal (brand name) Invega Tablet 3 mg active ingredient of medications subject to disposal (general name) paliperidone |
| 2011-700029 (○) | JP4597237 | Active Ingredient: Peramivir Hydrate Application: Children |
| 2011-700028 (○) | JP4597237 | Active Ingredient: Peramivir Hydrate Application: Children |
| 2011-700027 (○) | JP4262920 | Active Ingredient: Peramivir Hydrate Application: Children |
| 2011-700026 (○) | JP4262920 | Active Ingredient: Peramivir Hydrate Application: Children |
| 2011-700025 (○) | JP4102022 | Active Ingredient: Peramivir Hydrate Application: Children |
| 2011-700024 (○) | JP4102022 | Active Ingredient: Peramivir Hydrate Application: Children |
| 2011-700023 (○) | JP3856816 | Pregabalin (general name) |
| 2011-700023 (■) | JP3856816 | Pregabalin (general name) |
| 2011-700022 (○) | JP3856816 | Pregabalin (general name) |
| 2011-700022 (■) | JP3856816 | Pregabalin (general name) |
| 2011-700021 (○) | JP3856816 | Pregabalin (general name) |
| 2011-700021 (■) | JP3856816 | Pregabalin (general name) |
| 2011-700020 (○) | JP4277904 | Vesicare ROD tablet 2.5 mg, Vesicare ROD tablet 5 mg (Solifenacin succinate as active ingredient) |
| 2011-700020 (■) | JP4277904 | Vesicare ROD Tablets 5 mg (Solifenacin Succinate as Active Ingredient) |
| 2011-700019 (○) | JP3122141 | Vesicare ROD tablet 2.5 mg, Vesicare ROD tablet 5 mg (Solifenacin succinate as active ingredient) |
| 2011-700019 (■) | JP3122141 | Vesicare ROD Tablets 5 mg (Solifenacin Succinate as Active Ingredient) |
| 2011-700018 (○) | JP3014457 | Vesicare ROD tablet 2.5 mg, Vesicare ROD tablet 5 mg (Solifenacin succinate as active ingredient) |
| 2011-700017 (○) | JP2527860 | Zyprexa Zydis tablet 10 mg (active ingredient: olanzapine) |
| 2011-700017 (■) | JP2527860 | Zyprexa Zydis Tablet 10 mg (Active ingredient: Olanzapine) |
| 2011-700016 (○) | JP2527860 | Zyprexa Zydis tablet 5 mg (active ingredient: olanzapine) |
| 2011-700016 (■) | JP2527860 | Zyprexa Seidis Tablets 5 mg (Active ingredient: Olanzapine) |
| 2011-700015 (○) | JP2527860 | Zyprexa Tablets 10 mg (Active Ingredient: Olanzapine) |
| 2011-700015 (■) | JP2527860 | Zyprexa Tablets 10mg (Active Ingredient: Olanzapine) |
| 2011-700014 (○) | JP2527860 | Zyprexa Tablets 5mg (Active Ingredient: Olanzapine) |
| 2011-700014 (■) | JP2527860 | Zyprexa Tablets 5mg (Active Ingredient: Olanzapine) |
| 2011-700013 (○) | JP2527860 | Zyprexa tablet 2.5 mg (active ingredient: olanzapine) |
| 2011-700013 (■) | JP2527860 | Zyprexa Tablets 2.5 mg (active ingredient: olanzapine) |
| 2011-700012 (○) | JP2527860 | Zyprexa fine granules 1% (active ingredient: olanzapine) |
| 2011-700012 (■) | JP2527860 | Zyprexa fine grain 1% (active ingredient: olanzapine) |
| 2011-700011 (○) | JP4493003 | Minclear internal spray liquid 0.8% (brand name) |
| 2011-700011 (■) | JP4493003 | Minclear internal spray liquid 0.8% (L-menthol) |
| 2011-700010 (○) | JP4459167 | Minclear internal spray liquid 0.8% (brand name) |
| 2011-700010 (■) | JP4459167 | Minclear internal spray liquid 0.8% (L-menthol) |
| 2011-700009 (○) | JP4493018 | Minclear internal spray liquid 0.8% (brand name) |
| 2011-700009 (■) | JP4493018 | Minclear internal spray liquid 0.8% (L-menthol) |
| 2011-700008 (○) | JP4099622 | Common name: Pirifluquinazone |
| 2011-700008 (■) | JP4099622 | Common name: Pirifluquinazone |
| 2011-700007 (○) | JP4484023 | 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N-dimethyl-1,2,4-triazole-1-sulfonamide |
| 2011-700007 (■) | JP4484023 | Types of Pesticides: Amisulbroam Water Repellent Name of Pesticides: Lymei Flowable Active Ingredient Chemical Name: 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N-dimethyl- 1,2,4-triazole-1-sulfonamide |
| 2011-700006 (○) | JP4438919 | 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N-dimethyl-1,2,4-triazole-1-sulfonamide |
| 2011-700006 (■) | JP4438919 | 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N-dimethyl-1,2,4-triazole-1-sulfonamide |
| 2011-700005 (○) | JP4092591 | 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N-dimethyl-1,2,4-triazole-1-sulfonamide |
| 2011-700005 (■) | JP4092591 | Types of Pesticides: Amisulblom Hydrating Agent Name of Pesticide: Oracle Granulating Water Repellent Active Ingredient Chemical Name: 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl)- N, N-Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2011-700004 (○) | JP3693258 | Pregabalin (brand name: Lyrica Capsule 150 mg) |
| 2011-700004 (■) | JP3693258 | Pregabalin (brand name: Lyrica Capsule 150 mg) |
| 2011-700003 (○) | JP3693258 | Pregabalin (brand name: Lilyca Capsule 75 mg) |
| 2011-700003 (■) | JP3693258 | Pregabalin (brand name: Lilyca Capsule 75 mg) |
| 2011-700002 (○) | JP3693258 | Pregabalin (brand name: Lyrica Capsule 25 mg) |
| 2011-700002 (■) | JP3693258 | Pregabalin (brand name: Lyrica Capsule 25 mg) |
| 2011-700001 (○) | JP3000240 | Methyl = (E) -methoxyimino-{(E) -α- [1- (α, α, α-trifluoro-m-tolyl) ethylideneaminooxy] -o-tolyl acetate |
| 2011-700001 (■) | JP3000240 | Methyl = (E) -methoxyimino-{(E) -α- [1- (α, α, α-trifluoro-m-tolyl) ethylideneaminooxy] -o-tolyl acetate |
